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Abstract
A successful humoral immune response requires reciprocal signaling between T helper 
cells and B cells. Tlie first signal is antigen specific and is mediated by the interaction 
between the T cell receptor and antigen in association with major histocompatibility 
complex on B cells. The subsequent signals are provided by the costimulatory molecules 
CD40 and CD28 and their respective ligands. CD40L which is expressed on activated T 
helper cells interacts with CD40 on B cells providing the essential signal for thé induction 
of B cell activation and immunoglobulin -production. The importance of the CD40- 
CD40L interaction has been shown in patients suffering from X-linked 
immunodeficiency with hyper-IgM (HIGMl). The disease is characterized by the 
inability of B cells to undergo immunoglobulin isotype switching. Affected males 
experience recurrent infections and most infections are of bacterial origin, but HIGMl 
patients are also unusually susceptible to infections with opportunistic pathogens and 
often suffer from Pneumocystis carinii pneumonia and Cryptosporidium intestinal 
infection. Mutations in CD40L molecules are responsible for hyper IgM syndrome in 
humans.
To study the role of the CD40-CD40L interaction in vivo and to derive an animal model 
for HIGMl, I generated CD40 deficient mice using homologous recombination in 
embryonic stem (ES) cells. A targeting vector was constructed using an 8  kb CD40 
genomic fragment. The G418 resistance gene (NEC) was inserted into the 3rd exon to 
disrupt the CD40 gene and to allow selection. The targeting vector was transfected into 
ES cells and G418 resistant clones were isolated - and screened for homologous 
recombination by Southern blot analysis. Chimaeric mice were generated by injection of 
targeted ES cell clones into blastocysts. Germline transmission was obtained and 
heterozygous mutant mice hred to generate CD40 deficient mice.
Flow cytometric analysis of lymphocytes in CD40 deficient mice revealed normal 
development of B and T lymphocytes. CD40 deficient mice were immunized with KLH
and assessed for germinal centre formation. CD40 deficient mice did not generate 
germinal centres. Analysis of serum immunoglobulin levels showed that CD40 deficient 
mice displayed reduced levels of isotype switched immunoglobulins compared to wild- 
type mice. These results confirm the crucial role of the CD40-CD40L interaction in 
humoral immunity.
CD40 is also expressed on other antigen presenting cells and the involvement of the 
CD40-CD40L interaction in cell-mediated immunity was determined in CD40 deficient 
mice infected with Mycobacterium Bovis (BCG). Although CD40 deficient mice 
survived mycobacterial infection, the increased numbers of bacilli in spleen and lungs 
and the reduced production of IFN-y in response to mycobacterial infection indicates that 
CD40 deficient mice are more susceptible to infection with BCG than control mice.
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1: Introduction
Chapter 1 : Introduction
1.1 Acquired immune responses
The immune system can be divided into innate and acquired inununity. The effectors of 
innate immunity consists of non-specific activities of complement, natural killer cells and 
different phagocytic cells. In contrast, acquired, or specific, immunity is capable of 
recognizing and selectively eliminating foreign microorganisms and molecules. It 
displays specificity, diversity, memory and self/nonself recognition. Specific immunity 
can be divided into humoral and cell-mediated immunity. The humoral branch of the 
immune system involves B lymphocytes which recognize whole antigen via cell-surface 
immunoglobulin receptors. Antigen uptake and processing by B lymphocytes via surface 
immunoglobulin, is followed by presentation on MHC class II and interaction with T 
helper cells. This subsequently leads to proliferation and differentiation of B 
lymphocytes into antibody-secreting plasma cells and memory cells. Cell-mediated 
immunity involves both T-cytotoxic (Tc) and T-helper (Th) lymphocytes, and, in 
contrast to B lymphocytes, T lymphocytes only recognize antigen in association with 
MHC class I and II via surface T cell receptors. Activation of T helper cells via their T 
cell receptors requires presentation of antigen in association with MHC class II on 
antigen presenting cells (APCs), such as B cells, dendritic cells and macrophages. These 
cognate interactions lead to secretion of cytokines which aid in the activation of antigen 
specific cytotoxic T cells.
The interaction between the T cell receptor (TCR) and antigen in association with MHC 
class n  on B cells is the first step in the mutual activation of antigen specific T and B 
cells. In order to complete this mutual activation several costimulatory molecules are 
needed. The most important receptor-ligand molecules on T and B cells are CD40-CD40 
Ligand, and CD28/CTLA-4-CD80/CD86.
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1.2 Identification of ceiis required for induction of humoral 
immunity
Experiments performed in the 1960s and 1970s demonstrated that different types of cells 
must cooperate to generate a humoral immune response. Before B and T cells were 
defined, evidence that distinct subpopulations of cells were required to generate an 
antibody response came from adoptive-transfer experiments done by Henry Claman and 
co-workers. In the these experiments, irradiated mice were reconstituted with either 
syngeneic thymus cells alone, or bone marrow cells alone, or spleen cells alone, or with 
a mixture of thymus and bone marrow cells. The mice were then immunized with 
SRBCs (Sheep Red Blood Cells) and the ability of these reconstituted mice to produce 
antibodies against SRBCs was tested in a hemolytic plaque assay. Mice reconstituted 
with thymus cells alone had only a slight restoration in their ability to produce anti-SRBC 
antibodies, and mice reconstituted with bone marrow cells alone failed to produce anti- 
SRBC antibodies. However, mice reconstituted with both thymus and bone marrow cells 
gave a response as good as mice reconstituted with spleen cells (Claman et a l, 1966; 
Claman et a l, 1967). These experiments demonstrated that both thymus and bone 
marrow cells were necessary for the induction of the humoral response.
Claman’s experiments showed that both thymus and bone marrow cells were necessary 
to generate a humoral antibody response, but they did not identify which population of 
cells produced antibodies. The importance of an intact thymus, for the antibody response 
to SRBC, was shown by performing neonatal thymectomy in mice. Neonatal 
thymectomy in mice reduced the ability to make antibodies against SRBC to about 5-10 
percent of the normal response. This defect could be corrected in the adult mice by 
injection of either thymus cells or thoracic-duct cells, but not by bone marrow cells 
(Miller er a/., 1968). Mitchell and J. F. A. P. Miller (1968) subsequently demonstrated 
that bone marrow cells were the source of antibody producing cells. Irradiated and 
thymectomized mice were reconstituted with various populations of cells and immunized 
with SRBC, after which the spleen cells were assayed for plaque formation in response
1: Introduction
to SRBC. Instead of thymus cells, thoracic-duct lymphocytes were used as an enriched 
source of T cells. These experiments showed that the thoracic-duct cells and bone 
marrow cells in combination could generate the antibody response, confirming Claman’s 
findings. They then went one step further to identify the antibody-producing population 
by repeating the experiment with thoracic-duct lymphocytes and bone marrow cells of 
different MHC haplotypes. CBA (H-2'') mice were thymectomized and irradiated and 
reconstituted with CBA (H-2*') bone marrow cells. Two weeks later, these mice were 
injected with (CBA x C57BL/6)F1 thoracic-duct cells (H-2‘^ ) and SRBCs. Five days 
later the spleens of the reconstituted mice were removed and tested for the presence of 
cells producing antibodies against SRBC. By treating the spleen cells with antibody to 
the H-2‘" or H-2*’ MHC, it was possible to deplete the two populations selectively and 
determine the effect of each depletion on the antibody response to SRBC. Depletion of 
H-2'' cells removed both populations and abolished the antibody response to SRBC. 
However, removal of H-2*’ thoracic-duct cells did not affect the response. These results 
demonstrated that the bone marrow cells provided the antibody-forming cells (now 
known as B cells) and that the thoracic-duct cells provided T helper cells for generating 
the humoral response.
Further proof of the existence of two interacting subsets of lymphocytes involved in 
antibody production was provided by experiments using hapten-carrier conjugates which 
enabled immunologists to determine that the generation of a humoral antibody response 
required the associative recognition by T helper cells and B cells, each recognizing 
different epitopes on the same antigen (Rajewsky et al. 1969, Mitchison et al. 1971, Katz 
et al. 1970). One of the earliest findings with hapten-carrier conjugates was that a hapten 
(small organic compound) had to be chemically coupled to a carrier (protein) molecule to 
induce an antibody response to the hapten. A second important observation was that in 
order to generate a secondary antibody response to a hapten, the animal had to be 
immunized with the same hapten-carrier conjugate used for the primary immunization. If 
the secondary immunization was with the same hapten but conjugated to a different
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unrelated carrier, no secondary anti-hapten antibody response occurred. Thus, even 
though the animal was seeing the hapten for the second time, it was only able to 
recognize the hapten when coupled to the same carrier. This phenomenon is called the 
carrier effect. The carrier effect could be circumvented by immunizing the animal 
separately with the unrelated carrier. For example, the animal was immunized with DNP- 
OVA (day 0) and then immunized with BGG (unrelated carrier, day 7) and finally 
immunized with DNP-BGG (DNP-unrelated carrier, day 28). The secondary anti-DNP 
antibody response was now as high as if the animal had been immunized with DNP- 
OVA on day 0 and day 28 with an intermediate immunization of OVA (day 7) (Rajewsky 
et ai, 1969, Katz et ai, 1970). The carrier effect was also demonstrated in an adoptive- 
transfer model (Mitchison 1971a, Paul et al., 1970). Mice were immunized with NIP- 
CGG and spleen cells from these mice (donors) were injected into irradiated syngeneic 
recipients. These recipients were then immunized with NIP-CGG (homologous 
conjugate) or NIP-BSA (heterologous conjugate) and the anti-NIP antibody response 
was measured. An anti-NIP antibody response was only elicited if the recipients were 
immunized with the homologous conjugate (NIP-CGG). Mitchison (1971b) also showed 
that the injection of spleen cells obtained from mice immunized with BSA (carrier- 
primed) together with spleen cells from mice immunized with NIP-OVA (hapten-primed) 
into irradiated syngeneic recipients immunized with NIP-BSA elicited an anti-hapten 
antibody response, thereby bypassing the carrier specificity of the primary NIP-OVA 
immunization. These results demonstrated that carrier-primed cells could be raised 
independently of hapten-primed cells (i.e. carrier-primed and hapten-primed cells are 
distinct populations) and that carrier-primed cells could interact with hapten-primed cells 
(in the recipient) raised independently of the carrier-primed cells. By repeating the 
adoptive-transfer experiment described above, using an allotype marker on carrier- 
priiiicd cells, Mitchison demonstiated that carrier-primed cells (BSA-primed) did not 
produce an anti-hapten antibody (Mitchison, 1971b). Thus, the carrier-primed cells 
appeared to serve only as helpers and not as precursors of the anti-hapten antibody 
forming cells. Adoptive transfer experiments investigating the effect of anti-T-cell
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antiserum and complement treatment of carrier-primed cells or hapten-primed cells, 
revealed that the secondary anti-hapten antibody response was inhibited if carrier-primed 
cells were treated with anti-T-cell antiserum and complement, whereas treatment of 
hapten-primed cells had no effect on the anti-hapten antibody response. This provides 
further evidence that carrier-primed cells (helper cells) are thymus-derived cells while the 
anti-hapten producing cells are thymus independent (marrow-derived) (Raff, 1970, 
Mitchison, 1970c).
These experiments concerning thymus-bone marrow interactions and hapten-carrier 
conjugates led to the concept that two types of lymphocytes cooperate in the induction of 
an antibody response. As induction of an antibody response required the hapten to be 
chemically coupled to the carrier molecule it was assumed that antigen (hapten-carrier 
conjugate) was recognized by two specific receptors, one on the B cell and one on the T 
helper cell. This cellular cooperation hypothesis envisioned a B cell binding to the hapten 
and a T helper cell binding to carrier epitopes, with the hapten-carrier conjugate bridging 
the two cells, which would then lead to activation of the B cell (Mitchison, 1971b; 
Rajewsky, 1971). The discovery of MHC restriction between T helper cells and B cells 
(described below) meant that the cellular cooperation hypothesis was not sufficient and 
that any model of T-B cell interaction had to include a role for MHC class II molecules. 
The current model of T-B cell cooperation in the generation of antibody responses to 
protein antigens and hapten-protein conjugates involves presentation of peptides in 
association with MHC class II molecules. Antigen specific B cells bind the hapten- 
protein conjugate (via the hapten determinant) on membrane Ig molecules. After binding, 
the hapten-protein conjugate is internalized, processed in an endosomal pathway and 
peptides are presented to T helper cells in association with MHC class II molecules on 
the surface of the B cell. A T helper cell then recognize the processed peptide in 
association with MHC class II molecules via the T cell receptor and B cell activation 
results from interaction between molecules on the surface of the T and B cell, and by 
cytokines released by the T cells.
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The use of hapten-carrier systems enabled Katz and co-workers (Katz et a l,  1973) to 
show that carrier-primed T cells could only cooperate with hapten-primed B cells, if the 
T and B cells had identical MHC haplotypes. Adoptive transfer of BGG-primed T cells 
from strain A (H-2“) into an (A x B)F1 (H-2*^) recipient, followed by the transfer of 
DNP-KLH-primed B cells derived from strain A (H-2“) or from strain B (H-2*’). The 
recipient mice were then immunized with DNP-BGG, and the secondary response to 
DNP was measured. One complication which initially made the experiment unworkable 
was the allogeneic effect. The transferred strain A T cells recognized the strain B 
allogeneic MHC antigens of the FI recipient as foreign and could potentially activate the 
host B cells nonspecifically. This problem was solved by irradiating the (A x B)F1 
recipient after transfer of the BGG-primed strain A T cells. The irradiation eliminated 
unprimed alloreactive T cells whereas primed T cells, which were less susceptible to 
irradiation, survived. Strain A (H-2") or strain B (H-2**) B cells from DNP-KLH-primed 
mice were now transferred into the FI recipient, and the secondary response to DNP was 
measured. The results revealed that carrier-primed T helper cells with haplotype H-2" 
could only assist hapten-primed B cells in generating an anti-DNP antibody response if 
the B cells shared the same MHC haplotype (H-2"). Subsequent experiments using 
congenic H-2 mouse strains revealed that the portion of the H-2 complex which was 
crucial for the interaction between carrier and hapten-primed cells involved the I region, 
now known to code for MHC class B genes (Katz et al, 1974).
The discovery of monoclonal antibodies produced by hybridomas (Kohler et a l, 1975) 
allowed the identification and analysis of lymphocyte populations expressing different 
membrane proteins. These surface proteins were initially recognized as markers for 
lymphocytes subpopulations, but further analysis revealed that they also played 
important roles in the effector functions of these cells (The Leucocyte Antigen Facts 
Book, Barclay e ta l,  1997).
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1.3 Reciprocal signaling between T helper cells and B cells
The critical role of CD4* T helper cell activity for B cell activation and function became 
apparent when it was shown that direct physical interaction between T cells and B cells 
was necessary, since B cells proliferated when co-cultured with mitogen activated T 
cells, but not when cultured with the supernatant from these activated T cells (Clement et 
al., 1984). The use of membranes from activated T cells could replace whole activated T 
cells, and induce B cell proliferation (Brian, 1988). Suggesting that membrane molecules 
on activated T cells interacted directly with membrane molecules expressed on B cells, in 
order to induce B cell proliferation. The critical role of CD40 was later confirmed when 
activated T cells were rendered incapable of inducing B cell proliferation, due to the 
inhibitory effect of a soluble CD40-Ig molecule. The ligand on T helper cells was found, 
by use of the soluble CD40-Ig, to be expressed only on activated T helper cells (Noelle et 
al., 1992).
In addition to the CD40-CD40L interaction, another T and B cell receptor/ligand 
interaction has been found to be important for the mutual regulation of T and B cells. 
This involves CD28/CTLA-4 which is expressed on T cells and CD80/CD86 which is 
expressed on B cells (Lenschow et al., 1996).
Interactions between T and B cells must be regulated in order to prevent activation of 
self-reactive or bystander cells and experiments have shown that, to initiate activation of 
antigen specific T and B cells, distinct signals are required. The first signal is antigen 
specific and is mediated by the interaction between the T cell receptor/CD3 complex and 
antigen bound on MHC class II expressed by B cells. This induces the expression of 
CD40L on T cells. CD40L then interacts with CD40 which then upregulates the 
expression of CD80 and CD8 6  on the B cell. The T cell receives a signal through CD28 
mediated by the upregulated expression of CD80 and CD8 6  on the B cell. CD80/CD86 
interacting with CTLA-4, on the T cell, is thought to be a negative regulator of T cell 
activation. The activated T cell starts to secret cytokines, which further induces the
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upregulation of CD80/CD86 on the B cell. The final result is fully activated antigen 
specific T and B cells (Clark & Ledbetter, 1994; Durie et al., 1994; Lenschow et al., 
1996). Another possible sequence of events after the initial interaction between the T cell 
receptor/CD3 complex and antigen bound on MHC class H, is that CD80/CD86 binds to 
CD28/CTLA-4. This induces the upregulation of CD40L on the T cell and CD40L would 
then signal through CD40, inducing CD80/CD86 upregulation of expression, which 
would then result in amplification of the T cell response (Hollenbaugh et a i, 1994)
Experimental evidence that supports the two models described above is presented here. 
The presence of CD40 and MHC class II on resting B cells, or the T cell receptor/CD3 
complex and CD28 on T cells is insufficient to initiate mutual activation (Fuchs & 
Matzinger, 1992). Antibodies that cross-link CD3, resembling activation through TCR, 
induce expression of CD40L (Roy etal., 1993) which then interact with CD40 on the B 
cell. CD40 cross-linking induces the expression of CD80 (Ranheim & Kipps, 1993) and 
CD8 6  (Azuma et a i, 1993) on the B cell. In vitro studies on the regulation of CD40L 
were carried out using pigeon cytochrome C (PCC) TCR transgenic T cells. (Roy et a i,  
1995). In the presence of antigen presenting cells (APC), the addition of PCC induced 
CD40L expression on the T cells, an effect which could be inhibited by the addition of 
antibodies to MHC class H, CD4 or LFA-1. Antibodies that blocked CD80, CD8 6  and 
CTLA-4-Ig did not interfere with the PCC-induced upregulation of CD40L. As a result 
of PCC-induced upregulation of CD40L, B cells were induced to upregulate both CD80 
and CD8 6 . The upregulation of CD80 and CD8 6  could be blocked by an anti-CD40L 
mAB. These results suggest that interaction between the T cell receptor/CD3 complex 
and antigen bound on MHC class II induces the expression of CD40L and that 
costimulation by the CD80-CD28 interaction is not required for the expression of 
CD40L. This is in contrast to the findings that human T cells activated by mAb to the 
TCR/CD3 complex require a CD80-CD28 signal for the upregulation of CD40L (de et 
a l,  1993).
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The models for mutual activation of T and B cells described above are obviously very 
simplified models. CTLA-4 has a higher affinity for CD80/86 than CD28 and the 
addition of anti-CTLA-4 mAh to in vitro model systems of T cell activation generally 
leads to increased T cell proliferation, indicating that CTLA-4 is a negative regulator of T 
cell activation. This is confirmed by experiments showing that CTLA-4 deficient mice die 
at 2-4 weeks of age due to uncontrolled lymphocyte proliferation (Lenschow et al., 1996; 
Linsley & Golstein, 1996; Waterhouse et al., 1995). Adhesion molecules, such as 
CDl la/18-CD54 (LFA-l-ICAM-1), are also required for the interaction between T and B 
cells to occur (Barrett et a i, 1991). This reciprocal signaling may occur in the peripheral 
lymphoid T cell area, where CD40L^ T cells have been identified in both mice and 
humans, or in the light zones of germinal centres, where CD40L^ T cells have also been 
found (Lederman et a l, 1992a; Van et a l, 1993).
The central role of CD40L in initiating the clonal expansion and differentiation of B cells 
into antibody forming cells and memory cells is important, but it is equally important that 
B cells mature into “competent” antigen presenting cells by expressing high levels of 
costimulatory molecules (CD80/CD86), thereby inducing maximal T cell activation and 
cytokine production.
1.4 Structure of CD40 and cellular distribution
CD40 is a member of the tumor necrosis factor receptor (TNFR) family of receptors that 
include TNFRl, TNFR2, nerve growth factor receptor (NGFR), CD30, CD27, Fas and 
others. Members of the TNF receptor family are type-I membrane proteins and have a 
characteristic repeating extracellular cysteine-rich domain (Beutler & van, 1994). CD40 
is a 50 kDA protein that was first identified in 1986 by monoclonal antibodies which 
were found to induce proliferation in B cells (Clark & Ledbetter, 1986; Ledbetter et a l ,  
1987). A human cDNA clone encoding CD40 was isolated and it was found to encode a 
type-I membrane protein of 277 amino acids. Type-I membrane proteins are 
characterized by having the C-terminal part of the protein on the intracellular side of the
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membrane and the N-terminal part of the protein on the extracellular side of the 
membrane. The amino terminal region contains a 19 amino acid hydrophobic signal 
peptide, followed by a 193 amino acid extracellular domain including 22 cysteine 
residues and two potential N-linked glycosylation sites. The transmembrane part of 
CD40 consists of 22 hydrophobic residues and the cytoplasmic domain a 62 amino acids 
(Stamenkovic etal., 1989).
A cDNA encoding murine CD40 has also been isolated. A comparison of the amino acid 
sequence of human and murine CD40 showed some differences. The murine CD40 
protein contains a 21 amino acid amino terminal signal peptide, a 172 amino acid 
extracellular domain, a 22 amino acid hydrophobic transmembrane domain and a 90 
amino acid cytoplasmic domain. The extracellular domain of murine CD40 contains 23 
cysteine residues, 2 2  of which are conserved with respect to the human sequence and 
one N-linked glycosylation site which is shared with the human sequence. Overall, it 
was found that the extracellular human and murine domains are 62 % identical while the 
cytoplasmic domains are 78 % identical (Torres & Clark, 1992). Chromosomal mapping 
of the human and murine CD40 has shown that the human gene is located on 
chromosome 20 (Ramesh et al., 1993) whilst the murine gene is located on chromosome 
2 (Grimaldi et al., 1992). Analysis of the murine CD40 genomic structure revealed the 
presence of 9 exons spanning a region of 16 kb (Grimaldi et al., 1992).
CD40 is constitutively expressed on many cells including B cells, macrophages, 
follicular dendritic cells, thymic epithelium, endothelial cells and Langerhans cells 
(Alderson etal., 1993; Caux e ta l,  1994; Clark, 1990; Galy & Spits, 1992; Hollenbaugh 
e ta l ,  1995; Karmann et a l,  1995). This molecule plays a central role in both T and B 
cell activation. Studies show that activating human dendritic cells in vitro with TNF-a or 
soluble CD40L antibody increase their surface expression of CD40, CD80, CD54 and 
MHC class n  two- to three-fold, suggesting that maturation of dendritic cells to become 
“effective” antigen presenting cells requires increased surface expression of CD40. Not 
only does the surface expression of CD40 increase, but it seems that further signals
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through CD40 are required for DC’s to become fiilly effective (Sallusto & Lanzavecchia, 
1994). CD40 has also been reported to be expressed by human B cells in a soluble form, 
indicating that signaling to B cells through CD40 might be regulated by secretion of a 
soluble form of CD40 (van et al., 1994b). It has been suggested that CD40L binds to 
CD40 which is expressed at very low levels on T cells. CD4* T cells appear to respond 
to this CD40L cross-linking by proliferation and secretion of IFN-y, TNF-a and IL-2 
(Armitage era/., 1993).
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Figure 1. TNF and TNF receptor superfamilies. The receptors CD40, TNFR I and II, CD95, 
CD 134, CD 137, CD27 and CD30 are all type I membrane proteins containing cysteine-rich 
repeats (Tr). The ligands, shown here as trimers, are type II membrane proteins. Trimer 
domain (T). Potential N-linked glycosylation sites are shown as ball on stick. (Figure taken 
from Immunology Today, October 1997).
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1.5 Structure and expression of CD40 ligand
The ligand for CD40, CD40 ligand, is a member of the tumor necrosis factor (TNF) gene 
family, and was identified using monoclonal antibodies. Monoclonal antibodies were 
selected on the basis of their ability to block T cell induced B cell proliferation. This led 
to the identification of two antibodies, an anti-human antibody (5c8) (Lederman et al., 
1992b) and an anti-murine antibody (MR 1 ) (Noelle et al., 1992) both of which blocked 
the ability of activated T cells to induce B cell proliferation. Both antibodies recognized a 
protein of 30-39 kDa. The cDNA encoding the murine CD40 ligand was identified by 
screening a cDNA expression library using a CD40-Ig fusion protein (Armitage et al., 
1992a). The human cDNA encoding CD40 ligand was later isolated by subtractive 
hybridization and comparison with the murine sequence for CD40 ligand (Graf et al., 
1992; Hollenbaugh et al., 1992; Spriggs et al., 1992). A cDNA encoding the human 
CD40 ligand was isolated using the 5c8 mAB (Lederman et al., 1993).
Analysis of the cDNA clone containing the murine CD40 ligand showed that it encoded a 
260 amino acid polypeptide with typical characteristics of a type II membrane protein. 
Murine CD40 ligand is composed of a 22 amino acid cytoplasmic domain followed by a 
24 amino acid hydrophobic transmembrane domain and a 214 amino acid extracellular 
domain which contains a single potential N-linked glycosylation site (Armitage et al., 
1992a). Analysis of the cDNA clones of human CD40 ligand showed that it encodes a 
polypeptide of 261 amino acids. This polypeptide consists of a 22 amino acid 
cytoplasmic domain, a 24 amino acid transmembrane domain, and a 215 amino acid 
extracellular domain containing a single potential N-linked glycosylation site, in common 
with the murine CD40 ligand. Analysis of the genomic structure of human and murine 
CD40L revealed 5 exons with 4 intervening introns spanning a region of 13-14 kb 
(Tsitsikov et al., 1994; Villa et al., 1994). Chromosomal mapping of the murine CD40 
ligand showed that the gene was linked to H P R T  on the X chromosome (Padayachee et 
a l ,  1993), while the human CD40 ligand mapped to the q26 band of the long arm of the
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X  chromosome (Aruffo et al., 1993; Graf et al., 1992). Comparison of the murine and 
human CD40 ligand amino acid sequences showed 73% identity at the amino acid level. 
Comparison of the amino acid sequence of the extracellular domain of CD40 ligand with 
that of other known protein sequences showed that CD40 ligand is related to TNF-a and 
TNF-p (Beutler & van, 1994; Hollenbaugh etal., 1992).
CD40 ligand functions as a membrane-bound protein, however it has been reported that 
the supernatant from a murine T cell line, which expresses the membrane-bound form of 
CD40 ligand, also contains a soluble form of CD40L which induces B cell activation. 
This effect could be blocked using a CD40-Ig fusion protein. The biological function of 
the soluble form of CD40L is unknown (Armitage et al., 1992b; Graf et al., 1995). 
CD40L is not constitutively expressed on the cell surface, but can be detected on CD4^ T 
cells after in vitro activation with anti-CD3 mAb or PMA/ionomycin. Detectable levels of 
CD40L were found 2-4 hours following activation and maximal levels were detected 6 - 8  
hours post-activation. Subsequent down regulation occurred 24-48 hours post­
activation. Anti-CD3 activation of human CD8  ^ T cells did not induce expression of 
CD40L, although CD8  ^ T cells activated with PMA/ionomycin did express CD40L 
(Castle etal., 1993; Lane etal., 1992; Roy etal., 1993; Sad etal., 1997).
Murine CD4^ Thl and Th2 clones were shown to express high levels of CD40L 
following in vitro activation with anti-CD3 mAb and the expression of CD40L on these 
T helper subsets could also be regulated by cytokines. TGF-P downregulated the 
expression of CD40L on both subsets, whereas IFN-y only downregulated CD40L 
expression in Th2 cells. In this study lL-1, IL-2 and IL-4 had no effect on CD40L levels 
(Roy et a l,  1993). Immunohistology of the spleens of mice immunized with Keyhole 
Limpet Hemocyanin (KLH) revealed that CD40L expressing T cells were predominantly 
found in the outer periarteriolar lymphocyte sheaths (outer-PALS) and around the 
terminal arterioles. The greatest number of CD40L expressing T cells were observed 3-4 
days after immunization with KLH, and tlicsc cells produced IL-2, IL-4 and IFN-y with 
similar kinetics to those seen for CD40L expression. It was shown that B cells producing
14
1: Introduction
antibodies to KLH were located in close proximity to the CD40L expressing T cells (van 
etal., 1994a).
CD40L is expressed on activated basophils (Gauchat et al., 1993) and eosinophils 
(Gauchat et a l, 1995). In both cases, these activated cells could induce the production of 
IgE by B cells in the presence of IL-4. Functional CD40L has also been found on human 
blood dendritic cells. These dendritic cells could induce B cell IgG and IgA production, 
suggesting that CD40L on dendritic cells may regulate B cell activation and 
differentiation (Pinchuk et al., 1996). CD40L is also expressed on human B cell lines, 
which are able to induce resting B cells to produce immunoglobulin in a CD40-dependent 
manner. These results indicate that human B cells express a ligand for^CIMO identical to 
that expressed on activated CD4^ T cells (Grammer et al., 1995).
1.6 The CD40-CD40L interaction
The crystal structures of CD40 and a complex of C!D40^CD40L are still unknown. 
However, X-ray structures of TNF-a, TNF-p (Eck & Sprang, 1989; Eck et al., 1992; 
Jones et al., 1989), and the TNF-p/TNFR complex have been elucidated (Banner et al„ 
1993) and these structures have served as templates for three-dimensional models of the 
extracellular domains of CD40, CD40L, and CD40-CD40L complex (Bajorath et al., 
1995b). Using structure-based sequence alignments and computer modeling, surface 
residues in CD40 and CD40L were selected to be targeted for site-directed mutagenesis. 
Binding studies with the mutant proteins resulted in the identification of five CD40 
residues (E74, Y82, D84, N86, E l 17) and five CD40L residues (K143, Y145, Y146, 
R203, Q220) whose replacement with Alanine substantially affected the interaction of the 
two molecules (Bajorath et al., 1995a; Bajorath et al., 1995b). In all the binding 
experiments carried out, the stmctural integrity of the mutant proteins were determined 
using anti-CD40 and anti-QMOL mAbs, recognizing different conformational epitopes. 
These models predict that CD40L forms a trimer and that CD40 binds to the CD40L 
trimer at the interface between each of the monomers so that each CD40L trimer binds
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three CD40 molecules (Bajorath et al., 1995b). This is analogous to the TNF-P/TNFR 
complex (Peitsch & Jongeneel, 1993). In the TNF-p/TNFR complex, ligand binding has 
been proposed to result in receptor clustering and signal transduction (Banner et al., 
1993), a similar mechanism might be responsible for CD40 signaling (Bajoratli et al., 
1995b).
A crystal structure of an extracellular fragment of human CD40 ligand has now been 
determined. CD40L forms a trimeric molecule hke other members of the TNF family, 
such as TNF-a and TNF-P, and exhibits a similar overall folding pattern. Two residues 
(K143, Y145) appear to be directly involved in CD40 binding and the area immediately 
surrounding these two residues are also important for CD40 binding, whereas CD40L 
residues (S131, N180, F201, E202, N240) were not directly involved in CD40 binding. 
The CTMOL structure suggests that most of the point-mutations occurring in patients 
suffering from hyper IgM syndrome (see “X-linked immunodeficiency with hyper-IgM“) 
affect the folding and stability of the whole protein rather than directly affecting the 
binding site (Karpusas etal., 1995).
1.7 CD40 intracellular signaling
The mechanism of signal transduction by members of the tumor necrosis factor (TNF) 
receptor family has only just begun to be elucidated. The cytoplasmic domains of the 
receptors in this family do not contain any obvious enzymatic activities, such as a 
tyrosine kinase domain (Tewari & Dixit, 1996). The mechanism by which they couple to 
downstream cellular signaling events is still an enigma.
The role of the CD40 cytoplasmic domain in signal transduction was examined by Inui 
and co-workers (Inui et al., 1990). A cDNA encoding human CD40 was transfected into 
a murine B-cell lymphoma and a murine thymoma. Cross-linking of CD40 using anti- 
CD40 mAb resulted in inhibition of growth of these transfectants. By mutagenesis of the 
cytoplasmic domain of CD40 it was shown that a CD40 deletion mutant lacking Thr^^ ,^ 
or a point mutation in which Thr^^ was substituted with Ala, were unable to transmit
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downregulatory signals in this system. This suggests that Thr^ '^^  or a region around this 
residue is critical for CD40 signal transduction. The two major effects of CD40 activation 
on B cells is the activation of NF-kB and the activation of protein tyrosine kinases 
(PTKs). Cross-linking CD40 on resting human tonsillar B eclls and on B-cell lines 
results in the activation of transcription activator proteins p50, p65 (RelA), c-rel and NF- 
KB (Berberich et al., 1994). Furthermore, coculture of human tonsillar B cells with 
various concentrations of PTK inhibitors led to inhibition of anti-CD40 mAb mediated 
activation of NF-kB, demonstrating that PTK activity is required for CD40-dependent 
NF-kB activation (Berberich etal., 1994). The increase in PTK activity following cross- 
linking and activation of CD40 may play an important role in mediating the biological 
effects of CD40, as PTK inhibitors attenuate B-cell aggregation and immunoglobulin 
isotype switching in response to CD40 cross-linking (Kansas & Tedder, 1991; Ren et 
al., 1994a). Phosphorylation of the src related kinase lyn has been shown to occur 
within one minute of CD40 cross-linking, whereas phosphorylation of other src related 
kinases such asfyn ,fgr  and Ick remains unchanged. CD40 cross-linking also results in 
phosphorylation of phospholipase Cy2 and phosphatidylinositol (PI)-3-kinase. 
Phosphorylation of PI-3-kinase was shown to be associated with an increase in its 
enzymatic activity. These findings suggest that lyn, phospholipase Cy2 and PI-3-kinase 
play an important role in CD40 signal transduction (Ren et al., 1994b). As lyn does not 
appear to associate directly with CD40, it seems likely that other molecules are required 
for the initial stage of signaling by CD40 (Ren et al., 1994b).
Two molecules have been identified which bind the cytoplasmic domain of CD40. The 
first, TRAF2 (TNFR-associated factor 2), binds to the cytoplasmic domain of CD40 and 
to the cytoplasmic domain of TNFR2. The second, TRAF3 (TNFR-associated factor 3) 
is identified as a 64kDa protein that binds to the cytoplasmic domain of CD40 (Cheng et 
a l,  1995; Hu et al., 1994; Mosialos etal., 1995). This factor also binds to the LMPl 
protein of the Epstein-Barr virus, which is known to be a potent inducer of B cell 
activation and proliferation. TRAF2 and TRAF3 share a region of homology near their
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carboxyl termini, which binds the cytoplasmic domain of CD40, termed the TRAF 
domain (Rothe et al., 1994). In addition to the TRAF domain, TRAF2 and TRAF3 
contain an amino-terminal ring finger motif which may mediate protein-protein 
interactions. A possible role for TRAF2 is NF-kB activation. Overexpression of TRAF2 
activates NF-kB, whereas expression of the ring-finger tmncated version of TRAF2 
attenuates CD40-mediated NF-iÆ activation (Rothe et al., 1995). A tmncated version of 
TRAF3 lacking the ring-finger motif can act as a dominant negative inhibitor, blocking 
the induction of CD23, a low affinity receptor for IgE, which is activated by CD40 
ligation (Cheng et al., 1995), suggesting that TRAF3 is involved in CD40-mediated 
signaling. In contrast, overexpression of full-length TRAF3 blocks CD40-mediated 
activation of NF-kB (Rothe et al.; 1995). The reason for the discrepancy in TRAF3 
signaling is not clear. In addition to TRAF3 a new protein, TRAF5, has been found that 
binds the cytoplasmic tail of CD40. In vitro binding assays reveal that TRAF5 binds the 
cytoplasmic tail of CD40, but not the cytoplasmic tail of TNFR2. Overexpression of 
TRAF5 activates NF-kB, in contrast to TRAF3. The differences in signaling between 
TRAF3 and TRAF5. i.e. suppression versus activation of NF-kB and the fact that they 
both bind CD40, suggests that they may be involved in both common and distinct 
signaling pathways (Ishida et al., 1996b). Yet another molecule, TRAF6, has been 
identified by use of a yeast two-hybrid system. TRAF6 seems to bind a region on the 
cytoplasmic tail of CD40 that is different from the region that binds TRAF2, TRAF3 and 
TRAF5. Despite the difference in binding, TRAF6 is also involved in NF-kB activation 
(Ishida et al., 1996a). What still remains to be determined is, which molecular 
interactions link TRAF2, TRAF3, TRAF5 and TRAF6 to NF-kB activation.
1.8 Functional consequences of CD40 engagem ent
1.8.1 CD40 Induced immunoglobulin produotlon
Antibodies against CD40 in the presence of IL-4 were found to induce proliferation in 
human B cells (Clark & Ledbetter, 1986; Ledbetter et al., 1987). Other studies showed
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that Stimulation via CD40 in the presence of IL-4 induced immunoglobulin class 
switching from IgM to IgE and the combination of IL-2 and IL-4 induced the production 
of large quantities of IgM and IgA (Rousset et a l, 1991; Zhang et a l ,  1991). The ability 
of CD40 to induce B cell proliferation and isotype switching in vitro, suggested that the, 
CD40-CD40L interaction in vivo might play a role in antibody production. This was 
tested by use of a CD40L antibody (MRl), which blocks the CD40-CD40L interaction. 
Following immunization with either T cell dependent or T cell independent antigens, 
mice were treated with the MRl antibody. It was shown that the antibody blocked both 
primary and secondary antibody responses to T cell dependent antigens, but had no 
effect on the antibody response to T cell independent antigens (Foy et a l,  1993).
1.8.2 CD40 and Fas-induced apoptosis
Activation of B cells through CD40 was found to result in the induction of Fas 
expression, rendering B cells susceptible to Fas-induced apoptosis (Garrone et a l,  
1995). Another study showed the importance of signals received through the B cell 
receptor. Fas and CD40 for the survival or death of B cells interacting with T cells. 
When the B cell receptor is triggered simultaneously with CD40 and Fas, Fas induced 
apoptosis is inhibited. It is proposed that B cell receptor triggering leads to upregulation 
of CD86, which interacts with CD28 on the T celL This increased activation induces 
upregulation of CD40L and Fas and secretion of cytokines, leading to further 
differentiation of the B cells into plasma cells or memory cells. However, lack of 
triggering of the B cell receptor and continued CD40 and Fas ligation, leads to apoptosis. 
Prolonged triggering of the B cell receptor, CD40 and Fas, in the absence of cytokines 
also leads to apoptosis (Rathmell et a l, 1996).
1.8.3 CD40 induced Th l development
Dendritic cells (DC) are professional antigen presenting cells (AFC) specialized in 
antigen capture, migration to secondary lymphoid organs and T cell priming (Steinman, 
1991). CD40 cross-linking on human dendritic cells by CD40L was shown to upregulate
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the expression of CD80, CD86 and CD54, leading to increased capacity of DCs to 
stimulate proliferation of autologous or allogeneic T cells and IFN-y production by T 
cells. In addition, DCs were induced to produce high levels of IL-12 upon CD40 cross- 
linking (Celia et al., 1996; Peguet et al., 1995). A similar study with murine dendritic 
cells showed that CD40 cross-linking induced IL-12 production by dendritic cells, and 
that IL-12 production could be down regulated by IL-4 and IL-10 (Koch et al., 1996). 
IL-12 production by human monocytes could be triggered by activated T cells and this 
could be inhibited by a soluble CD40 (CD40-Ig) antibody blocking the CD40-CD40L 
interaction (Shu et al., 1995). It has been established that IL-12 is responsible for the 
development of Thl responses (Trinchieri, 1995) and these results suggest that the 
CD40-CD40L interaction is important for the priming of Thl T cells via the stimulation 
of IL-12 secretion by antigen presenting cells. This hypothesis was tested in an in vivo 
model for a Thl-mediated disease, the hapten reagent 2,4,6-trinitrobenzene sulfonic acid 
(TNBS) induced colitis. This experimental animal model of colitis has been shown to be 
Thl-mediated as the majority of the infiltrating CD4^ T cells predominantly secrete IFN- 
y. Treatment with anti-CD40L antibodies during the induction of the Thl-mediated colitis 
was able to prevent the disease and a decrease in IL-12 production was observed. When 
mice treated with TNBS and anti-CD40L were also administered recombinant IL-12, the 
effect of anti-CD40L was reversed and severe disease resulted. This study confirmed the 
role of CD40-CD40L in the priming of Thl effector cells (Stuber et al., 1996).
1.9 Germinal Centres
Germinal centres aie the anatomical sites in which B cells undergo somatic 
hypermutation and immunoglobulin isotype switching, followed by differentiation into 
either plasma cells or memory cells (Kelsoe, 1996). When an organism is challenged 
with a pathogen or antigen via the skin or mucosal surfaces, the antigen is captured by 
immature dendritic cells (Steinman, 1991). The dendritic cells then mature during 
migration into the T cell rich areas of secondary lymphoid organs, such as the spleen, 
lymph nodes and Peyer’s patches. Once they have reached the T-cell rich area (Figure 2.
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A.), the mature dendritic cells, now called interdigitating dendritic cells (IDC), present 
antigen derived peptides bound to MHC class II, to naive antigen specific CD4^ T cells 
(MacLennan et al., 1997). These antigen activated CD4^ T-cells either leave the T ceU 
rich area to become recirculating effector- and memory-cclls, or migrate to the outer zone 
of the T cell rich area. In the outer zone the antigen activated C!D4^  T cells associate with 
naive antigen specific B cells that have been activated through their B cell receptor (BCR) 
by free antigen (MacLennan et al., 1997). After this cognate interaction between activated 
CD4^ T cells and activated B cells, the activated CD4^ T cells migrate into the light zone 
of the germinal centre or become recirculating effector- or memory-cells. The activated B 
cells migrate to extrafoUicular sites where they either differentiate into plasma cells that 
are mainly short-lived (Smith et al., 1996), or into centroblasts to form the dark zone of 
the germinal centre (Liu et al., 1991; MacLennan et al., 1990). B cell growth in 
extrafoUicular sites is not associated with somatic mutation in Ig variable-region genes 
(Jacob etal., 1991a), but memory B cells with mutated Ig variable-region genes can be 
induced in secondary responses to proliferate in extrafoUicular sites and differentiate into 
plasma ceUs (Toellner et al., 1996).
In the dark zone the centroblasts activate a somatic hypermutation mechanism that acts on 
their Ig variable region genes, which changes the affinity and specificity of the B ceU 
receptor (Berek et al., 1991 ; Jacob et a l, 1991b). The centroblasts continue to proliferate 
with a ceU cycle time of 6-7 hours. There is no increase in numbers of centroblasts, 
however, as they continually give rise to non-dividing centrocytes, which then migrate 
into the foUicular dendritic ceU (FDC) network (Liu et a l,  1991; Zhang et a l,  1988). 
Having undergone affinity maturation of the Ig variable region in the dark zone, the 
centrocytes are now selected in the light zone of the germinal centre on the basis of their 
abiUty to bind and process antigen held on FDC and make cognate interaction with 
antigen activated germinal centre T ceUs (MacLennan, 1994). There is a high death rate 
among B cells in germinal centres. This occurs among centroblasts as well as centrocytes 
but the greatest concentration of dying cells is found among the centrocytes in the Ught
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zone (Hardie etal., 1993). Apoptosis in these germinal centre B cells seems to correlate 
with high expression of apoptosis-inducing genes, such as c-myc, p53, Bax and Fas in 
the absence of Bcl-2. Apoptosis of cultured centrocytes can be delayed for some hours 
by crosslinking their BCR with anti-Ig coated onto erythrocytes (Martinez et al., 1996). 
The fact that CD40L is expressed by activated T cells (Armitage et al., 1992a) pointed to 
the possibility that germinal centre T cells might be involved in the selection of 
centrocytes. This hypothesis was supported by results showing that a more efficient 
inhibition of apoptosis in centrocytes could be achieved by CD40 cross-linking with 
CD40 monoclonal antibody (Liu et al., 1989) or recombinant CD40L (Holder et al., 
1993), The survival signal delivered through CD40 does not act by upregulating Bcl-2 
expression, but apoptosis is inhibited for several hours before Bcl-2 starts to be 
expressed in centrocytes (Holder et al., 1993).
The role of CD40-CD40L in the development of germinal centres and the generation of 
memory B cell development was examined in vivo. Mice were immunized with sheep red 
blood cells (a thymus-dependent antigen), treated with anti-CD40L antibody (MR-1), 
and the development of germinal centres was evaluated using immunohistochemical 
staining for the presence of germinal centres 9-11 days after immunization. The results 
showed that the formation of germinal centres was completely inhibited as a result of 
treatment with anti-QMOL antibody. Furthermore, adoptive transfer experiments 
demonstrated that the generation of antigen-specific memory B cells was inhibited by 
blocking the QMO-QMOL interaction, with no IgGl production by memory B cells 
(Foy et al., 1994). Another study demonstrated that in vivo treatment with anti-QMOL 
antibody inhibited both primary and secondary immunoglobulin responses to thymus- 
dependent antigens, whereas the immunoglobulin response to thymus-independent 
antigens was unaltered (Foy et al., 1993). The QMO-QMOL interaction was found to be 
necessary for memory B cell development to thymus-dependent antigens but not 
germinal centre formation, in experiments using a soluble QMO fusion protein (QMO- 
Ig) that blocked the QMO-QMOL interaction (Gray et al., 1994). The reason for the
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discrepancy in the requirement for the CD40-CD40L interaction in germinal centre 
formation is unknown, but it is argued that the soluble CD40 fusion protein may be 
incapable of efficient blocking of the CD40-CD40L interaction involved in germinal 
centre formation (Foy et al., 1994).
Germinal centre T cells not only express CD40L (Casamayor et al., 1995), but may also 
express Fas-ligand. In vitro experiments have shown that CD40L is not able to protect 
germinal centre B cells from Fas mediated apoptosis and even primed resting B cells are 
sensitive to Fas-mediated apoptosis (Garrone et al., 1995), however anti-Ig could inhibit 
this Fas-mediated apoptosis. Therefore, germinal centre B cells will die by apoptosis if 
they do not interact with T cells expressing CD40L within a short period of time or if 
they interact with T cells expressing CD40L and Fas-ligand in the absence of B cell 
receptor triggering (Rathmell et al., 1996). These results support a model for selection in 
the germinal centres. Centrocytes that have undergone somatic hypermutation but only 
have low-affinity antigen receptors die by apoptosis due to their failure to bind antigens 
on follicular dendritic cells. Centrocytes with high-affinity antigen receptors will bind 
antigen on FDCs, take up the antigen and present it to gemiinal centre T cells. These T 
cells will then deliver a rescue signal via CD40L and the centrocytes start to differentiate 
into plasma cells or memory B cells (MacLennan, 1994).
In vitro experiments have shown that in addition to the involvement of CD40L in 
preventing Fas-mediated apoptosis and it’s role in subsequent plasma cell and memory 
cell development, CD40L also produces a negative signal that prevents human germinal 
centre B cells from differentiating into plasma cells. Germinal centre B cells undergo 
strong proliferation in the presence of IL-2 and IL-10, as long as CD40L is provided. 
Upon withdrawal of the CD40L, germinal centre B cells rapidly differentiate into plasma 
tells (Arpiii tl a l,  1995). A similai* study examined the role of CD40 cross-linking on 
human centrocytes co-cultured with either naive T cells or memory T cells. Both T cell 
populations were induced to express CD40L, before co-culture with centrocytes. It was 
found that centrocytes formed conjugates with the memory T cells and the cells in these
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conjugates differentiated into memory B cells. The effect was lost if the CD40-CD40L 
interaction was blocked by an anti-CD40L antibody. Centrocytes co-cultured with naive 
T cells did not differentiate into memory B cells. Taken together these experiments 
suggest that CD40 cross-linking induces centrocytes to differentiate into meinoiy B cells 
and differentiation of centrocytes require memory T cells (Casamayor et al., 1996).
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1: Introduction
1.10 Immunoglobulin class switching
Immunoglobulin class switching occurs when IgMffgD^ B cells switch expression to a 
different heavy-chain constant region (C„), which results in a change in both the class of 
antibody and in the effector function. The expressed variable region (V(D)J-region) of 
both heavy- and light-chains do not change, therefore the specificity of antigen binding is 
unaltered (Stavnezer, 1996a). Immunoglobulin class switching in IgM^gD^ B cells starts 
approximately 6 days after activation by thymus dependent antigens in vivo (Stavnezer, 
1996a). The mechanism resulting in class switching is a switch recombination event, in 
which the V(D)J region recombines with a downstream heavy-chain constant region 
(C^^J and the intervening DNA is deleted, resulting in the following isotypes; IgG, IgE 
and IgA. The switch recombination event occurs between tandemly repeated sequences, 
called switch regions, which are located upstream of each heavy-chain constant region. 
Sterile “germline” transcripts, are produced prior to the switch recombination event and 
have been shown to be essential for class switching to occur (Coffman et al., 1993; 
Sideras et al., 1989). Germline transcripts lack the V(D)J-encoded sequence and 
therefore cannot diiect synthesis of inununoglobulin. Transcription of these gennline 
transcripts starts 5’ to the switch region, proceeds through the heavy-chain constant 
region (C^^ J  and terminates at the normal poly(A) sites for secreted or membrane bound 
Ig heavy-chain mRNAs. After switch recombination, DNA 5’ to the switch region is 
deleted from the chromosome and thus germline transcripts cannot be produced after 
class switching, instead, a functional V(D)J-Ch mRNA is produced (Liu et al., 1996; 
Lutzker & Alt, 1988; Stavnezer, 1996b). Class switching to IgG, IgA and IgE occurs by 
DNA recombination, in contrast to an alternative mechanism, RNA processing, that 
occurs for production of IgD, which is co-expressed with IgM on mature B cells 
(Stavnezer, 1996a).
Cultured mouse and human IgM^ B cells can be induced to switch to all classes of 
antibody isotypes by B-cell mitogens such as lipopolysaccharide (TI-1) for mouse B
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cells and by Staphylococcus aureus Cowan I for human B cells, in the presence of the 
appropriate cytokine (Stavnezer, 1996b). Immunoglobulin class switching in B cells is 
influenced by both CD40 cross-linking and the presence of different cytokines. In vitro 
studies have shown that purified human B cells could be induced to produce IgE by 
cross-linking CD40 (CD40 mAb) in the presence of recombinant IL-4 (Jabara et at., 
1990). IL-4 also augments class switching to IgA in murine B cells activated in vitro 
with LPS or CD40L in the presence of IL-5 and transforming growth factor-p (TGFp) 
(McIntyre etal., 1995). IL-10 induces isotype switching to IgGl and IgG3 in human 
CD40 activated B cells (Malisan et al., 1996) and to IgG3 in murine LPS activated B 
cells (Shparago etal., 1996). CD40 activation of murine splenic B cells has been shown 
to induce germline and e transcripts independently of cytokines (Warren & Berton, 
1995). Cross-linking surface-Ig on B cells with dextran (TI-2) induces germline Yp 
and Y%g transcripts, but not % and e (Zelazowski et al., 1995). Thus, it appears that both 
CD40 and surface-Ig signaling contribute to the isotype specificity of class switching.
1.11 X-linked immunodeficiency with hyper-lgM (HIGM1)
The X chromosome-linked form of the hyper IgM syndrome (HIGMl) is a rare disorder 
characterized by the inability of B cells to undergo immunoglobulin isotype switching. 
Affected males experience recurrent infections, usually within the 1st year of life, when 
levels of maternally-derived antibodies decline. Most infections are of bacterial origin, 
but HIGMl patients are also unusually susceptible to infections with opportunistic 
pathogens and often suffer from Pneumocystis carinii pneumonia and Cryptosporidium 
intestinal infection. These are diseases that are often observed with T-cell 
immunodeficiencies but not with other forms of hypogammaglobulinemia (Notarangelo 
et al., 1992). Haematological disturbances, such as anaemia, thrombocytopenia, and 
neutropenia are common in HIGMl patients. Autoimmunity and increased susceptibility 
to neoplasms are also well documented in HIGMl. HIGMl patients have normal 
numbers of circulating B cells. The overall early-mortality rate in HIGMl patients is not 
known, but the figure appears to be around 10% from a survey of 67 patients. HIGMl
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patients often suffer from life-threatening infections in spite of intravenous 
immunoglobulin and antibiotic prophylactics (Notarangelo e ta l,  1992).
Affected individuals have normal or elevated semm concentrations of IgM and decreased 
serum levels of IgG, IgE, and IgA (Geha et a l, 1979; Levitt et a l,  1983). The primary 
antibody response, that of IgM, develops normally upon in vivo antigenic stimulation. 
However, boosting results in poor secondary responses, with no expression of IgG 
specific antibodies (Nonoyama et a l,  1993). It has been shown that peripheral blood 
mononuclear cells from HIGMl patients, when stimulated with pokeweed mitogen in 
vitro, only secrete IgM, thus resembling the in vivo situation (Levitt et a l,  1983; Mayer 
e ta l ,  1986). Patients suffering from HIGMl show no development of germinal centres 
in the lymph nodes (Notarangelo et a l, 1992). The lack of immunoglobulin class 
switching seems to be a defect in B cell function, but the primary role of defective T 
helper cell activity was also established, when it was shown that B cells from HIGMl 
patients differentiated into IgG-secreting cells if cocultured with activated T cells (Mayer 
et a l ,  1986). With the exception of helper T cell activity, the in vitro and in vivo 
activation of T cells as measured by mitogen induced proliferation, response to 
alloantigen and delayed-type hypersensitivity is usually normal in HIGMl patients 
(Benkerrou gf a/., 1990).
Molecular genetic analysis of HIGMl patients revealed that the gene responsible for 
HIGMl mapped to Xq24-27 (Mensink e ta l,  1987), and was shown to be distinct from 
theXLA gene (Malcolme ta l,  1987). The study of a larger number of HIGMl patients 
allowed for further refinement of the HIGMl gene location to Xq26-27 (Padayachee et 
a l, 1993). Mapping of the CD40L gene to the q26.3-27.1 region of the X-chromosome 
by fluorescence in situ hybridization (Aruffo et a l,  1993; Graf et a l,  1992; Kroczek et 
a l,  1994), provided the initial evidence that CD40L was involved in HIGMl. The 
characteristics of the disease, low levels of isotype switched immunoglobulins, IgG, 
IgA, and IgE, indicated a failure in the ability to switch from IgM to other 
immunoglobulins. This was compatible with the finding that stimulation through CD40
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in the presence of cytokines was required to induce immunoglobulin class switching and 
secretion of inununoglobulins (Rousset et a l, 1991; Zhang et al., 1991).
To exclude a defect in the B cells of HIGMl patients, the capacity of B cells to secrete 
immunoglobulin was compared in HIGMl patients and age-matched controls. Peripheral 
blood lymphocytes (PBL) were cultured in the presence of pokeweed mitogen, a 
compound inducing immunoglobulin synthesis by activating B and T cells and allowing 
them to cooperate. PBL of HIGMl patients were unable to secret IgG, IgA or IgE in 
contrast to the controls, who were able to switch normally from IgM secretion to other Ig 
isotypes. However, when B cells from HIGMl patients were cross-linked directly 
through CD40 in the presence of Staphylococcus aureus Cowan (SAC) and IL 4 or IL 
10, the B cells produced IgG, IgA and IgE normally (Durandy et al., 1993; Korthauer et 
al., 1993). These findings confirm the unimpaired intrinsic capacity of B cells in HIGMl 
patients to undergo immunoglobulin class-switching in vitro and to produce 
immunoglobulin of all isotypes (Korthauer et al., 1993). Earlier analysis of 
immunoglobulin heavy-chain genes in B cells from HIGMl patients by use of genetic 
probes of constant and switch regions showed normal gene patterns (Mayer et al., 
1986). These results show that the inability to switch in these patients is due to 
ineffective helper T cell activity for B cell differentiation.
The cloning of the human CD40L molecule (Graf et al., 1992; Hollenbaugh et al., 1992; 
Spriggs et al., 1992) and the development of a soluble CD40-Ig fusion protein (Fanslow 
etal., 1992; Lane etal., 1992; Noelle etal., 1992) has enabled the analysis of the defect 
in HIGMl patients at the molecular level. Cell surface analysis of activated T cells from 
three males, all from unrelated families, demonstrated that CD40L expression was 
defective, since all three HIGMl patients failed to bind soluble CD40-Ig (Korthauer et 
al., 1993; Kroczek et al., 1994). However, the use of CD40L-specifie rabbit antisemm 
against a recombinant polypeptide derived from the first 137 amino acids of the 
extracellular portion of the CD40L protein showed that non-functional CD40L was 
expressed on activated T cells in some, but not all patients (Korthauer et al., 1993). In
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order to identify the basis for the failure of activated T cells from HIGMl patients to bind 
CD40-Ig, the CD40L mRNA was analysed. All three patients had point mutations, 
leading either to protein truncation, complete abrogation of cell surface expression or 
drastic amino acid changes (Korthauer et al., 1993). Other groups have also identified 
mutations in the CD40L protein from patients with HIGMl (Aruffo et al., 1993; Di et 
al., 1993). Apart from a Met^g-Arg substitution that affects the transmembrane portion of 
the protein, all other mutations appear to be located to the extracellular part of the protein, 
especially within the TNF homology domain, corresponding to amino acids 123-261 
(Kroczek et al., 1994). Three patients have been identified with a point mutation in the 
same codon (Trp,^) leading either to stop codons or a non-conservative amino acid 
substitution (Kroczek gf a/., 1994). This point mutation leads to complete abrogation of 
CD40-Ig binding. These findings are in agreement with the finding that amino acids 143 
and 145 in the CD40L protein are important for the binding of CD40 (Bajorath et al., 
1995a; Bajorath etal., 1995b).
In contrast to the above mentioned studies, hyper-lgM syndrome patients with functional 
CD40L have also been studied (Callard et al., 1994; Conley et al., 1994; Durandy et a l,  
1997). T cells from these patients were all able to bind to the CD40-Ig fusion protein and 
sequencing data showed that the CD40L cDNA appeared normal. However, serum IgG, 
IgA and IgE was undetectable and histology showed lack of germinal centres in the 
spleen. B cells from these patients were unable to synthesize IgG, IgA and IgE in vitro 
when stimulated with anti-CD40 mAb in the presence of IL-4 or IL-10. Sequence 
analysis of CD40 and CD40 binding proteins, TRAF2 and TRAF3, revealed no 
abnormalities in the protein coding regions in B cells from CD40L positive patients. 
Further studies traced the defect to phosphatidyl-inositol 3 (PI3) kinase activation and 
subsequent induction of NF-kB (Durandy et a l,  1997). Altogether, these results show 
that patients suffering from HIGMl have a defect either in CD40L or in the CD40- 
triggered activation cascade, both of which account for the lack of germinal centre 
formation and immunoglobulin isotype switching.
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Patients with HIGMl have normal or elevated levels of serum IgM, indicating that IgM 
synthesis and secretion can proceed in the absence of a functional CD40-CD40L 
interaction. In HIGMl patients with elevated IgM, levels of IgM often fluctuate, and 
increases in IgM levels often coincide with infection. This probably reflects the response 
to antigenic stimulation (Kroczek et al., 1994).
1.12 Generation of a gene-deleted, m ouse by homologous 
recombination In embryonic stem cells
The most definitive way of establishing the function of a gene in vivo is the generation of 
a gene-deleted mouse (“knockout mouse”) by targeted mutation of the gene. The whole 
process of making a gene-deleted mouse is dependent upon the occurrence of a 
homologous recombination event that occurs between the targeting vector and the 
endogenous gene in mouse embryonic stem (ES) cells.
The targeting vector contains sequences homologous to the endogenous gene, and once 
introduced into ES cells by electroporation, the sequences that are homologous can 
recombine with and replace the endogenous gene. Positive and negative selection 
markers are used to select for cells in which a homologous recombination event have 
taken place (Figure 3.). The positive-selection marker, a neomycin resistance gene 
(NEC) is inserted into an upstream exon and the negative selection-marker, a viral 
thymidine kinase gene (TK) is inserted outside the homologous sequences. If a 
homologous recombination event occurs, the ES cells will be resistant to G418 (protein 
synthesis inhibitor) and insensitive to FIAU/gancyclovir (nucleotide analogue 
incorporated by HSV-tk). The presence of the inserted DNA (NEO) in the upstream part 
of the endogenous gene ensures that transcription is disrupted, leading to a non­
functional gene. Targeting vectors can be designed such that one or more exons will be 
deleted if homologous recombination takes place and the presence of the desired 
recombination can be verified by Southern blot analysis or PCR.
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ES cells in which the endogenous gene has been disrupted are injected into mouse 
blastocysts, and these blastocysts are then implanted into a pseudopregnant foster mother 
(Figure 4.). The foster mother will give birth to chimaeric mice. The tissues in these 
cliimaeric mice are a mixture of the gene disrupted ES cells derived from one strain of 
mice (129Sv, agouti coat colour) and cells from the wild-type blastocysts (C57BL/6, 
black coat colour). Chimaeric mice where most of the tissue is derived from the gene 
dismpted ES cells (mmnly agouti coat colour) will have a sex bias towards males, since 
the ES cell line is male-derived (XY ES cells). In combination with a female blastocyst, 
male ES cells wiU often produce a fertile, phenotypic male chimaeric mouse. These sex- 
converted chimaeric mice are advantageous for breeding since they will only transmit the 
ES cell genotype. If the ES cells colonize a male blastocyst the resultant chimaeric mouse 
will transmit both the wild-type genotype and the ES cell genotype. Chimaeric males are 
then mated with wild-type females. The resultant offspring will be either black (wild- 
type) or agouti (“germline transmission”). Only 50% of the agouti offspring will be 
heterozygous for the gene disruption. Mice heterozygous for the gene disruption can then 
be mated to produce offspring homozygous for the gene dismption. Such “knockout 
mice” are deficient in the expression of the targeted gene.
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Figure 3. Disruption of the endogenous locus with a sequence replacement vector. The 
targeting vector can integrate into the genome either by homologous recombination or 
random integration. The positive selection marker (NEO) selects for cells which have 
integrated the targeting vector and the negative selection marker (TK) ensures that only 
cells which have integrated the vector at the correct locus are resistant to FIAU. Taken 
from Cellular and Molecular Immunology by Abul Abbas, Jordan S. Pober, Andrew H. 
Lichtman. 1994.
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Figure 4. Generation of germ-line chimaeras from embryonic stem (ES) cells. ES cells 
are transfected with the targeting vector. This is followed by enrichment for targeted ES 
cell clones (positive and negative selection markers, Figure 3) which have integrated the 
targeting vector at the correct locus. Targeted ES cells are then injected into blastocysts 
and the blastocysts are transferred into a foster mother. The resulting chimaeric mouse is 
bred with wild-type mice to check for germline transmission. Taken from (Capecchi, 
1989).
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1.13 CD40 deficient mice
To study the role of CD40 in vivo and to produce an animal model for hyper IgM 
syndrome, I generated CD40 deficient mice using homologous recombination in 
embryonic stem cells.
The analysis of CD40 deficient mice will provide a definite proof of whether the CD40- 
CD40L interaction is important for germinal centre formation and immunoglobulin class 
switching. Patients suffering from hyper-lgM syndrome fail to show germinal centres, 
and this is likely to be caused by a defect in the expression of CD40L (Korthauer et al., 
1993). Furthermore, blocking the QMO-QMOL interaction in vivo with soluble anti- 
CD40L antibody abrogated germinal centre formation in mice (Foy et al., 1994). Patients 
with hyper-lgM syndrome have elevated or normal levels of IgM and low levels of 
isotype switched immunoglobulins, IgG, IgA, and IgE, indicating a failure in the ability 
to switch from IgM to other immunoglobulins (Geha et al., 1979; Levitt et al., 1983). 
The treatment of mice with anti-QMOL antibody inhibited the expression of all 
immunoglobulins in secondary responses to KLH (Foy et al., 1993), confirming the role 
of QMO-QMOL in isotype switching. Immunization of QMO deficient mice with KLH 
and immunohistochemical analysis of spleens in QMO deficient mice will determine 
whether the QMO-QMOL interaction is important in germinal centre formation. Analysis 
of semm from QMO deficient mice will provide the answer to whether immunoglobulin 
class switching is regulated by the QMO-QMOL interaction.
Patients with hyper-lgM syndrome are unusually susceptible to infections with 
opportunistic pathogens and often suffer from Pneumocystis carinii pneumonia and 
Cryptosporidium intestinal infection. These are diseases that are often observed with T- 
cell immunodeficiencies but not with other forms of hypogammaglobulinemia 
(Notarangelo etal., 1992). It will be interesting to determine whether the absence of the 
QMO-QMOL interaction leads to functional T ceU abnormalities directly or indirectly 
through defective activation of antigen-presenting cells. Cross-linking of QMO on
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dendritic cells and monocytes induces secretion of IL-12 (Celia et al., 1996; Peguet et 
al., 1995; Shu et al., 1995), which is important for the development of Thl responses 
(Trinchieri, 1995). This suggests that the CD40-CD40L interaction might be involved in 
cell-mediated immunity (Thl development) as well as humoral iiiununity.
To determine whether the CD40-CD40L interaction is important for cell-mediated 
immunity to Bacillus Calmette-Guerin (BCG). CD40 deficient mice were infected with 
BCG. Survival and bacterial counts in spleen, lung, and liver of CD40 deficient mice 
were analysed. The analysis of tuberculin Purified Protein Derivative (PPD) induced 
IFN-Y, IL-12, TNF-a and nitric oxide production by splenocytes of BCG infected CD40 
deficient mice wiU reveal any defect in Thl development.
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Chapter 2: Materials and Methods
2.1 Molecular Biology
2.1.1 Agarose gel electrophoresis
1 % (w/v) agarose gels were made by dissolving agarose and ethidium bromide (60 fig, 
10 flg/fil) in boiling Ix Tris-acetate buffer and pouring the solution into a gelform with 
an appropriate slot former. The gels were run with DNA samples in Ix Tris-acetate 
buffer at 50-200 mA. After electrophoresis, gels were photographed under UV- 
illumination (Stratagene: Eagle Eye; Mitsubishi: video copy processor).
2.1.2 Isolation of DNA fragments from an agarose gel
After electrophoretic separation in an agarose gel and visualisation by ethidium bromide 
staining and UV-illumination, the relevant fragment(s) were isolated using a strip of 
GFC-filter and dialysis tubing. The agarose gel was cut below the fragment band and the 
GFC-filter on top of the dialysis tubing was placed in the crack below the fragment band. 
Electrophoresis was continued until all the DNA had transferred to the GFC-filter as 
judged by UV-illumination. The GFC-filter (Whatmann, glass microfibre filters, cat. no. 
1822025) was transferred to a 0.5 ml Eppendorf tube without a tip and then placed on 
top of a 1.5 ml Eppendorf tube. The Eppendorf tube was centrifuged at 14000 rpm 
(Hereaus Biofuge) for 5’. The solution of approximately 30 fil containing the fragment 
was extracted with phenol/chloroform and the aqueous phase was passed through a 
Sephadex G50 spin colunm in preparation for ligation.
2.1.3 Isolation of plasmid DNA (miniprep)
Harvesting and lysis of bacteria was based on the principle of the alkali-SDS method in 
which SDS binds and denatures proteins and lipids and NaOH denatures the DNA, 
resulting in lysis of the cells. The cellular debris including chromosomal DNA is 
precipitated by centrifugation and removed and plasmid DNA is recovered from the
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supernatant by ethanol precipitation and dissolved in TE. A single colony was inoculated 
into 2 ml LB medium containing 40 p,g/ml Ampicillin in 3 ml wells of a microtiter plate. 
These were grown for 7-14 h at 37 °C. with constant shaking (200 rpm). The cultures 
were centrifuged 2600 rpm for 3’ and the supernatant discarded (Sorvall Centrifuge). 
The pellet was resuspended in 100 |xl Sol I and lysed with 200 \i\ Sol U, then 150 pi Sol 
m  was added and the plate was shaken flat on a bench. Cell fragments and genomic 
DNA will be in a well defined aggregate. The plate was centrifuged at 2600 rpm for 4 ’ 
and the supernatant was transferred to a clean 3 ml well. 1 ml 96% ethanol was added to 
precipitate the plasmid and centrifuged for 4’ at 2600 rpm. The ethanol was removed and 
the DNA was resuspended in 80 pi TE and transferred to a small microtiter plate. 80 pi 
5M LiCl was added to precipitate proteins for 5’ at -20 °C. The samples were centrifuged 
2600 rpm 3’ and transferred to an Eppendorf tube. The DNA was ethanol precipitated 
once again and dissolved in 50 pi TE, yielding 25-50 pg plasmid DNA.
2.1.4 Isolation of plasmid DNA (maxiprep)
A single colony was inoculated into 10 ml of LB containing 40 pg/ml ampicillin and 
grown o/n at 37 °C with vigorous shaking. The overnight culture was seeded into 400 ml 
LB/amp and grown 37 °C o/n. The culture was transferred to 500 ml Beckmann bottles 
and centrifuged at 4000 rpm (Beckmann J6 MC centrifuge) for 20’ at 4 °C. The 
supernatant was discarded and the pellet resuspended in 4 ml solution I and transferred to 
50 ml tubes (Beckmann centrifuge).A further 0.5 ml of solution I was added containing 
4 mg/ml lysozyme, vortexed and incubated RT for 10’. 8 ml of solution II was added to 
the mix witli vortexing and then incubated on ice for 5 \ Then 4.5 ml of solution HI was 
added with vortexing and the sample incubated on ice for 15’. The supernatant was 
recovered after centrifugation at 4000 rpm for 20’ at 4 °C. 11 ml isopropanol, was added 
to the supernatant and the DNA was pelleted by centrifugation at 14000 rpm for 20’ at 4 
°C. The supernatant was discarded and the DNA pellet dried. The pellet was resuspended 
in 3 ml ddH^O plus (44 pi of 1 M Tris pH 8.0 + 27 pi of 0.5 M EDTA pH8.0), allowing 
approximately 1 hr for resuspension. 4.4 g CsCl + 300 pi EtBr (lOmg/ml) was added
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before loading the contents into a 13x48 mm Optiseal tube (Beckmann 362185). This 
was centrifuged for 3.5 hr at 70K rpm in a VTi80 rotor at 20 °C. Extraction of CsCl 
band was performed according to the procedure described in Maniatis (Molecular 
Cloning: A laboratory Manual, Sambrook, Fritsch, Maniatis). The plasmid DNA was 
then butanol extracted to remove contaminating EtBr, followed by ethanol precipitation, 
air drying and resuspension in 500 pi ddHjO. Protein and RNA were removed by 
digestion with 20 pg/ml RNAse for 60’ at 37 ®C followed by 60’ digestion with 100 
pg/ml proteinase K. Phenol/chloroform extraction followed by ethanol precipitation was 
used to remove the enzymes. Lastly the DNA pellet was washed in 70 % ethanol, air 
dried and resuspended in 500 pi TE and the DNA concentration determined.
2.1 .5  Plating and screening genomic library
Bacteria (LE392) were grown in 10 ml LB-medium containing 0.2 % maltose and 10 
mM MgClg, o/n at 37 °C. The bacteria were infected with lambda phage containing the 
genomic library (Lambda Dash 9H-129) by mixing 100 pi MgSo/CaCl2 buffer (10 mM 
final), 300 pi bacteria, 100 pi SM buffer, and phage (5.0 xlO* pfu/plate) and incubated 
10* at 37 °C. 10 ml Top agar (45-48 °C) was added to the infected bacteria, mixed gently 
and poured onto LB-agar plates (15 150mm LB-agar plates had been pre-prepared for 
this purpose). These were incubated at 37 ®C for 12-16 hr. The plates were then 
incubated at 4 °C for 1 hr. Duplicate filters (HybondN+) were made for each plate by 
placing the filters on the plates making sure of the orientation of the filters by making 
holes through filter and agar using a 25 gauge needle. The corresponding holes in the 
filters were marked on the bottom of the plate. The filters were gently peeled off and 
dried. Phage DNA bound to the filters was denatured by soaking in 0.5 M NaOH, 1.5 M 
NaCl and neutralised in 1.0 M Tris-HCl pH 7.5, 1.5 M NaCl. Any agarose was 
removed using gauze. Filters were rinsed in 2x SSC and dried on 3MM paper and baked 
at 80 ®C for 2 h, ready for hybridisation. Any positive plaques that were identified were 
extracted and a subscreening performed if necessary. For a detailed description of this
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procedure please see Maniatis (Molecular Cloning: A Laboratory Manual, Sambrook, 
Fritsch, Maniatis).
2.1 .6  Phage maxiprep
Bacteria (LE392) were grown o/n at 37 in LB-medium containing 10 mM MgCl^ and
0.2 % maltose. Five different dilution’s of phage were made and mixed with 1 ml of 
bacteria plus 10 pi MgSo/CaCl^ buffer (1 M) and incubated 10' at 37 °C. 100 ml of LB- 
medium containing 10 mM MgSo/CaCl^ was added to the infected bacteria and 
incubated at 37 for 5-8 hr until cell lysis occurred. The phage dilution giving 
complete cell lysis was identified and another 4 x 100 ml bacterial cultures containing the 
appropriate phage dilution were set up and incubated at 37 °C for 5-8 h until lysis. The 5 
lysates (500 ml) were pooled, 2 ml of chloroform was added and the mix shaken for 15'. 
2 mg of DNAse and RNAse were added and incubated for 30' at 37 ®C. 30 g of NaCl 
was added and incubated for 15' on ice and the cellular debris was pelleted by 
centrifugation at 4000 rpm for 30', 4 °C (Beckmann Centrifuge). 50 g PEG (8000) was 
added to the supernatant and incubated 60' on ice. The intact phage were pelleted by 
centrifugation at 4000 rpm for 30',4 °C and resuspended in 12 ml SM buffer. 
Chloroform extraction followed by centrifugation at 3000 rpm for 10', 4 °C was 
performed once. The aqueous phase was centrifuged 25000 rpm for 30' (SW40 rotor, 
Beckmann ultracentrifuge) and the phage pellet resuspended in 1 ml SM buffer. Phage 
were purified on a CsCl density gradient and ph%e DNA extracted according to Maniatis 
(Molecular Cloning: A Laboratory Manual, Sambrook, Fritsch, Maniatis).
2 .1 .7  DNA extraction with phenol/chloroform
The standard way of removing proteins from DNA solutions is to extract once with 
phenol/chloroform/isoamylalcohol (25:24:l,v/v/v). The use of more than one organic 
solvent ensures a more efficient deproteinization. The organic solvents and aqueous 
phase (DNA containing solution) were mixed and then centrifuged for 1-2* in an 
eppendorf centrifuge (Heareus Biofuge) at 14000 rpm. The aqueous phase was re­
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extracted with one volume of chloroform/isoamylalcohol (24:1, v/v) to remove traces of 
phenol, centrifuged and then ethanol precipitated.
2.1.8 Ethanol extraction of DNA
Ethanol precipitation is an efficient way to concentrate and desalt a DNA sample. The 
DNA sample (e.g. after phenol/chloroform extraction) was adjusted to 300 mM NaCl 
and 2.5 volumes of 96% ethanol was added. The DNA was precipitated for 2 h at -20 “C 
or for 15’ at -70 ®C. The sample was centrifuged for 30’ (Heraeus Biofuge), the 
supernatant discarded and the pellet washed twice with 70% ethanol to remove as much 
salt as possible. Finally, the residual ethanol was evaporated by air drying.
2.1.9 DNA extraction with n-butanol
It is possible to concentrate DNA by extraction with water-free n-butanol as DNA and 
salt is insoluble in the organic phase but water is not. The DNA was extracted with two 
rounds of 3-10 volumes of n-butanol, reducing the volume of the DNA-containing 
aqueous phase considerably. After centrifugation the n-butanol was removed and the 
aqueous phase ethanol precipitated to remove the residual salt.
2.1.10 5 ’-end labeling with T4 polynucleotide kinase
T4 polynucleotide kinase catalyses the transfer of y-phosphates from ATP to 5’-hydroxyl 
ends of DNA. The enzyme works equally well on single-stranded and double-stranded 
DNA. However, in the latter case the transfer is more efficient on protruding 5’-ends 
than on blunt ends and does not work on recessed 5’-ends. 1-40 pmol of 
oligonucleotides were incubated with Ix kinase buffer, 50 fiCi (y-^^P)ATP, 2 units of T4 
polynucleotide kinase in a total volume of 20 p,l. The reaction mixture was placed at 37 
®C for 30’ and stopped by addition of EDTA to lOmM. The volume was adjusted to 100 
pi with TE buffer and the enzyme was removed by ethanol extraction. The 5’-end labeled 
oligonucleotides were separated from unincorporated nucleotides on a sephadex G50 
spin-column and ethanol precipitated. DNA was recovered in TE buffer.
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2.1.11 Déphosphorylation of DNA
To be able to label DNA fragments (except synthetic oligonucleotides) with T4 
polynucleotide kinase or to prevent religation of compatible DNA ends it is necessary to 
remove a 5 -phosphate group. This can be done with Calf Intestinal alkaUne 
phosphatase, CIP. Normally 0.01 units of CIP is added to dephosphorylate 1 pmole of 
5’-ends. If the DNA is to be run on an agarose gel for purification, no further treatment 
is necessary prior to addition of glycerol loading buffer. Otherwise CIP must be 
inactivated and salts from CIP preparation removed.
1.0 unit of CIP was added to a total volume of 50 pi Ix CIP buffer containing 1.0-3.0 
p,g DNA (immediately after the restriction enzyme digestion) and incubated for 20’ at 37 
“C. The CIP was then inactivated by heating the reaction to 68 °C in the presence of 1% 
SDS, extracting with phenol/chloroform and passing the aqueous phase through a 
sephadex G50 spin-column.
2.1.12 Restriction enzyme digestion
1-3 units of restriction enzyme is normally used to digest 1 p,g of DNA. Due to the 
inhibitory effect of glycerol, the restriction enzyme must always contribute less than 1/10 
volume of the final reaction mixture. Restriction enzyme digestion was carried out in a 
total volume of 50 pi Ix TA buffer (100 mM Tris-HCl, pH 7.9, 200 mM K-acetate, 100 
mM Mg-acetate), 1-3 units of the appropriate enzyme and lug DNA and incubated for 1- 
2 h at 37 °C. Restriction digestion was stopped by the addition of glycerol gel-loading 
buffer containing a final concentration of 10 mM EDTA.
2.1.13 Ligation of DNA fragments (vector and insert)
DNA ligation is catalyzed by T4 DNA ligase. A phosphodiester bond is made between 
juxtaposed 5’-phosphoryl and 3’-hydroxyl DNA ends. High backgrounds of religated 
vector can thus be reduced either by dephosphorylation with CIP or by cutting the vector 
with restriction enzymes that create noncompatible ends.
42
2: Materials and Methods
The ligation reaction was performed in Ix ligase buffer, 10 mM ATP and 3 units of T4 
ligase, in a total volume of 15 pi and incubated for 6 h at 15 °C. As controls, reaction 
mixtures containing either vector or insert alone were included. The ratio of vector/insert 
was varied in order to achieve a high insertion efficiency.
2.1.14 Transformation of competent E.coli cells 
Preparation of competent E.coli cells (JM109, Promega).
A single colony was inoculated into 25 ml LB/amp niedium and incubated 37 °C o/n with 
vigorous shaking. 5ml of the overnight culture was then seeded into 500 ml LB medium 
and shaken at 37 ”C until an ÜD Ag^ o of O.45-0.55 was reached. The cells were chilled 
on ice for 2 h. and collected by centrifugation at 2500x g for 15’-20’,4 ®C. The cells 
were resuspended in 10-20 ml ice cold trituration buffer and diluted to 500 ml with the 
same solution. The cells were centrifuged at 1800x g for 10’ and gently resuspended in 
50 ml ice cold trituration buffer. 80 % glycerol was added dropwise with gentle swirling 
to a final concentration of 15 % (v/v). 0.2-1 ml aliquots of the cells were made and 
frozen on dry ice prior to long term storage at -70 °C.
Transformation of competent cells.
The ligation mixture was added to 200 pi competent E.coli cells and placed on ice for 10’ 
and then heat shocked at 37 °C for 5’. 500 pi LB medium (37 °C) was then added and 
the cells incubated 37 ®C for a further 45’. The mixture was centrifuged 5-10” (Heraeus 
biofuge) at 14000 rpm and 500 pi supernatant was removed. The cells were resuspended 
and spread on agar plates supplemented with 40 pg/ml ampicillin. Plates were incubated 
inverted at 37 °C for 12 h. Colonies of transformed cells were then subjected to “Mini 
Prep” analysis, to isolate positive clones.
2.1.15 Random primer labeling of hybridization probes 
(Stratagene, Prime It RmT Random Primer)
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25-50 ng of DNA (probe) was added to a reaction tube containing, unlabelled dNTPs, 
random prime buffer and random sequence nonamers. ddH^O was added to a final 
volume of 42 |il. The mixture was boiled 5’, centrifuged briefly to collect the 
condensation and then 5 pi of (a-^^P)dCTP (50 pCi) and 3 pi of magenta DNA 
polymerase (4U/pl) was added. The sample was mixed and incubated at 37 °C for 5’- 
30’. After incubation, 150 pi of ddH^O was added to the reaction mixture. To remove 
unincorporated radioactive nucleotides, the 200 pi reaction mixture was passed through a 
sephadex G50 spin column, 1700 rpm for 2’ (Sorvall centrifuge). The labeled DNA was 
denatured by heating to 95-100 °C for 5’, then chilled on ice before hybridisation. 
Probes with a specific activity of 1.0x10^ dpm/pg can be produced with most DNA 
substrates.
2.1.16 Isolation of high molecular weight DNA from mouse tails
1 cm of tail was cut and placed in a 1.5 ml eppendorf tube. The tail was minced using a 
small pair of scissors. 700 pi of mouse tail buffer and 35 pi of 10 mg/ml solution of 
Proteinase K was added and the tail was incubated at 55-60 °C overnight. After 
Proteinase K digestion, 20 pi of RNAse A was added and incubated at 37 °C for 1-2 h 
before organic extraction twice in phenol/chloroform (1:1) (200 pi) and once in 
chloroform (200 pi).The sample was centrifuged 2’ at 13000 rpm (Heraeus Biofuge) and 
the aqueous phase transferred to a clean eppendorf tube. DNA was precipitated by the 
addition of an equal volume of isopropanol at room temperature (invert several times to 
ensure complete mixing) and centrifugation at 13000 rpm 10’ (Heraeus Biofuge) The 
supernatant was discaided and the DNA pellet air dried. The pellet was resuspended in 
150 pi ddH^O at 4 °C o/n. A 1:100 dilution of the DNA was made and the CD Ajgo/iso nm 
determined. The yield is usually between 50-100 pg DNA.
2.1 .17 Restriction enzyme digest of mouse genomic DNA
10 pg of DNA was digested in a total volume of 40 pi containing Ix BamHI buffer, 1 
mM spermidine, 100 pg/ml BSA, 3 U/pg of BamHI restriction enzyme and ddHjO. The
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sample was incubated at 37 °C o/n, centrifuged briefly to collect the condensation before 
adding 4 pi gel-loading buffer and heating to 56 ®C for 2’ prior to loading onto a 0.7 % 
agarose gel.
2.1.18 Agarose gel electrophoresis of mouse genomic DNA
After restriction enzyme digest, the DNA was loaded onto a 0.7 % agarose gel (Ix TAB) 
and electrophoresed at 80 V (1.85 V/cm) for 4-5 hours. This gives good separation of 
DNA fragments of 5 -23 kb. The DNA was visualised by staining with ethidium bromide 
and then photographed under UV-illumination. The gel was then submerged in 
denaturing buffer for 30’, followed by a quick rinse in H^O and then submerged in 
neutralizing buffer for a further 30’ and rinsed in H^O. This denatured the DNA in 
preparation for Southern blotting.
2.1.19 Southem blotting
A glass dish was filled with blotting buffer (20x SSC) and a glass plate placed across the 
dish, covered with two sheets of Whatmann 3MM filter paper, saturated with blotting 
buffer. The gel was placed on the 3MM filter paper and trapped bubbles were removed. 
The gel was surrounded with Saran wrap to prevent the blotting buffer being absorbed 
directly into the paper towels above. A sheet of Hybond-N+ filter (positively charged 
nylon membrane, Amersham) was cut to the exact size of the gel and placed on top of the 
gel. Again, trapped bubbles were removed. Two sheets of 3MM p g ^ r wetted with 5x 
SSC were placed on top of the filter, and a stack of dry paper towels was placed over the 
filter paper. A glass plate was placed on top of the paper towels with a 0,5-1.0 kg weight 
on top. Transfer of DNA was allowed to proceed for 2-16 h. The filter was then placed 
with the DNA side up on 3MM paper soaked in 0.4 M NaOH. Efficient DNA fixation 
was achieved after 15’-30’. Lastly the filter was rinsed gently in 5x SSC for not more 
than 1 ’, prior to hybridisation.
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2.1.20 Hybridization protocol
The Hybond hT filter was placed in a hybridization oven (Techne: Hybridiser HB-1) in 
40 ml of hybridization buffer (church) at 65 °C for 1 h. The 40 ml of hybridization buffer 
was then poured away and replaced with 20 ml of hybridization buffer and the denatured 
labeled probe and hybridized o/n at 65 °C. The filter was washed in 2x SSC, 0.1 % SDS 
for 15’ at RT, followed by another wash in O.lx SSC, 0.1 % SDS for 30’ at 65 °C. The 
filter was removed from the hybridization cylinder, wrapped in Saran warp and place 
under film overnight. The autoradiograph was developed to visualise probe 
hybridisation. If an oligonucleotide probe was used, the hybridization temperature was 
48 ° C and the filter was washed 2 times in 2x SSC, 0.1 % SDS at 48 ®C,
2.1.21 Filter stripping protocol
For successful removal of probes, filters must never be allowed to dry out during or after 
hybridization and washing. Filters were washed at 45 ®C for 30’ in 0.4 M NaOH, then 
transferred to a solution containing O.lx SSC, 0.1 % SDS, 0.2 M Tris-HCl and 
incubated for a further 15’. Autoradiography for a normal exposure time was used to 
check that all probe had been removed. The filter was then available for further 
hybridization.
2.1.22 Polymerase chain reaction (PCR)
The polymerase chain reaction is a technique for the in vitro amplification of specific 
DNA sequences by the simultaneous primer extension of complementary strands of 
DNA. 50-100 ng of genomic DNA or 1-2 ng of cloned DNA was added to a reaction 
tube containing, 200 pM dNTPs, Ix Tag buffer, 1 pM of each primer, 1 pi Taq 5U/pl 
(Thermus aquaticus, heat stable DNA polymerase) and ddHjO, to a final volume of 50 
pi. Mineral oil was layered on top to avoid evaporation during the heating and cooling 
cycles. The dénaturation step was normally performed at 94 ®C and the annealing 
temperature depended on the oligonucleotide primers used and was normally in the range
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of 60-68 °C. Extension was carried out at 72 °C (PCR Machine; Hybaid Omnigene). 25 
to 35 cycles were sufficient to produce 100 ng-1 pg of DNA.
2.1.23 Isolation of genomic DNA from cultured cells
The purification procedure is based on the selectivity of the QIAGEN resin which allows 
isolation of pure genomic DNA from cultured cells. Genomic DNA purified with 
QIAGEN resin columns has an average length of 80-100 kb, and is free of contaminants. 
2 ml of ice-cold buffer Cl was added to every 2 ml of cell suspension (1.0 x 10^  
cells/ml) and mixed by inverting several times. The cells were incubated for 10’ on ice 
and then centrifuged at 4 °C for 15’ at 1300xg and the supernatant discarded. 1 ml of ice- 
cold buffer Cl and 3 ml of ice-cold ddH^O were added to the pelleted nuclei which were 
then resuspended by vortexing. The nuclei were centrifuged again at 4 °C for 15’ 1300g 
and the supernatant discarded. 5 ml of buffer G2 was added and the nuclei resuspended 
by vortexing for 10” -30” . 95 pi of QIAGEN protease (20 mg/ml) was added and the 
nuclei incubated at 50 °C for 30’-60’. The sample was applied to a QIAGEN resin 
column, entering the resin by gravity flow. The column was washed twice with 7.5 ml 
of buffer QC and the genomic DNA was eluted with 5 ml of buffer QF. The DNA was 
precipitated by the addition of 3.5 ml of isopropanol ensuring thorough mixing and then 
centrifuged at 5000g 4 °C for at least 15’. The supernatant was discarded and the DNA 
pellet washed with 2 ml of cold 70 % ethanol, air dried and resuspended in 150 pi TE 
pH 8.0 o/n at 4 °C. DNA concentration was measured at Ajgonm- For pure DNA the 
A260n„/A280nm ^atio should be 1.7-1.9. (Spectrophotometer Cecil, CE 2040).
2.1.24 Linearizing DNA construct for electroporation
Restriction enzyme digest of the targeting DNA constmct was carried out at 37 °C for 2 
h. A small aliquot was run on an agarose gel, to check for complete restriction digestion. 
The DNA construct was precipitated by adding 1/10 volume of sodium acetate plus 2 1/2 
volume of 100 % ethanol at -20 °C for 10’. The DNA was centrifuged at 13000 rpm 
(Heraeus Biofuge) for 10’.The DNA was kept sterile so supernatant was discarded and
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the pellet dried in a sterile tissue culture hood. The DNA was resuspended in 100 pi 
sterile PBS in preparation for electroporation.
2.1.25 Screening for homologous recombination using PCR
The strategy is to amplify a novel DNA fragment created by the correct homologous 
recombination of endogenous genomic DNA with a targeting vector containing the G418 
resistance gene (NEC). One primer binds to the neo cassette and the second primer just 
past the short arm of the targeting vector, within the endogenous locus. After eight days 
of G418 selection, ES colonies were visualized by holding the plate up to the light and 
individual colonies marked on the bottom of the plate. Half of each colony was 
transferred with a 10 pi tip. 20 colonies were pooled. The master plate was replaced in 
the incubator and the pooled ES cells centrifuged at 13000 rpm (Heraeus biofuge) for 
15” and the supernatant removed. Cells were resuspended in 30pl ddH^O and boiled for 
10’ followed by centrifugation at 13000 rpm 10” . 1 pi of Proteinase K (10 mg/ml) was 
added and the cells incubated at 50 °C for 2 h. The cells were boiled for 10’ and 
centrifuged 13000 rpm 10’, ready for PCR amplification. The PCR programme used 
was: Denaturing temp.; 94 °C for 1’. Annealing temp.; 62 °C for 1’. Elongation temp.; 
72 °C for 2’ for 40 cycles. The reaction mix contained 200 pM specific primers, Ix Taq 
reaction buffer, 1 pM of each dNTP, 1 pi Taq 5U/pl. 10 pi of the PCR reaction was 
analysed on an agarose gel. The DNA was blotted onto Hybond-N+ membrane and 
hybridized with a probe spanning the expected PCR fragment. Membrane was washed 
and placed under film for o/n exposure. If positive pools were identified, the PCR and 
Southern blot was then lepcatcd for each individual colony in the positive pool. Positive 
ES colonies were transferred to plates containing fibroblasts, expanded and then frozen 
down. The homologous recombination event was confirmed by Southem blot analysis.
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2.1.26 Southern blot analysis using DNA prepared directly in a 96 well 
plate
The ES cells on the gelatin-coated plates were grown until the medium was very yellow, 
and the medium was changed every day for 4-5 days. The wells were rinsed twice with 
PBS and 50 pi of lysis buffer was added per well. The plates were incubated o/n at 60 
®C in a humid atmosphere. 100 pi of NaCl/ethanol solution (75 mM NaCl in ethanol) 
was added and the plate was incubated for 30’ at RT without mixing. The nucleic acids 
were precipitated as a filamentous network. The plate was inverted carefully to discard 
the solution, leaving the nucleic acids attached to the plate. Excess liquid was blotted on 
paper towels and the DNA rinsed 3 times with 150 pi of 70 % ethanol per well. The 
ethanol was discarded by inversion of the plate each time. After the final wash, the plate 
was inverted and allowed to dry on the bench. The DNA was cut with restriction 
enzymes. Each restriction digestion mix contained Ix BamHI buffer, 1 mM spermidine, 
100 pg/ml BSA, RNAse (100 pg/ml), 3 U/pg of BamHI restriction enzyme, and 
ddHgO. 30 pi of the restriction digest mix was added to each well, mixed and then 
incubated at 37 °C o/n in a humid atmosphere. Gel electrophoresis loading buffer was 
added to each well and electrophoresed as described in section “2.1.18 Agarose gel 
electrophoresis of mouse genomic DNA”.
2.2 Tissue culture
2.2.1 Preparation of primary embryonic fibroblasts
Twenty 15-17 day old fetuses were dissected in PBS. Heads, liver and attached intemal 
organs were removed and as much blood as possible was removed by washing twice in 
PBS. Carcasses were minced with scissors in a small volume of PBS. 50 ml Trypsin- 
EDTA was added and the mixture transferred to 500 ml conical flasks containing sterile 
glass beads (Borosilicate solid-glass beads, Aldrich cat.no. Z 14392-8). The flasks were 
incubated at 37 °C, with stirring, for 30’. This step was repeated twice with the addition 
of more Trypsin-EDTA. The solution was decanted from the beads and centrifuged 1200 
rpm 5’ (Sorvall) and washed twice in PBS. The cells were resuspended in complete
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medium and viable cells counted. Cells were plated at 5x10® cells/150 mm plate and 
medium changed after 24 h. When confluent (2-3 days), each plate was plated onto 5 
further plates. When these plates were confluent they were frozen in liquid nitrogen (1 
plate/1 vial, freezing medium: complete medium, 30 % FCS, 10 % DMSO).
2.2.2 Growth of primary embryonic fibroblasts
1 Nunc tube of frozen fibroblasts was thawed rapidly in a waterbath (37 °C) and 
transferred to 10 ml of medium. Cells were centrifuged at 1200 rpm for 5’ (Sorvall RT 
6000 D). Supernatant was removed and the pellet resuspended in 10 ml of medium. The 
cells were transferred to a 150 mm tissue-culture and a further 15 ml of medium added. 
The fibroblasts were grown at 37 °C, 5 % CO^ for 48 h. or until confluent. Spent 
medium was removed and replaced with 10 ml of medium containing 0.01 mg/ml 
Mitomycin C (to inhibit further differentiation of the fibroblasts) and incubated for a 
further 2-3 h at 37 °C, 5 % CO .^ Medium was removed and the cells washed twice in 15 
ml PBS. Cells were treated with Trypsin-EDTA for 2’ at 37 °C, 5 % COj to make a 
single cell suspension. Cells were aliquoted into 8-10 60 mm tissue-culture dishes and 
incubated 37 °C, 5 % CO^ for 3 h. These fibroblasts were then used as feeders for ES 
cells.
2.2.3 Culture of ES cells on fibroblasts
Newly thawed ES cells usually grow slowly. The growth depends on the cell density. 
As a general rule, the more dense the cells, the faster the growth. It is important to keep 
the time in culture to a minimum and to dissociate clumps of cells at each passage. Check 
the cells frequently, ideally twice a day and change the medium every day. The important 
thing is that the ES cells remain totipotent and can thus contribute both to somatic tissues 
and most importantly, to the germline of mice. Totipotent cell colonies are oval and look 
shiny under phase contrast microscope. Individual cells can not be seen within 
undifferentiated cell colonies. In contrast, differentiated ES cell colonies are flat, granular 
and appear grayish under the microscope.
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One vial of ES cells was thawed as described below. ES cells were transferred to a 30 
mm tissue-culture dish containing fibroblasts and grown at 37 ®C, 5 % COg. When the 
ES cells were confluent they were treated with Trypsin-EDTA for 2’ at 37 °C, 5 % CO^ 
to make a single cell suspension and transferred to a 60 imn tissue Culture dish containing 
fibroblasts. Further expansion of ES cells was carried out using 60 mm tissue culture 
dishes containing fibroblasts. Each 60 mm dish was split into 2 or 3 60 mm dishes.
2.2.4 Freezing ES cells
ES cells (on feeders) were washed twice in PBS and treated with Trypsin-EDTA for 2’ at 
37 ®C, 5 % COj. 10 ml of medium was added to make a single cell suspension which 
was centrifuged 1200 rpm (Sorvall) for 5*. The supernatant was discarded and the cells 
resuspended in 2 ml freezing medium (4 °C) at a density of approximately 2-3x 10® 
cells/ml (10 % DMSO, 30 % FCS, 70% complete medium). 1 ml of ES cells were 
aliquoted into each Nunc freezing vial. These were wrapped in bubble-plastic and frozen 
slowly o/n at -80 °C before transfer to liquid nitrogen for long term storage.
2.2.5 Thawing ES cells
1 Nunc tube of frozen ES cells were thawed quickly in a waterbath (37 °C) and 
transferred into 10 ml of medium. Cells were centrifuged at 1200 rpm for 5’ (Sorvall RT 
6000 D). The supernatant was removed and the cells resuspended in 1 ml of medium. ES 
cells were transferred to a 30 nun tissue-culture dish containing fibroblasts and grown at 
37 T ,  5 % COj.
2.2 .6  Electroporation of ES cells and G418 selection
DNA can be transfected into ES cells by application of a high voltage electrical pulse to a 
suspension of cells and DNA. The electrical pulse punches holes through the cell 
membrane through which the DNA passes. This procedure results in the death of about 
50 % of the ES cells.
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ES cells were passaged a day or two before the electroporation. The medium on ES cells 
growing on fibroblasts was replaced approximately 3 h before the electroporation (5x 10® 
cells/60 mm tissue culture dish), these were washed twice with PBS treated with 
Trypsin-EDTA for 2’ at 37 °C, 5 % CO^. and 5 ml of complete medium was added to 
make a single cell suspension. Cells were centrifuged at 1200 rpm (Sorvall RT 6000 D) 
for 5*. The supernatant was removed and the cell pellet resuspended in 5 ml of complete 
medium and then counted on a haemocytometer. The volume of the resuspended ES cells 
was adjusted to give 5x10® cells/0.7 ml suspension. 0.7 ml of suspension was removed 
as a control for G418 resistance. The appropriate amount of linearized DNA construct 
(32 p.g in 100 p.1 PBS/5x 10® cells) was added to the cell suspension and mixed well. 
The 0.8 ml cell/DNA mix was transferred to an electroporation cuvette (BioRad, Cat. no. 
165-2088). The settings used were: Capacitance 250 fiF, Voltage 340, Time constant 
3ms (BioRad, gene puiser). Electroporated cells were allowed to recover at RT for 15* 
and then 0.4 ml of electroporated cells was plated onto a 100 mm gelatinized tissue 
culture dish containing complete medium plus LIF (Leukaemia Inhibitory Factor). Cells 
were incubated at 37 °C, 5 % COj for 48 hr at which point G418 selection was 
commenced. Complete medium containing LIF and 300 pg/ml G418 was added and the 
medium changed every day for 7-8 days. G418 resistant colonies began to appear at this 
time and at day 9 or 10 the colonies were ready for screening by PCR or by Southem 
blot analysis.
2.2 .7  Picking and expanding ES cell colonies
After electroporation, tire ES cell colonies were allowed to grow for 8-12 days to become 
visible. Single colonies were seeded into each well to avoid a further cloning step. Plates 
containing the colonies were washed with PBS and then PBS was added to cover the 
plate. Colonies were visualized by holding the plate up to the light and marked on the 
bottom of the plate. A 96 well U-bottomed plate was prepared by adding 25 pi of 
Trypsin-EDTA solution to each well. The original 10cm plate was placed on a 
microscope in a Laminar Flow Hood and individual colonies were picked with a micro-
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pipetter and disposable sterile tips (1-10 pi) in a maximum volume of 10 pi. Each colony 
was transferred to the trypsin solution in the 96 well plate prepared earlier. After 96 
colonies were picked, the 96 well plate was placed at 37 °C, 5 % COg for 10’. During the 
incubation, a previously prepared 96 well feeder plate (flat bottomed wells), containing 
200pl of medium and fibroblasts was aspirated to remove the medium and 150 pi of 
fresh complete medium was added per well. The trypsinized colonies were retrieved 
from the incubator and add 25 pi of complete medium was added per well. Clumps of 
cells were broken up by moving the cell suspension up and down with the multi-channel 
pipetter 5-10 times. The entire contents of each well were transferred to a well in the pre­
prepared feeder plate. The plate was transferred to the incubator and the ES cells grown 
to confluence (approximately 2-3 days). When the ES cells approached confluence, they 
were washed twice with PBS and trypsinized using 50 pi of trypsin solution per well for 
10’. 50 pi of complete medium was added to each well and clumps were broken up by 
vigorous pipetting. 50 pi of the cell suspension was replated onto a gelatinized 96 well 
(flat bottomed) plate without feeder cells. The remaining cells in the original 96 well plate 
were frozen by adding 50 pi of 2x freezing medium as described in “Freezing and 
thawing ES cells”. The gelatinized plate was grown to confluence for DNA preparation 
and analysis by Southem blot analysis. Once the targeted clones were identified, the 
appropriate wells (colonies) were retrieved from the freezer and expanded for blastocyst 
injection.
2.2.8 Freezing and thawing ES cells in 96 well plates
The medium was changed 4 hours before freezing. The medium was removed by 
aspiration and cells were rinsed twice with PBS. 50 pi trypsin was added to each well 
and the plate incubated for 10’ at 37 °C, 5 % 00%. 50 pi of 2x freezing medium was then 
added per well and the colonies were resuspended evenly 100 pi of sterile mineral oH 
was placed over each well to prevent degassing and evaporation during storage at -70 ®C. 
The 96 well plate was sealed with parafilm and stored at -80 °Ç. The optimum storage 
time was less than 2-3 weeks before retrieval of targeted clones.
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To thaw, the 96 well plate was removed from the freezer and placed at 37 °C for 10’-15’. 
Targeted clones were transferred to a 1 cm well (24 well plate) with feeder cells 
containing 2 ml of complete medium. The medium was changed next day to remove the 
DMSO and the oil. Cells were grown to confluence and cultured as described in section 
“2.2.3 Culture of ES cells on fibroblasts” .
2.2.9 Karyotyping
ES cells that were split the previous day onto gelatinized 60 mm tissue culture dishes 
were used for karyotyping. 0.1 ml of colcemid (Gibco, Karyomax colcemid, 10 pg/ml) 
was added to the cells and incubated for 2 h at 37 °C, 5 % CO^ to arrest the cells in late 
prophase, making it easier to count individual chromosomes. Cells were treated with 
Trypsin-EDTA for 2’ at 37 °C and a single cell suspension made. Cells were centrifuged 
at 1200 rpm (Sorvall) for 5’, the supernatant removed and the cells resuspended in PBS. 
Cells were centrifuged 1200 rpm for 5’, the supernatant discarded and the pellet 
resuspended gently in 5 ml 0.075 m KCl at RT for 10’. Cells were centrifuged at 1200 
rpm for 5’ and the supernatant removed and the pellet resuspended by gentle flicking. 1 
ml fixative (3 parts of methanol to 1 part of acetic acid) was added and the cells incubated 
on ice for 10’. The cells were centrifuged 1200 rpm for 5’ and the supernatant removed 
and resuspended in 200 pi fixative. Cells were added drop-wise onto an ethanol-washed 
slide from a height of 1-3 feet using a pasteur pipette. Slides were stained in 1 % lacto- 
acetic orcein for 15’, rinsed in 45 % acetic acid/water and allowed to dry. The number of 
chromosomes in each individual cell were counted using light microscopy (magnification 
X 25).
2.3 Introduction of mutations into the mouse germiine
2.3.1 Production of mouse blastocysts
C57BL/6 (B6 ) mice were used to obtain the recipient blastocysts. Mating pairs were set 
up 4  days before the injection, and vaginal plugs checked the next morning. 2  females
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were mated per male (60 females). Plugged females were identified and separated from 
the males and kept in a separate cage. These females were sacrificed 3 days later to obtain 
the 3.5 day blastocysts.
2.3.2 Preparation of foster mothers for blastocyst injection
Fj hybrid females (B6  x CB A) were used as foster mothers for the chimeras as they have 
a very high pseudopregnancy rate and provided good care for their litters. Foster mothers 
were used at 2.5 days of pseudopregnancy and therefore Therefore were set up for 
mating with sterile males on the same day that the plugs were checked in the B6  females 
(see previous section). 2 Fj hybrid females were mated per vasectomised male (30 
females). The next morning plugged females were collected into a separate cage.
2.3.3 Obtaining the blastocysts
The B6  females were sacrificed by cervical dislocation. The abdomen was opened and 
the genital system, including the uterus, oviducts and ovaries were pulled out. The fat 
pad and mesenteric blood vessels were cut away from the uterus. The 2 horns of the 
uterus were separated by cutting between the ovary and the oviduct at the proximal end 
and at the bifurcation of the uterine horns at the distal end. The blastocysts were flushed 
out of the uterus into a 6  cm tissue culture plate using a 2 ml syringe and a 25 gauge 
needle inserted into the oviduct-end of the uterus. Secum medium was used for culturing 
and flushing the blastocysts When all the uteri were flushed, the blastocysts from the 
plates were collected with a finely drawn Pasteur pipette and put together in a drop of 
Secum medium covered with mineral oil, These were placed in the incubator (37 °C, 5 % 
CO2) until fully expanded for injection.
2.3.4 Injection needles and holding pipettes
The injection needle will carry the ES cells into the blastocoele. To work properly, it 
should have a diameter of 20 p.m at the sharp end. A good needle is the key to a 
successful injection day, if the needle is not working properly (the flow of the cells
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cannot be controlled properly or the point is not sharp enough to penetrate the 
blastocysts) it is best to prepare a new one. The holding pipette will keep the blastocyst 
steady while the needle penetrates it and injects the ES cells. A holding pipette should be 
prepared with an external diameter of 100 |xm, and an intemal diameter of 20 p,m. The 
very end of the pipette should be polished to permit good holding and to avoid damaging 
the blastocysts. For a detailed description of injection needle and holding pipette 
preparation please see “Guide to Techniques in Mouse Development” Edited by Paul M. 
Wasserman, and Melvin L. DePamphilis. 1993.
2.3 .5  Blastocyst injection
The ES cells were fed with complete medium 3 hours before the injection and then 
washed and trypsinized for 2’ at 37 °C. The trypsin was washed off the cells which were 
then centrifuged and the supernatant discarded. Complete medium was added to the cell 
pellet and a single cell suspension made by vigorous pipetting. One drop of ES cells was 
transferred to a 3 cm tissue culture dish (the remainder were stored at 4 °C) just above 
where a drop of Secum medium containing 5-10 blastocysts had been placed. The 3 cm 
tissue culture plate was covered with mineral oil and placed under the microscope (Leitz, 
Labovert, microinstmments Ltd.) prior to injection. 16 ES cells were collected with the 
injection needle and moved to the drop containing the blastocysts. A blastocyst was 
picked up with a gentle vacuum on the holding pipette and lowered until it touched the 
bottom of the plate. The microscope was focused on an intercellular junction at the 
equatorial plane of the blastocyst, and the height of the needle was adjusted to bring it 
into focus in the same plane. The injection needle was inserted through the intercellular 
space and the ES cells were injected slowly. When finished, the needle was withdrawn 
and the injected blastocyst separated from the uninjected group. This procedure was 
completed with each blastocyst in turn. For a detailed description of Blastocyst injection 
please see “Guide to Techniques in Mouse Development” Edited by Paul M. Wasserman, 
and Melvin L. DePamphilis. 1993.
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2.3.6 Blastocysts transfer into foster mothers
When the injections were completed, the blastocyst were left in the incubator for 1-2 h to 
allow reexpansion to occur. A foster B6 xCBA female was anaesthetized by 
intr2q)eritoneal injection with Hypnorm/Hypnovel. The back of the mouse was rinsed 
with ethanol and a small incision was made in the back, 1/3 of the length of the mouse 
from the base of the tail. The skin at the incision was moved ventrally with a needle until 
the ovary was seen through the body wall as a pink structure surrounded by fat. A small 
incision in the body wall was performed and the ovary and oviduct pulled out, handling 
the reproductive tract by the attached fat. The injected blastocysts were transferred to the 
uterus by making a hole with a 25G needle, close to the oviduct end. Using a finely 
drawn Pasteur pipette, 8  injected blastocysts were transfered into the uterus. If possible 
only one uterine horn was used in each female. The uterus was returned to the abdominal 
cavity and the skin closed with a metal clip. The female was placed on a warm surface to 
allow her to recover and then transferred to a cage. The gestation time is approximately 
17 days. For a more detailed description please see “Guide to Techniques in Mouse 
Development” Edited by Paul M. Wasserman, and Melvin L. DePamphilis. 1993.
2.4 Functional assays
2.4.1 Antibody staining of mouse peripheral blood lymphocytes
Blood was harvested into a heparinised c^illary tube and transferred to a 1.5 ml 
eppendorf tube containing 0.2 ml 0.9 % saline and heparin (20 lU/ml, 20000 lU/L). The 
blood was transferred to a polystyrene tube (round bottom tube, 12x75 mm. Falcon 
2052) and 1.25 p.g of CD40 mAb was added, mixed and incubated 5’ on ice. 0.5 p,g of 
B220 mAb was then added, mixed and incubated for a further 30’ on ice. 4 ml of Geys 
lysis buffer was then added for 5’ at RT to lyse red blood cells. The tube was inverted 3- 
4 times and centrifuged at 1200 rpm (Sorvall RT 6000 D) at 4 °C for 7’. The supernatant 
was discarded and the blood quickly resuspended on a whirlimixer. The cells were 
washed once in FACs buffer (PBS, 1 % BSA, 0.1 % azide), centrifuged 1200 rpm at 4
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°C for 7’ and the supernatant discarded before final resuspension in 0.5 ml FACs-buffer. 
Samples were stored in the dark at 4 °C prior to flow cytometric analysis within 18 h of 
the staining procedure (FACScan, Becton Dickinson, CellQuest).
2.4.2 Flow cytometric analysis of lymphatic organs and peripheral blood
Single cell suspensions were prepared as described (see section “7n vitro B cell 
proliferation”). 4 ml of Geys lysis buffer was then added for 5’ at RT to lyse red blood 
cells. The tube was inverted 3-4 times and centrifuged at 1200 rpm (Sorvall RT 6000 D) 
at 4 °C for 7’. The supernatant was discarded and the cells quickly resuspended on a 
whirlimixer. The cells were washed once in FACs buffer (PBS, 1 % BSA, 0.1 % azide), 
centrifuged 1200 rpm at 4 °C for 7’ and the supernatant discarded before final 
resuspension in 0.5ml FACs-buffer. The cells were then counted and 1.0x10® cells were 
aliquoted into to a polystyrene tube (round bottom tube, 12x75 mm. Falcon 2052). The 
cells were labeled with antibodies to the following cell surface markers: CD4, CD8 , 
CD40, B220, IgM, and lastly ap-TCR. The same labeling method was used as 
described for red blood cells (see section “Antibody staining of mouse peripheral blood 
lymphocytes”) the only difference being that Ijig of each antibody was used for staining 
splenocytes and cells from the lymph nodes and thymus. Samples were stored in the 
dark at4°C prior to flow cytometric analysis within 18 hours of the staining procedure 
(FACScan, Becton Dickinson, CellQuest).
2.4.3 In vitro B cell proliferation
B lymphocytes were purified from the spleens of wt and CD40 deficient mice. A single 
cell suspension was made and washed in buffer (PBS, 2 mM EDTA, 0.5 % BSA) and B 
lymphocytes were purified using MACS (Magnetic Cell Sorting of Mouse Leukocytes) 
CD45R microbeads and positive selection (RS+) columns. A single cell suspension was 
made from spleens by breaking up the spleens and passing the cells through a 70 \im 
nylon mesh using a 2 ml syringe plunger in 5 ml buffer. The cells were centrifuged at 
1200 rpm 5’ (Sorvall RT 6000 D) and the supernatant discarded. The pellet was
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resuspended to give 10^  total cells per 90 pi of buffer. 10 p,l of MACS CD45R (B220) 
microbeads were added per 10^total cells, mixed well and incubated for 15’ at 6-12 °C. 
Cells were washed by adding 1 ml of buffer, centrifuging at 1200 rpm for 5’, removing 
the supernatant completely and resuspending the resulting cell pellet in 500 pi of buffer 
per 10® total cells. The magnetically labeled cell suspension was pipetted onto an RS+ 
column, inserted into the magnetic field of a VarioMACS magnet. The cell suspension 
was allowed to run through the column which was then washed with 500 pi of buffer. 
The effluent was collected as the negative fraction. The column was washed twice more 
with 500 pi buffer and this effluent was pooled with the previous negative fraction. The 
column was removed from the VarioMACS magnet and placed over a new collection 
tube. 1 ml of buffer was applied to the reservoir of the RS+ column and the cells flushed 
out using a 2 ml syringe plunger. The resultant cell preparations were more than 95 % 
pure B cells as determined by flow cytometric analysis (FACScan, CellQuest) for surface 
CD45R, CD40, CD4 and CD8 .
B cells were cultured in RPMI 1640 containing 10 % FCS, L-Glutamine, 
pcnicillin/strcptomycin, p-mercaptoethanol. For proliferation assays, B cells (3.5 x 10® 
cells/well; 200 pi) were cultured for 72 hours in 96 well round-bottom tissue culture 
plates in the presence of 2 p.g/ml LPS, 50 U/ml IL-4, 25 p,g/ml CD40 mAB. Cultures 
were pulsed with 1 p,Ci/well of (®H)thymidine (Amersham) for the last 18-24 hours of a 
72 hour culture period and then harvested onto glass fiber filters. (®H)thymidine uptake 
was measured by a liquid scintillation counter (1205 Betaplate, Wallac).
2.4.4 Immunohistochemistry
Mice were immunized with 100 p,g KLH in complete Freund’s adjuvant. Ten days later 
the spleens were removed and placed in embedding compound and snap-frozen in liquid 
nitrogen and then stored at -80 °C. Up to 48 tissue sections of 5-10 p,m were cut using a 
cryostat (Kryostat 1720, UETTZ) and left until the next day at RT. The sections were 
fixed in acetone (AnalaR acetone, BDH) for 10’ and air dried for 30’. Slides were
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wrapped in foil and stored at -20 °C. Slides were thawed for 10’ and a two-step indirect 
staining method was used. Primary antibody was diluted to the correct concentration and 
applied to the tissue section for 30’-45’ at RT. The section was washed in TBS and an 
cnzyiiie-cûiijügâted secondary antibody was then added and incubated for 30’-45’ at RT. 
The sections were washed and substrate (Diaminobenzidine or Fast red) was added and 
incubated until the desired color intensity had developed. Counterstaining was carried out 
using haematoxylin and the section was then placed under a coverslip.
Primary antibodies: 1.) Biotinylated Peanut agglutinin, 2.) FTTC conjugated rat anti­
mouse CD40, 3.) Rabbit anti-CD3,4.) Rabbit anti-CD79a.
Secondary antibodies: 1.) Avidin horseradish peroxidase conjugate, 2.) Rabbit anti-FTTC 
horseradish peroxidase conjugate, 3.) Goat anti rabbit horseradish peroxidase conjugate. 
4.) Avidin alkaline phoshatase conjugate.
Substrate: DAB (Diaminpbenzidene) and Fast red. (Sigma).
2.4.5 Preparation of serum from blood
The mouse was sacrificed and bled out using a 1 ml syringe. The blood was clotted in a 
15 ml Falcon tube for 4 h at RT and placed o/n at 4 °C to allow clot retraction. The clot 
was gently loosened from the sides of the tube with a wooden applicator stick without 
breaking up the clot which was then discarded and the serum was transferred to a 15 ml 
Falcon tube. Remaining blood cells and debris were pelleted by centrifugation for 10’ at 
2700g 4°C (Sorvall RT 6000 D). The semm was then ready for analysis of 
immunoglobulin levels.
2.4.6 ELISA
Detection of serum immunoglobulin isotypes was performed using a sandwich-ELISA. 
NUNC polysorp plates were coated with anti-mouse IgM, IgGl, IgG2a, IgG2b, IgG3 
and IgE diluted in PBS/0.05% NaNj to a final concentration of 20 p.g/ml and incubated
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overnight at 4 ®C. Plates were then blocked with PBS containing 1% BSA, 0.3% 
Tween, 0.05% NaNj and incubated for 2 hrs at 37 ®C. Plates were then washed 3x in 
ELISA wash buffer (see buffers and solutions). Mouse inimunoglobulin standards for 
each of the isotypes and serum from wild-type and CD40 deficient mice were diluted in 
PBS, 0.1% BSA, 0.3% Tween, 0.05% NaNj and added to the plates and incubated for 
2 hrs at 37 ®C. The starting concentration of the standards was 500 ng/ml and these were 
then diluted 2 fold with a total of 11 dilutions. The starting dilution of semm for the 
detection of the different immunoglobulin isotypes was: IgM: 1:500; IgGl: 1:1000; 
IgG2a: 1:1000; IgG2b: 1:1000; IgG3: 1:500; IgE: undiluted. These were then diluted 2 
fold with a total of 11 dilutions. Plates were washed 5x with ELISA wash buffer and 
alkaline phosphatase-conjugated isotype specific antibodies (anti-mouse Ig-AP) were 
then added at a final concentration of 2 p,g/ml (diluted in PBS) and incubated 1 hr at 37 
®C. Plates were then washed lOx in ELISA wash buffer and PNPP (p-nitrophenyl 
phosphate, 1 mg/ml) substrate was added and color intensity determined at 405 nm in an 
ELISA microplate reader (Dynex MRX TC2). Semm immunoglobulin isotype 
concentrations were calculated using the software program Revelation 3.04.
2.4 .7  Mouse ELIspot (IFN-y)
MAHA plates were coated with 50 pJ of 10 pg/ml R4 monoclonal antibody in sterile 
PBS. Incubated overnight at 4 ®C. Wells were washed 5 times with 200 pi of PBS, 
followed by blocking of nonspecific binding by complete RPMI-1640 medium 
containing 10 % FCS for 2 h at room temperature. 1.0x10® cells in 50 pi were added to 
the per well and the antigen were added on top, either 250 ng/ml or 1 pg/ml Tuberculin 
PPD (Tuberculin purified protein derivative BP) in a total of 200 pi of medium. Cells 
plus antigen were incubated undisturbed for 18-24 h at 37 °C. Next day, cells were 
flicked out and the wells washed 3 times with PBS, then once with water and tlien twice 
more with PBS. 50 pi of biotin conjugated rat anti-mouse IFN-y antibody in PBS (1 
pg/ml) were added to the wells and incubated 2 h at room temperature or overnight at 4 
°C. Wells were washed 5 times in PBS and 50 pi of streptavidin poly alkaline
61
2; Materials and Methods
phosphatase ( 1  |ig/ml) were added and the plate were incubated 2  h at room temperature. 
Wells were washed 5 times with PBS and 50 pi of developing reagent (BIORAD: AP- 
conjugate substrate kit) were added. Colour developed at room temperature for 1-2 h, 
wells were then washed 5 times with tap water and allowed to air dry, before counting 
spots.
2.4.8 Mycobacterial counts (colony-forming units)
Homogenates of spleen, liver and lung were prepared in 1 ml of PBS/Tween-80 
(0.05%). 200 |il of homogenized tissue was plated at 2.5, 5- or 10-fold serial dilution 
(diluted in PBS) onto Middlebrook 7H10 agar plates. Colony-forming units (bacterial 
colonies) were counted 2-3 weeks later.
2.4.9 Histology (BCG infected mice)
Tissue sections were fixed in 10% formalin and embedded in paraffin blocks. Sections 
(5 pm) were stained with hematoxylin and eosin. Hematoxylin stains the nucleus blue, 
whereas eosin stains the cytoplasm red. Sections were also stained by the Ziehl-Neelsen 
method for acid fast bacilli using the following method. Take sections to water. Rinse in 
distilled water. Cover sections with filter paper dampened with distilled water. Apply 
staining solution to filter paper on sections. Rinse in distilled water. Decolourise sections 
in 1% acid alcohol. Rinse in distilled water. Counterstain in 1% methylene blue in 1% 
acetic acid. Dehydrate, clear and mount. Result: acid-fast bacilli stain red and nuclei stain 
blue.
2.4.10 Statistical analysis:
The results from the various analyses carried out in this thesis were compared using 
Student’s t-test. This was used to evaluate whether the differences between the means of 
the parameters studied were significantly different. It was assumed that the results 
obtained from the two populations (wild-type and mutant mice ) were normally 
distributed and that the standard deviations of the two populations were equal. A
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significance level of 5% was chosen, and P values below this indicated that the 
differences in the two populations being compared were significant, (Essentials of 
Medical Statistics, Betty R. kirkwood).
2.5 Buffers and Solutions
2.5.1 Molecular biology
Solution I: 50 mM Glucose 
25mMTris-Cl pH 8.0 
lOmMEDTA
Solution II: 0.2 MNaOH 
1 %SDS
solution IQ: 3 MKOAc 
2  MHOAc
lOx kinase buffer: 500 mM Tris-Cl pH 7.6 
100 mM MgClj 
50 mM DTT 
1 mM Spermidine 
1 mM EDTApH8.0
lOx TA buffer: 1 M Tris-acetate
2 M K-acetate
1 M Mg-acetate
lOx Ligation buffer: 500 mM Tris-Cl pH 7.4 
100 mM MgClg 
100 mM DTT 
10 mM Spermidine 
10 mM ATP 
1 mg/ml BSA
lOx CIP buffer: 500 mM Tris-Cl pH 9.0 
10 mM MgClj 
1 mM ZnClg
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10 mM Spermidine
IxTE buffer: 10 mM Tris-Cl pH 7.6 
Im M  EDTApHS.O
IxTBE buffer:
lOx Loading buffer, agarose gel:
Hybridisation buffer (church):
Mousetail buffer:
89 mM Tris-Cl pH 7.8 
89 mM Borate
2 :mM EDTA pH 8.0
15 % Ficol
0.25 % Bromphenol blue
0.25 % Xylen cyanol
1 0 0 mM EDTA pH 8.0
0.5 M NaPo^ pH 7.2
7 % SDS
5 mM EDTA
( 1 % BSA)
50 mM Tris-HCl pH 8.0
1 0 0 mM EDTA
1 0 0 mM NaCl
1 % SDS
Lysis buffer (ES cells): 10 mM Tris pH 7.5 
10 mM EDTA 
10 mM NaCl 
0.5 % sarcosyl
Add Proteinase K to a final concentration of 1 mg/ml just prior to 
use.
Denaturing solution: 1.5 M NaCl 
0.5 M NaOH
Neutralising solution: 1.5 M NaCl 
0.5 M Tris-HCl pH 7.2 
1 mM EDTA
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20x SSC: 3 M NaCl 
0.3 M NagCitrate
Buffer Cl: Dissolve 109.54 g sucrose, 1.02 g MgClj.ôHjO, 1.211 g Tris 
base in 800 ml ddH^O. Add 100 ml 10 % Triton X-100 solution. 
Adjust pH to 7.5 with HCl. Adjust the volume to 1 liter with
ddHjO.
Buffer G2: Dissolve 76.42 g GuHCl, 11.17 g Na^-EDTA ^H^O, 3.633 g 
Tris base in 600 ml ddH^O. Add 250 ml 20 % Tween-20, 50 ml 
10 % Triton X-100. Adjust the pH to 8.0 with HCl. Adjust the 
volume to 1 liter with ddH^O.
Buffer QC: Dissolve 58.44 g NaCl, 10.46 g MOPS in 800 ml ddH^O. 
Adjust the pH to 7.0 with NaOH. Add 150 ml pure ethanol. 
Adjust the volume to 1 liter with ddHgO.
Buffer QF: Dissolve 73.05 g NaCl, 6.055 g Tris base in 800 ml ddl^O. 
After the addition of 150 ml pure ethanol adjust the pH to 8.5. 
Adjust the volume to 1 liter with ddH^O.
50xTAE; 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5 M EDTÀ 
pH 8.0. Adjust the volume to 1 liter with ddH^O.
SM Buffer 5.8 g NaCl
2 . 0  g MgSo4.7H20
50 m il  M TrisHCl (pH 7.5)
5 ml 2 % gelatin solution
HgO to 1 liter
Plasmids: pGEM-7Zf(+) (Promega) 
pGEM-1 lZf(+) (Promega)
pMCl Neo (contains the neo structural gene from Tn5)
2.5.2 Tissue culture
ES cell lines: D3: derived from mouse strain 129/Sv.
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RI: derived from mouse strain (129/Sv x 129/SvJ) F,.
Medium for ES cells (complete medium):
DMEM - 500 ml (Gibco-BRL; Ix; 41965-039).
Fetal Calf Serum - 80 ml (Sigma; F-4884; lot. 51H-0546).
100 % FCS batch tested, heat inactivated at 56 ®C for 30’. 
L-Glutamine - 5 ml (Gibco-BRL; lOOx; 25033-010).
Pen/Strep - 5ml (Gibco-BRL; 5000IU; 15070-022).
Sodium Pyruvate - 5 ml (Gibco-BRL; lOOmM; 11360-039). 
P-mercaptoethanol - 0.5 ml (0.1 M) (Sigma; 14.3 M; M7522).
G418 selection medium:
Complete medium.
G418 added to complete medium at a final concentration of 
300 pg/ml. Geneticin (G418 sulfate; Gibco-BRL; 11811-031). 
LIF (Leukaemia Inhibitory Factor) 500 U/ml
Gelatin: 1 % (Sigma; Type A from porcine skin; G-2500)
Mitomycin C: (Sigma; M0503; 2mg).(10 pg/ml complete medium).
PBS: Phosphate buffered Saline. PBS tablets (OXOED PBS Dulbecco
A tablets; BR14a; Ca^ and Mg^ free.
Trypsin-EDTA: (Gibco-BRL; Ix; 45300-019)
2.5.3 Functional assays
Geys lysis buffer: Solution A: (1 liter)
35 g NH4CI
1.85 gKCl 
0.56 gNa^HPO,
0.12 gKHgPO^
5.0 g Glucose
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Sterilise by Alteration: 0.22 pm filter.
Solution B:(500 ml)
2.1 gM gC V ôH ^O  
0.7 g MgSO^^H^O 
2.25 g CaCl^ ^H^O
Autoclave.
Solution C: (500 ml)
11.25 gN aH C O j
Autoclave.
Mix solutions:
A: 100 ml
B: 25 ml
C: 25 ml
ddHjO: 350 ml
total 500 ml
FACS buffer: PBS, 1 % BSA, 0.1 % azide.
EL-4: Interleukin-4 (50 units/ml) (Pepro Tech inc.; cat.no. 214-14)
LPS: Lipopolysaccharide 1 mg (Sigma; cat.no. L 6529)
PPD: Tuberculin purified protein derivative BP.(EVANS medical)
BCG: Percutaneus BCG vaccine. BCG: bacillus Calmette-Guerin
(Copenhagen sub-strain 1077). 1.0x10^ viable units per I.V. 
injection. (EVANS medical).
MACS CD45R microbeads:
MACS colloidal super-paramagnetic microbeads conjugated to 
monoclonal rat anti-mouse CD45R (B220) antibodies.
Isotype: rat IgGj^. Clone: RA3-6B2. (Miltenyi Biotec; cat no. 
495-01).
MACS separation columns:
RS+ positive selection separation columns. (Miltenyi Biotec; cat. 
no. 413-01).
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RPMI1640 medium:
Medium for B cell proliferation.
RPMI 1640- 500 ml (Sigma; R 8758).
Fetal Calf Serum - 50 ml (Sigma; F-4884; lot. 51H-0546).
100 % FCS batch tested, heat inactivated at 56 ®C for 30*. 
L-Glutamine - 5 ml (Gibco-BRL; lOOx; 25033-010).
Pen/Strep - 5ml (Gibco-BRL; 5000IU; 15070-022). 
P-mercaptoethanol - 0.5 ml (0.1 M) (Sigma; 14.3 M; M7522).
ELISA wash buffer: 0.9% NaCl, 0.005M K^HPO^, 0.005M KH^PO^, 0.025% 
Tween. (For lOL: 90g NaCl, 100 ml 0.5M KgHPO^, 100 ml 
KH2PO4, 25 ml 1:10 diluted Tween 20. Adjust to pH 7.0).
ELISA substrate: PNPP (Sigma) diluted at 1 mg/ml in diethanolamine buffer.
Diethanolamine buffer:
48.5 ml diethanolamine, 400 mg MgCl^ x bH^O, 100 mg NaN^, 
add 450 ml H^O. Stir for 1 hr in the DARK, pH 9.8 (with con. 
HCL) add ~ 500 ml to 1 litre. Store at 4 °C.
2.5.4 Introduction of mutations into the mouse germiine
Mineral oil: Embryo tested (Sigma; cat.no. M8410)
Glass tubing: Holding pipette, injection needle (World Precision Instruments;
1.0/0.75, RTW 100-4)
Glass capillary tubes: Transfer pipettes (BDH; cat.no. 314/1100/12)
Silicone oil: Dow Coming 200/200cS (BDH; cat. no. 63008-4C)
Hypnorm (Fentanyl)/Hypnovel (midazolam), 0.2 ml/20 g mouse (veterinary surgeon)
Injection microscope: Leitz, Labovert FS, Microinstruments Ltd.
Pipette puller:
Microforge:
Beveller:
Vertical pipette puller, model 720C, David Kopf 
Instruments, Tujunga,Califomia, U.S.A.
Alcatel-Annecy , TY 4160, Microinstmments Ltd. 
1300 M Beveller, World Precision Instruments.
Secum Medium:
EDTA
NaCl
g/lOOOml
0.037
5.546
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KCl 0.356
KH2 PO4  0.162
MgS04.7H20 0.294 
NaHC03 2.106
Glucose 1.000
Na-lactate (DJ^) 3.05 ml
Ca-lactate.5 H2 0  0.527
Na-pyruvate 0.028
G-penicillin 0.075
Streptomycin.S04 0.050
BSA 3.000
Phenol Red 1 ml/1% solution
Weigh out all ingredients, except Phenol red, Na-lactate, BSA, in one weighing boat. 
Add 980 ml of ddH2 0  in a sterile tissue culture flask. Add Phenol red and Na-lactate, 
stir until all chemicals are dissolved. Sprinkle BSA on top of medium. DO NOT STIR. 
Leave o/n at 4 ®C. Filter the medium slowly, in order to avoid bubbles. Store at 4 for 
not more than one month.
69
3: CD40 deficient mice
Chapter 3: Generation of CD40 deficient mice
3.1 Generation of a targeting vector for CD40
When a fragment of genomic DNA is introduced into a mammalian cell it can locate and 
recombine with the endogenous homologous sequences and this is called gene targeting. 
Gene targeting has been widely used in mouse embryonic stem (ES) cells to make 
mutations at different loci (genes) so that the phenotypic consequences of a specific 
genetic modification can be assessed in vivo (Figures 3. and 4.). In this chapter the 
generation of a vector to specifically target CD40 and the subsequent production of CD40 
targeted embryonic stem cell clones is described. The production of chimaeric mice, the 
establishment of germiine transmission and lastly the interbreeding of mice heterozygous 
for the mutant allele to generate CD40 deficient mice is also described.
The first experimental evidence for the occurrence of gene targeting in mammalian cells 
was made in a fibroblast cell hne where a selectable artificial locus introduced by Lin and 
coworkers, corrected a deficiency in the thymidine kinase gene of that cell line (Lin et a i, 
1985). Another study demonstrated that homologous recombination could also occur 
between a plasmid containing sequences from the p-globin gene and the endogenous p- 
globin gene in erythroleukaemia cells (Smithies et al., 1985). In general the frequencies 
of gene targeting events in mammalian cells are low. This is probably related to the fact 
that transfected DNA can also integrate into random chromosomal sites. The relative 
frequency of targeted to random integration events will determine the ease with which 
targeted clones may be identified in a gene targeting experiment. A targeting vector is 
designed to recombine with and mutate a specific chromosomal locus. The minimal 
requirements of a targeting vector are that it should have homologous sequences to the 
desired chromosomal integration site and positive and negative selection markers 
providing strong selection for cells with a targeted integration. The positive selection 
marker in a targeting vector may serve two functions. Its primary function is as a 
selection marker to isolate the rare transfected cells that have integrated DNA. Secondly
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the positive selection marker can serve as a mutagen, for instance, if it is cloned into a 
coding exon of the gene or replaces coding exons. Many targeting vectors also use a 
negative selection marker which is positioned at the end of the homologous sequences. 
The negative selection marker renders cells, which have integrated the targeting vector 
into a random chromosomal site, sensitive to FIAU/gancyclovir. The neo gene, encoding 
a bacterial aminoglycoside phosphotransferase, renders a given cell resistant to the 
antibiotic G418 (an inhibitor of protein synthesis), so that it can be positively selected 
(Colbere et al., 1981). The thymidine kinase gene (tk ) is of viral origin (herpes simplex 
virus, HSV) and facilitates the incorporation of antiviral drugs such as gancyclovir and 
FT AU (l-(2’-deoxy-2’-fluoro-b-D-arabinofuranosyl)-5-iodouracil) into DNA during 
replication. These base analogs block the incorporation of additional bases and thereby 
induce a termination of replication that will lead to cell death. Thus, cells which have 
randomly integrated the targeting vector and the tk gene can be negatively selected 
(Borrelli et a i, 1988; St et a i, 1987).
Two distinct designs are commonly used for gene targeting in mammalian cells, 
replacement and insertion vectors. These vector-types are constructed differently so that 
following homologous recombination they yield different integration products. The basic 
elements of a replacement vector are, homologous sequences to the target locus, a 
positive selection marker, bacterial plasmid sequences and a linearization site outside of 
the homologous sequences of the vector (Figure 6  and 8 ). The final recombinant mutant 
allele can be described as a consequence of double reciprocal recombination between the 
vector and the chromosomal sequences. This is equivalent to a replacement of the 
chromosomal homology with all components of the vector which are flanked on both 
sides by homologous sequences. Any heterologous sequences at the ends of the vector 
homology are excised from the vector and are not recovered as stable genomic sequences 
following targeting. The recombinant allele generated in a gene targeting experiment 
using a replacement vector typically has a positive selection marker inserted into a coding 
exon or a coding exon is deleted and replaced by the positive selection marker.
71
3: CD40 deficient mice
Disruption of the coding sequence by the positive selection marker will in most instances 
ablate a gene’s function. However, in some situations a truncated protein may be 
generated which retains some biological activity. Therefore, null alleles are more likely to 
occur if the positive selection marker is inserted into an upstream exon rather than a 
downstream exon. This ensures that only the very N-terminal portion of the polypeptide 
should be made. Another important consideration is exon skipping. An artificially large 
exon with an inserted positive selection marker may not be recognized by the RNA 
splicing mechanism and could be skipped (Robberson et al., 1990). Thus, transcripts 
initiated from the endogenous promoter may delete the mutated exon from the mRNA. If 
this involves a coding exon, containing the positive selection marker, without a unit 
number of codons, then the net result will be both a deletion and a frame-shift mutation 
of the gene, which should generate a null allele. However, if the disrupted coding exon 
has a unit number of codons which is spliced out, this would result in a protein with a 
small in-frame deletion which may retain partial or complete function.
The position of the positive selection marker with respect to the homologous sequences 
of the vector will determine the type of sereen that must be used to deteet the ES eell 
clones targeted with a gene replacement event. One common screening method for 
targeted ES cell clones is based on PCR amplification. This is accomplished by using 
one primer which hybridizes to the positive selection marker and a second primer which 
hybridizes to the target chromosomal sequences just beyond the homology used in the 
vector (Figure 7.). Thus, replacement vectors designed for screening by PCR 
amplification require that the positive selection marker is inserted at an asymmetric 
location near one end of the homologous sequences, while still leaving sufficient 
homology for the formation of a crossover. This gives a vector with one long arm and 
one short arm of homologous sequences. Another common screening method for ES cell 
clones targeted with a gene replacement vector uses Southern blot analysis (Figure 9.). 
For this it is important to design the vector and identify a unique probe(s) and restriction 
sites so that such analysis is unambiguous and can discriminate between the wild-type
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allele and the predicted targeted allele. This analysis is ideally performed with a probe 
that is not contained in the homologous sequences of the targeting vector (external probe, 
probes A and B in Figure 7. and 9.) and a restriction enzyme digest that does not cut in 
the homologous sequences o f the vector or where at least one restriction enzyme site is 
located outside the homologous sequences of the vector (Figure 7. and 9.).
The basic elements of an insertion vector are, a region of homologous sequence to the 
target locus which has a unique linearization site, a positive selection marker and a 
bacterial plasmid backbone. The major difference between the two vector types 
(replacement and insertion vectors) is that the linearization site of an insertion vector is 
made in the homologous sequences of the vector. An insertion vector undergoes single 
reciprocal recombination (vector insertion) with its homologous chromosomal target 
which is stimulated by a double stranded break (linearization site) in the vector. Since the 
entire insertion vector is integrated into the target site, including the homologous 
sequences of the vector, the recombinant allele generated by such a vector becomes a 
duplication of the target homology separated by the heterologous sequences in the vector 
backbone. The duplication of exon sequences is usually sufficient to generate a null 
allele. However, to ensure that exon duplication will create a mutation at the protein level 
it may be necessary to introduce stop codons into a single exon in the targeting vector. 
Screening for the recombinant allele generated by an insertion vector can be done by 
PCR amplification or Southern blot analysis. The best restriction enzyme digest for 
Southern blot analysis will be with an enzyme that does not cut within either the 
homology of the target locus or the vector backbone. As I have described previously, the 
use of an external probe in Southern blot analysis is necessary. An ES cell clone which 
has inserted one unit of the vector into the target locus will show an increase in the size 
of the restriction fragment which matches exactly the size of the targeting vector.
To obtain sequences from the murine CD40 gene, a murine genomic library containing 
genomic sequences from the mouse strain 129/Sv (Lambda Dash 9H-129/Sv) was plated 
and screened using a 930 bp cDNA probe (Plating and screening procedure is described
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in section 2.1.5). The CD40 cDNA probe was produced by PCR amplification, as 
described in section 2.1.22, using primers hybridizing to exon 1 (Primer 1) and just 
downstream of exon 9 (Primer 9) on cDNA isolated from mouse splenocytes. The 
mammalian genome contains approximately 3 x 10’ bp and one phage, on average, 
contains a genomic insert of approximately 12 kb (12 x 10^  bp). To ensure that the entire 
genome was represented in this screening, a minimum 2.5 x 10  ^ clones (phages) would 
need to be plated out and screened for the gene of interest. 7.5 x 10  ^ clones were plated 
and screened for the presence of CD40 genomic sequences. This yielded 3 positive 
phage clones (Figure 5.). The 3 positive phage clones were isolated and amplified in the 
phage maxiprep method described in section 2.1.6. Restriction enzyme digests, using 
enzymes BamHI, SaR, Sad , Kpn\, BgtQ., EcoRI, Xhoi, Xbal, HindUl, and agarose gel 
electrophoresis on phage DNA (described in section 2.1.1 and 2.1.12) and subsequent 
Southern blot analysis (described in section 2.1.19-2.1.20) using oligo-nucleotide 
primers (primers 1 -8 ) to probe for the different exons, revealed that phage clone 1 
contained exon 1 , whereas phage clone 2  contained exons 2 - 6  and phage clone 3  
contained exons 2-9 (Figure 5.). Both clones 2 and 3 were ideal for the generation of a 
replacement targeting vector as they contained sufficient sequence to allow homologous 
recombination to occur and the presence of an EcoRI restriction site in exon 3 allowed 
for the insertion of the positive selection marker and stop-codons.
74
X —
&
X  —
S—
w —
I
I
s -
I
I
1
Û
I \
H  I
PQ u  J
<s
1^:
X —
S —
5 —
I  ^U W=d
I
o  o\73 ^
!i
l |
I k
£ 3  
m o?i
I Io "5
.Xo\
( S
% ï
I!
w
il
ÎII
lflrfi
!|SJ=00
li^  G w
U o<^
I
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Two different targeting vectors were made, construct 1 (Figure 6 .) and construct 2 
(Figure 8 .)- Construct 1 was made by ligating the Xbal restriction fragment from the 
CD40 gene, containing exons 2-5, into a pGEM-1 lZf(-) vector (Figure 6 .B.I.) as 
described in section 2.1.12-2.1.13. The cloning step was followed by PCR amplification 
of a 3 kb region spanning exons 2-4. The primers used were the T7 polylinker primer 
(primer 12) and a primer hybridizing downstream of exon 4 (primer 4). The resulting 
PCR fragment was then cloned into a pGEM-7Zf(+) vector (Figure 6.B.2.). The last 
step in generating construct 1 was to clone the G418 resistance gene (NEO) into the 
EcoRI site of exon 3. The G418 resistance gene consisted of the neo structural gene 
(aminoglycoside phosphotransferase, derived from the bacterial transposon Tn5) and the 
promoter driving the expression of this G418 resistance gene (derived from the herpes 
simplex virus thymidine kinase gene (HSV-rk)). To increase the efficiency of the tk 
promoter a 65 bp fragment derived from the polyoma virus enhancer was inserted 
upstream of the tk promoter (Thomas & Capecchi, 1987). The G418 resistance gene 
confers resistance to Geneticin (G418) which is an inhibitor of protein synthesis.
The pGEM-7Zf(+) vector containing the cloned CD40 PCR fragment (Figure 6.B.2.) 
was cut with the enzyme EcoRL and an oligonucleotide linker with a Sal I restriction site 
was ligated into the EcoRl restriction site. The linker, consisting of primers 13 and 14, 
contains a Sail restriction site and stop-codons in all three reading frames. Ligation of the 
linker into the EcoRI restriction site abolishes this restriction site due to nucleotide 
changes in the linker sequence. The vector containing the cloned PCR fragment (Figure 
6.B.2.) and the linker fragment was subjected to restriction digestion with EcoRI, and E. 
coli was transformed with the restriction digest. This ensures that only vectors containing 
the cloned PCR fragment and the linker fragment {Sail restriction site) will support 
bacterial growth, whereas vectors without the linker, still containing the EcoRI site, will 
be linearized and as a result, cannot support bacterial growth. The correct vector was 
then amplified in a miniprep (described in section 2.1.3) and then cut with Sail restriction 
enzyme to remove concatamers of the linker and to prepare the vector for ligation of the
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G418 resistance gene into the SaH restriction site. The G418 resistance gene (NEO) was 
cut out of the plasmid pMClNeo by a SaH-Xhoi restriction digest and ligated into the 
SaH site of the vector containing exons 2-4 of the CD40 gene. The Sad and Xhol 
restriction sites are compatible for ligation purposes. The final outcome of the cloning 
procedure is a targeting vector containing a 3 kb fragment of the CD40 gene with a G418 
resistance gene (1.2 kb) inserted into the engineered Sad site (previously EcoRI site) of 
exon 3 (Figure 6.B.3.). The linker served two purposes, it introduced a Sad site 
enabling the cloning of the G418 resistance gene {Sad-Xhol restriction digest) into exon 
3, and the linker also contained stop-codons in all three reading frames, terminating 
transcription of the CD40 gene in the event of homologous recombination. The G418 
resistance gene was inserted upstream of the putative binding site (residues E74, Y82, 
D84, N8 6 , E l 17) for CD40L, thereby abolishing any ligand binding of a truncated 
CD40 protein (Bajorath cr a/., 1995b).
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Figure 6 . Cloning of targeting construct 1. A.) Partial restriction map of the CD40 gene. B.) 
Cloning procedure for construct 1. Xbal fragment of the CD40 gene was cloned into pGEM- 
1 lZf(-) vector (B. 1.), followed by PCR ampUfication of a 3 kb region spanning exons 2-4. The 
PCR product was cloned into the BamHl-Xhol restriction site of a pGEM-7Zf(+) vector (B. 2.). 
Finally, cloning of the G418 resistance gene into the Sail restriction site of exon 3 (B. 3.). NEO: 
G418 resistance gene, The antisense primer (primer 4, exon 4) and the T7 primer (primer 12) 
used in the PCR amplification are shown by small arrows (B. 1.). Black boxes represent exons 
1-9. Restriction enzyme sites: Xb, Xbal\ S, S a d ’, E, EcoRI; B, RamHI; X, Xhol’, Sa, Sail. 
Dashed hnes show cloning sites in the polylinker.
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Construct 1 was designed so that the initial screening for the homologous recombination 
could be carried out using PCR amplification (Figure 7.C.). Homologous recombination 
was detected using PCR amplification on genomic DNA extracted from electroporated 
ES cells using a primer (primer 11) inside the G418 resistance gene (NEO) and a primer 
to exon 5 (primer 5) outside the region of homology, giving a 1 kb product (Figure 
I.e .). Screening for homologous recombination by PCR is described in detail in section 
2.1.25. Subsequent confirmation of the homologous recombination event would be 
carried out by EcoKV restriction enzyme digest on genomic DNA, followed by Southern 
blot analysis using a 820 bp fragment spanning exon 6  as an external probe (probe B). A 
targeted mutation would yield a 6 . 2  kb fragment, whereas the non-targeted wild-type 
allele would give a 5 kb fragment (Figure 7.C.).
Constmct 2 was made by cloning an Xbal-Xhol restriction fragment of the CD40 gene, 
containing exon 6 , (Figure 8 .B.I.) into a pGEM-llZf(+) vector. Then an Xbal 
restriction fragment of the CD40 gene containing exons 2-5 was cloned into the Xbal site 
of the vector, resulting in an 8  kb genomic fragment spanning exons 2-6 of the CD40 
gene (Figure 8 .B.2 .). Cloning of the G418 resistance gene into the EcoRI restriction site 
of exon 3 requires that only one EcoRI restriction site is present in the vector and the 
CD40 fragment (exons 2-6). Due to the presence of an EcoRI restriction site in the 
polylinker of the pGEM-llZf(+) vector, the 8  kb genomic fragment (HindHl-Xhol, 
exons 2-6) was excised and then cloned into a pGEM7Zf(+) vector, having no EcoRI 
restriction site in the polylinker (Figure 8.B.3.). This facilitated the cloning of the G418 
resistance gene into the exon 3 EcoRI restriction site (Figure 8.B.4.), as described for 
construct 1 .,
Screening for homologous recombination occurring with construct 2 was only possible 
using BamHl restriction enzyme digestion followed by Southern blot analysis (Figure 
9.). A targeted mutation would give a 10 kb fragment, with a BamHl restriction site 
introduced by the G418 resistance gene targeted into the CD40 gene, whereas the non­
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targeted wild-type allele would give a 23 kb fragment when probed with the external 
probe, probe A, which spans exons 7-8 (Figure 9.C.). The BamHl restriction site in the 
wild-type allele that generates this 23 kb fragment lies 5’ (upstream) to the CD40 gene. 
This latter BomHI restriction site is not shown in Figure 9.
Screening of ES cell clones for a homologous recombination event by Southern blot 
analysis should be unambiguous, therefore identification of a probe suitable for 
verification of a homologous recombination event is cmcial. The probe used in the 
Southern blot analysis must hybridize outside the homologous sequences of the targeting 
vector. The criteria for which restriction enzyme to use is that it should generate a 
fragment unique to the homologous recombination event. This unique fragment should 
be labeled by the probe (Figure 7 and 9). In this study I found that external probes 
(probes A and B) derived from exon sequences of the CD40 gene by PCR amplification 
specifically labeled both the wild-type allele and the targeted allele, whereas probes 
derived from intron sequences would bind several restriction enzyme fragments or give a 
“smear” in a Southern blot analysis (data not shown). The non-specific binding of 
probes derived from intron sequenees was probably caused by repetitive sequences. I 
also found that the size of the probe was important for detection of restriction enzyme 
fragments in a Southern blot analysis. Probes ranging from 80-280 bp, even when 
derived from exon sequences, failed to detect any restriction fragments in a Southern blot 
analysis (data not shown). Thus, probes used in Southern blot analysis should be 
derived from exon sequences and the length of the probe should be in the range of 0.5- 
1.2 kb. Ideally the Southern blot strategy and probe(s) should be defined and checked 
for suitability in the Southern blot analysis before the targeting vector is made.
Large quantities of construct 1 and 2 were made using the maxiprep method and purified 
on a CsCl gradient as described in section 2.1.4. This yielded very clean plasmid DNA 
which was necessary for efficient transfection of ES cells. Both targeting vectors were 
linearized, using an enzyme restriction site outside the homologous sequences, prior to 
transfection. Constructs 1 and 2 were hnearized with Xbal and HindQl, respectively,
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and prepared for electroporation (described in section 2.1.24). Previous studies have 
shown that linearizing the targeting vector increases the targeting frequency, however 
there is no advantage in isolating the homologous sequences from the bacterial plasmid 
DNA constituting tlie rest of the vector (Hasty etal., 1991b). The advantage of construct 
1 over construct 2, is that the screening procedure using PCR amplification is quicker 
than restriction enzyme digestion and southern blotting. More G418 resistant clones can 
be screened in a shorter time. The constructs are now ready for transfection into 
embryonic stem cells.
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Figure 8. Cloning of targeting construct 2. A.) Partial restriction map of the CD40 gene. B.) Cloning 
procedure for construct 2. Xbal-Xhol restriction fragment of the CD40 gene cloned into pGEM-llZf(+) 
vector (B. 1.), followed by cloning of Xbal restriction fragment of the CD40 gene into the Xbal site of the 
pGEM-llZf(+) vector (B. 2.). The 8 kb CD40 genomic fragment (HindUl-XhoT) was then cloned into a 
pGEM-7Zf(+) vector (B. 3.) and the G418 resistance gene cloned into the Sail restriction site (B. 4.). NEO: 
G418 resistance gene. Black boxes represent exons 1-9. Restriction enzyme sites: Xb, Xhal\ S, Sacl\ Sa, 
Sall\ E, EcoRI; B, BamHl-, X, Xhol. Dashed lines show cloning sites in the polylinker.
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3.2 Production of targeted embryonic stem ceii ciones
Pluripotent mouse embryonic stem (ES) cells derived from inner cell mass (ICM) cells of 
mouse blastocysts were isolated and conditions for maintaining them in culture were 
initially developed by two laboratories (Evans & Kaufman, 1981; Martin, 1981). The in 
vitro culture of ES cells is dependent on the cytokine leukaemia inhibitory factor (LIE) 
(Smith et al., 1988; Williams et al., 1988). This protein is essential for maintaining the 
growth of ES cell in vitro since, in its absence, ES cells will differentiate and eventually 
cease to proliferate. Leukaemia inhibitory factor can be applied to the ES cells in two 
different ways. Currently the best approach, and the most effective one for long-term 
culture, is to culture the ES cells on a feeder layer of mouse primary embryonic 
fibroblasts. The feeder layers synthesizes and secretes LIE into the culture medium, 
which facilitates the continuous proliferation of undifferentiated ES cells. The alternative 
is to culture ES cells in medium which is supplemented with recombinant LIE. Apart 
from the requirement for LIE, ES cells are very sensitive to the type and quality of fetal 
calf serum (ECS) in which they are grown. Because the quality of fetal calf serum can 
vary from batch to batch, it is essential to test each batch of serum to ensure that it is 
optimal for ES cell growth. The use of stringent tissue culture conditions ensures that 
these cells maintain their ability to contribute to all tissues in chimaeras, even after genetic 
manipulation. The important thing is that the ES cells maintain their pluripotency (remain 
undifferentiated) and can thus contribute both to somatic tissues and most importantly, to 
the germiine of mice. Newly thawed ES cells usually grow slowly and the growth 
depends on the cell density. As a general rule, the more dense the cells, the faster the 
growth. It is important to keep the time in culture to a minimum and to dissociate clumps 
of cells at each passage. Check the cells frequently, ideally twice a day and change the 
medium every day. Undifferentiated ES cell colonies are oval and look shiny under the 
phase contrast microscope. Individual cells can not be seen within undifferentiated cell 
colonies. In contrast, differentiated ES cell colonies are fiat, granular and appear grayish 
under the microscope. However, even if an ES cell culture appears undifferentiated, this
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does not guarantee germiine transmission. Some ES cells have been found to be able to 
form somatic, but not germiine cells in chimeras (this was found to be the case in this 
study). The reason for this is unknown. Such cells cannot be distinguished from 
germline-competent ES cells by morphology, karyotype or any other in vitro test. 
Therefore, prior to use in gene targeting experiments, the germiine competence of an ES 
cell line should be confirmed by the generation and test breeding of chimaeras.
The ES cell lines used in the experiments described here were D3 (Doetschman et al., 
1985) and R1 (Nagy er al., 1993). D3 was derived from mouse strain 129/Sv and R1 
was derived from mouse strain (129/Sv x 129/SvJ)F,. D3 ES cells were electroporated 
witli construct 1 (Figure 7.) and G418 resistant colonies appeared after 8-10 days. 
Electroporation of ES cells and G418 selection is described in section 2.2.6. In total, 
1600 G418 resistant clones were screened by PCR using the primer (primer 11.) 
hybridizing inside the NEO gene and primer 5 (exon 5) hybridizing outside the region of 
homology (Figure 7.C.). In the event of homologous recombination occurring, a 1 kb 
PCR amplification product would have been seen. Screening for homologous 
recombination using PCR is described in section 2.1.25. Unfortunately a 1 kb PCR 
product was never detected in the initial screening. PCR products of 1 kb would 
occasionally appear after gel electrophoresis, but Southern blot analysis using a specific 
oligo-nucleotide primer 4 (primer 4) failed to confirm the presence of any specific 1 kb 
PCR products. 1 therefore decided to use construct 2 for the generation of targeted ES 
cell clones.
D3 and R1 ES cells were electroporated with construct 2 (Figure 9.) as described in 
section 2.2.6 and G418 resistant clones were screened for homologous recombination 
events by Bàm HI restriction enzyme digestion and Southern blot analysis on genomic 
DNA. The procedure used for screening by restriction enzyme digestion and Southern 
blot analysis follows. The G418 resistant clones were picked into individual wells of a 
96-well plate and left to grow until confluent. The ES cell clones were then split into a 
“masteiplate” and a “replica plate”. The “masterplate” was frozen down whereas the
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“replica plate” was used for the Southern blot analysis on the individual ES cell clones. A 
detailed description of picking and expanding ES cell clones in 96-well plates is shown 
in section 2.2.7. Extraction of genomic DNA from ES cell clones grown in 96-well 
plates is described in section 2.1.26.
Southern blot analysis was performed on each individual ES cell clone using the external 
probe A (Figure 9.C.) after digestion with 5amHI restriction enzyme. Those cells that 
had undergone a homologous recombination event would yield a 23 kb fragment 
corresponding to the single intact wild-type CD40 allele and also a 10 kb fragment 
corresponding to the mutant targeted allele (Figure 10). To confirm that the G418- 
resistance gene (NEO) was part of the 10 kb mutant restriction fragment, a probe 
consisting of NEO coding sequence was used as a radioactive probe in the Southern blot 
analysis. This would hybridize to the mutant allele giving a single 10 kb band. Randomly 
integrated constructs yielded restriction fragments of different sizes (Data not shown). 
The correctly targeted clones were retrieved from the “masterplate” (described in section 
2.2.8), expanded and frozen in liquid nitrogen. Targeted ES ceU clones were now ready 
for karyotyping and subsequent blastocyst injection.
Table 1. shows 4 electroporations and the number of targeted clones obtained in each 
experiment. In total 12 ES cell clones were found to have a targeted disruption of the 
CD40 gene. As seen in Table 1., the frequency of homologous recombination in G418- 
resistant clones varied from 1/82 to 1/580 and the overall targeting frequency was 1/172.
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Table 1. Electroporation of ES cells with construct 2. The individual targeted clones were 
given numbers, shown in brackets.
Electroporation: ES cell line: G418-resistant
clones:
Number of 
targeted clones:
Targeting frequency 
of G418-resist, 
clones:
1 . R1 580 6  (34, 40, 55, 
61, 65, 77)
1/96
2 . D3 580 1 (2 1 ) 1/580
3. D3 580 1(55) 1/580
4. D3 329 4 (3, 5, 85, 89) 1/82
Electroporation of ES cells with construct 1 (Figure 7.) yielded no targeted clones. The 
lack of homologous recombination events using construct 1 could be explained by the 
presence of short homologous sequences which only allowed a 3 kb overlap. Another 
possibility was that the detection of homologous recombination by PCR amplification 
was not sensitive enough. The conditions for the PCR could have been optimized by 
making a control targeting construct containing exon 5 (this exon is absent in construct 
1). ES cells could then be transfected with the control targeting construct and PCR 
amplification conditions optimized. However, this may have introduced other problems 
such as a risk of contamination, giving rise to many false positive PCR products. Several 
studies have described the relationship between the length of homology and the targeting 
frequency (Hasty et al., 1991a; Thomas & Capecchi, 1987). As a general rule it has been 
shown that, the greater the length of homology, the higher the targeting frequency. The 
ideal length of the homologous sequences in a targeting vector is approximately 8 - 1 0  kb. 
This will also allow for unique restriction enzyme sites which can be used to linearize the 
vector prior to electroporation and also to allow unambiguous detection of targeted clones 
using Southern blot analysis of G418 resistant clones. The targeting frequency is 
probably dependent on both the length of the homologous sequences and access to the 
endogenous locus. Another important factor may be the use of isogenic DNA.
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Polymorphic variations between the targeting vector and the chromosome have been 
shown to affect targeting frequencies adversely (te et a i,  1992). This study showed that 
the frequency of homologous recombination events in 129/Sv derived ES cells was 
twenty times higher with a targeting construct containing isogenic DNA (129/Sv derived 
construct) compared with a targeting vector containing polymorphic DNA (BALB/c 
derived construct). There seems to be a great deal of variability between different loci 
even with isogenic constructs of the same homology. In this study I used isogenic DNA 
for my targeting vector, avoiding the possible reduction in targeting frequency through 
the influence of polymorphic sequences.
Positive selection (NEO) w ^  used to select targeted clones arising from transfection with 
both constructs 1 and 2 (Figure 7. and Figure 9.) A negative selection marker (TK), 
although not increasing the targeting frequency, could have been used to decrease the 
number of clones in the screening procedure. I decided not to use a negative selection 
marker based on information showing that FIAU/gancyclovir (nucleotide analogue 
incorporated by HSV-tk) might reduce the potential of the targeted ES cells to go into 
germline (Rahemtulla, personal communication).
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Figure 10. Southern blot analysis of G418-resistant ES cell clones. Lanes 1-5: 
BamYil restriction enzyme digest of genomic DNA from G418-resistant 
clones, blotted onto Hybond-N+ and hybridized with a radioactively labeled 
3 ’-flanking probe (probe A.). Lanes 1-2 and 4-5 all display a 23 kb restriction 
fragment corresponding to the wild-type allele. Lane 3 displays both a 23 kb 
and a 10 kb restriction fragment indicating the presence of a normal allele and 
a targeted mutant allele.
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3.3 Generation of germline chimeras from targeted ES 
ceils
3.3.1 Karyotyping of ES  cells
The continuous culture of ES cells is a very delicate process and care must be taken to 
keep them in an undifferentiated state, to secure germline transmission. The only way of 
distinguishing undifferentiated from differentiated ES cells is to look at their 
morphology. As described previously, pluripotent ES cell colonies are oval and look 
shiny under phase contrast microscopy and individual cells cannot be seen within 
undifferentiated cell colonies. In contrast, differentiated ES cell colonies are flat, granular 
and appear grayish under the microscope. One problem that can occur is that although ES 
cells are undifferentiated (as defined by their morphology) they can lose or acquire 
chromosomes during extended culture. To ensure the correct number of chromosomes, 
once targeted ES cell clones have been identified and expanded, they must be 
karyotyped. Karyotyping is achieved by blocking actively growing ES cells in late 
prophase, using the method described in section 2 .2 .1 0 ., and then counting the number 
of chromosomes in each individual cell. Normal mOuSe Cells contain 40 chromosomes. 
R1 andD3 ES cell lines were karyotyped (Figure 11.). R1 targeted ES cell clones (34, 
65, 77) and D3 targeted ES cell clones (3, 5, 21, 55) were selected on the basis of their 
morphology and karyotyped (Figures 12. and 13.). Both R1 and D3 have a normal 
distribution of cells with ^  chromosomes, but D3 seems to have a higher percentage of 
cells (70%) with a normal number of chromosomes (shown in Figure 11.). Of the R1 
targeted ES cell clones shown in Figure 1 2 ., 34 was found to have 80% of it’s cells with 
a normal karyotype compared to only 55% in the R1 ES cell line (Figure 11). This was 
probably due to the fact that the homologous recombination event happened by chance to 
take place in an ES cell with a normal karyotype. Independently of this event, the ES cell 
was then able to maintain a stable karyotype throughout culture. Of the D3 targeted ES 
cell clones shown in Figure 13., only clones 5 and 55 showed a normal distribution.
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around 40 chromosomes, with a lower percentage of cells having a normal karyotype, 
compared to the original D3 ES cell line (Figure 11).
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Figure 11. Karyotyping of R1 and D3 ES cell lines. The number o f chromosomes in 
each individual cell was counted and a total of 50 cells were counted for each cell line. 
The bars represent the percentage of those 50 cells having the number of chromosomes 
indicated.
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Figure 12. Karyotyping of targeted R1 ES cell clones. The number of chromosomes in 
each individual cell was counted and a total of 50 cells were counted for each cell line. 
The bars represent the percentage of those 50 cells having the number of chromosomes 
indicated.
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Figure 13. Karyotyping of targeted D3 ES cell clones. The number of chromosomes in 
each individual cell was counted and a total of 50 cells were counted for each cell line. 
The bars represent the percentage of those 50 cells having the number of chromosomes 
indicated.
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3.3.2 Injection of targeted ES cell clones into C57BU6 blastocysts
Most ES cell lines that are currently in use have a male genotype (XY). This has two 
advantages. The first is that the male ES cell lines, when injected into female blastocysts 
(XX) , will tend to bias the development of the resulting chimaera toward a male 
phenotype. In phenotypically male chimaeras, XY germ cells (i.e. those derived from the 
ES cells) will form functional gametes, whereas XX germ cells (i.e. those derived from 
the host blastocyst) will not form functional gametes. This sex conversion presumably 
occurs when XY cells colonize sufficient portions of the various tissues which determine 
sex in the developing embryo. This sex conversion is not always complete in chimaeras 
and occasionally results in an infertile hermaphrodite. Secondly, a male chimaera can 
produce more offspring over its reproductive life span than a female, so that even 
chimaeras with a relatively low percentage contribution of the ES cells to the germline 
can be detected. Transmission of the male derived ES cell genotype has been reported to 
occur from female chimaeras. Since XY cells do not normally undergo oogenesis in 
chimaeras, this phenomena may be due to the loss of part or all of the Y chromosome, 
resulting in XO cells which are capable of forming ovaries (Kuehn et a i ,  1987).
Another important consideration is the strain of mouse from which the ES cells are 
derived and the strain of embryo (blastocyst) into which they will be introduced. This is 
particularly relevant for producing germline chimaeras since certain strains have, in 
combination with others, a competitive advantage in their development. Thus, many 
chimaeras will be predominantly composed of cells derived from the dominant strain, 
increasing the likelihood that the ES cells will contribute to the germline (Schwartzberg et 
a i ,  1989). ES cell lines derived from the 129 strain of mice, when injected into 
blastocysts of the C57BL/6 strain, tend to predominate in the chimeras. The 129 ES cells 
have an agouti coat color genotype, whereas the C57BL/6 embryos is black. Therefore, 
the chimaeras produced from this combination will be a colour mix of agouti and black 
(Figure 14.). If the ES cell line is particularly “good” at making chimaeras, extreme
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individuals composed almost entirely of the ES genotype can be produced (95%-99% 
agouti coat colour). ES cell lines have also been derived from the C57BL/6 strain of mice 
(Ledermann & Burki, 1991) and the BALB/c strain of mice (Raul M. Torres, Laboratory 
Protocols .., Appendix C). The choice of which ES cell line to use may be dictated by 
the genetic background necessary for the experiments or the source of DNA used in the 
targeting construct. The appropriate genetic background can always be obtained by 
backcrossing, although at a substantial price in terms of time. If the targeted mutation has 
been generated in 129 ES cells and germline transmission has been obtained, then mice 
homozygous for the targeted mutation must be backcrossed (e.g. onto C57BL/6) 10 
times to gain 99.91% homozygosity on all alleles. Ultimately, the goal is to deliver the 
targeted mutation to the germline.
The targeted ES cell clones were selected for injection into C57BL/6 blastocysts on the 
basis of the result of the karyotyping and their morphology. The clones selected were 34 
R l, 65 R1 and 55 D3. The targeted ES cell clones (stored in liquid nitrogen) were 
thawed and grown until confluent (section 2.2.5). On the day of injection, the 
blastocysts were recovered as described in section 2.3.1 and the chosen targeted ES cell 
clone was prepared by trypsinization and washing in complete medium. 16 ES cells were 
injected into each blastocyst (section 2.3.5) and 12-16 injected blastocysts were 
transferred into a pseudo-pregnant foster mother (section 2.3.6). 17 days later the foster 
mother gave birth to both wild-type and chimaeric mice. Although all blastocysts had 
been injected, only some of these became colonised by the targeted ES cells, giving rise 
to chimaeric mice. Table 2. shows the number of blastocysts injected with each ES cell 
clone and the number of chimaeras born. 24% of the progeny were chimaeric for ES cell 
clone 34 R l, however 68% were chimaeric for ES cell clone 55 D3. It was important that 
the targeted ES cells contributed to most of the differentiated tissue in the chimaeric 
mouse and more importantly, that they contributed to the germline cells of that mouse. 
The targeted ES cell clones were derived from a male ES cell line (R l and D3) and male 
ES cells in combination with a female blastocyst often produce a fertile phenotypic male
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chimaera. Thus those male chimaeric mice with a mainly agouti coat colour were most 
likely to pass on the mutated allele and comparison of the male to female ratio among the 
chimaeric mice gave a good indication of the likelihood of germline transmission. 70% of 
the chimaeric mice generated from injection with the 55 D3 ES cell clone were males 
compared to 66% in those chimaeras generated by injection with the 34 R l ES cell clone.
Table 2. Production of chimaeras. The number of chimaeras is shown as a percentage of 
the total number of offspring (in brackets). The number of male chimaeras is shown as a 
percentage of total number of chimaeras (in brackets).
ES cell 
clone
Total no. of
injected
blastocysts
Total no. of
offspring
born
Number of
chimaeras
born
No. of male and 
female chimaeras
Germline-
transmission
34 R l 279 91 24
(26%)
16 males 
(66%)
8 females
65 R l 165 28 4
(14%)
1 male 
(25%)
3 females
55 D3 107 69 47
(68%)
33 males 
(70%)
14 females
1 male (95% 
agouti)
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Figure 14. shows a male chimaera, notice the appearance of both black (blastocyst 
derived) and agouti (ES cell derived) coat colour.
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3.3.3 Breeding chimaeras to check for germline transmission
Males with 70-95% agouti coat colour were set up for breeding with 
(C57BL/6xDBA2)F, females in preference to C57BL/6 females, to check for germline 
transmission. The reason that F, females were used rather than C57BL/6 female mice 
was because they have larger litters and are less likely to cannibalize their offspring. 1 
male chimaera (95% agouti) generated from the 55 D3 ES cell clone finally resulted in 
germline transmission. Once germline transmission was achieved the male chimaera was 
bred with C57BL/6 females. This allowed backcrossing of the targeted deletion onto a 
C57BL/6 genetic background. The offspring were either black (wild-type) or agouti 
(germline transmission) and only 50 % of the agouti offspring were heterozygous for the 
mutant allele. The agouti offspring were screened for the presence of the mutant allele by 
PCR amplification (section 2.1.22) using primer 2 (hybridizing to exon 2) and primer 11 
(hybridizing to the NEO gene) resulting in a product of 500 bp (data not shown). PCR 
amplification was carried out on genomic DNA extracted from the tails of the mice 
(section 2.1.16). Mice heterozygous for the mutant allele were interbred and DNA was 
extracted from the tails of the offspring. This was used to screen for the presence of 
homozygous mutant alleles using BamUl restriction enzyme digestion and Southern blot 
analysis. Figure 15 shows a representative result from this screening process. A wild 
type C57BL/6 DNA control and a targeted ES cell clone DNA control was included 
(lanes 1 and 10 respectively). Lanes 2-9 contain DNA from offspring derived from the 
heterozygote interbreeding. Lanes 6 and 7 are the only two showing the presence of 
mutant alleles at both loci. Mice homozygous for the targeted disruption of CD40 were 
set up for mating to produce a colony of CD40 deficient mice.
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Figure 15. Southern blot analysis of the offspring resulting from interbreeding of mice 
heterozygous for the mutant CD40 allele. BamHl restriction enzme digests of genomic 
DNA extracted from mouse tails, blotted onto Hybond-N+ and hybridized with a 
radioactively labeled probe (probe A). Lane 1: wild-type control +/+. Lanes 2-5: 
heterozygotes +/-. Lanes 6-7: homozygotes -/-. Lanes 8-9: wild-type +/+. Lane 10: ES 
cell clone 55 D3 +/-.
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Chapter 4: Analysis of CD40 deficient mice
4.1 Phenotypic analysis of lymphocytes in CD40 deficient 
mice
CD40 is expressed throughout most stages of B cell development, including progenitor 
B cells expressing CD34 (Saeland et al., 1992) and ligation of CD40 induces tyrosine 
phosphorylation, proliferation and expression of CD23 in precursor B cells (Saeland et 
al., 1993; Uckun et al., 1991). Thymic epithelial cells also express CD40 and cross- 
linking of these cells with an anti-CD40 antibody increases Granulocyte/macrophage- 
colony stimulating factor (GM-CSF) secretion (Galy & Spits, 1992). These observations 
suggested that CD40 may play an important role in both B and T lymphocyte 
development. Therefore it was important to examine whether the absence of CD40 would 
affect the surface phenotypes of T and B lymphocytes in peripheral blood and lymphoid 
organs and also whether the proportions of these cells in the periphery and organs would 
change.
To examine the surface expression of CD40 on lymphocytes in the mutant mice, the 
capacity of peripheral blood lymphocytes to bind a CD40 mAb was analysed (Figure 
16.A.). Peripheral blood lymphocytes were isolated as described in section 2.4.1 from 
wild-type and mutant mice. The peripheral blood lymphocytes from both sets of mice 
were then stained with monoclonal antibodies to the following surface molecules, CD40, 
B220, CD4 and CDS (as described in section 2.4.1, Appendix B). The same total 
number of events were collected for each individually stained sample from both mutant 
and wild-type mice, allowing me to determine the proportion of cells in the peripheral 
blood that were B220 positive (B lymphocytes) or that were CD4 or CDS positive (T 
lymphocytes). The intensity of the staining observed also allowed me to assess whether 
the levels of surface marker expression were different in the CD40 deficient mice as 
compared to the wild-type mice. Flow cytometric analysis of the subsets of cells within 
peripheral blood lymphocytes of wild-type and mutant mice was carried out on the
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FACScan (Becton Dickinson) using CellQuest software. The analysis revealed that B 
lymphocytes from wild-type mice expressed both B220 and CD40 at the cell surface, 
resulting in a double-positive population. However, the mutant mice only expressed 
B220 on the surface of their B cells, resulting in a single-positive population (Figure 16. 
A.). This confirms that the targeted gene disruption has abrogated the expression of 
functional CD40 in the mutant mice (the lack of CD40 expression in mutant mice is also 
shown in Figure 18. B. and E.). The availability of a specific antibody for CD40 made 
the search for surface expression relatively straight forward. If no monoclonal antibody 
had been available, expression of the CD40 gene could have been tested by a Northern 
blot analysis using CD40 cDNA as a probe or reverse transcriptase (RT) PCR on 
splenocytes.
Flow cytometric analysis using the B220 monoclonal antibody to look for B cells in the 
peripheral blood, showed that the proportion of B cells expressing B220 in the wild-type 
mice was equal to the proportion of B cells expressing B220 in the mutant mice and that 
the relative levels of B220 at the surface was similar in both groups of mice. This was 
quantitated by staining a fixed volume of blood and ten thousand cells were then counted 
on the flow cytometer. Also flow cytometric analysis of T lymphocyte subsets in the 
peripheral blood expressing CD4 and CDS in wild-type and mutant mice was found to be 
the same (Figure 16. A.). To confirm that the proportions of T and B lymphocytes in the 
peripheral circulation of CD40 deficient mice remained the same, despite the lack of 
functional CD40 expression, a single cell suspension of mesenteric and popliteal lymph 
nodes was stained with CD4 mAb, CDS mAb, B220 mAb and IgM mAb. Flow 
cytometric analysis (Figure 16. C.) revealed two single positive populations for CD4 
expression and CDS expression and no difference in the proportions of each of the CD4 
positive and CDS positive lymphocytes were found in wild-type compared with mutant 
mice. The proportion of B lymphocytes, as determined by B220 and IgM staining of the 
lymph nodes in both wild-type and mutant mice, were the same. Splenocytes from wild- 
type and mutant mice were also stained with monoclonal antibodies to the following
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surface markers CD4, CDS, B220 and IgM. The proportions of B and T lymphocytes in 
spleens of wild-type and mutant mice were indistinguishable (data not shown).
The total number of T and B cells in the peripheral lymphoid organs of both groups of 
mice was indistinguishable. This was assessed by counting the total number of cells in 
each organ (hemocytometer) and 1.0x10*’ cells were then stained with the appropriate 
antibody (described in section 2.4.2). 1.0 x 10'* events were then counted on the flow 
cytometer. This gave me the proportion of T cells (or B cells) in this sample. This 
proportion could then be used to calculate the total number of T or B cells in the organs 
(data not shown). This suggested that the lack of functional CD40 had no effect on the 
proportions and numbers of T or B lymphocytes in the peripheral organs of the mutant 
mice.
The involvement of CD40 in thymocyte development was assessed by staining the 
thymus with specific antibodies. A single cell suspension of cells from the thymus was 
made as described in section 2.4.2 and the cells stained with monoclonal antibodies 
specific for CD4, CDS and a f-T C R . Double staining for CD4 and CDS expression 
(Figure 16. B.) revealed a double-positive CD44-CD84- population of thymocytes and 
two single positive populations, CD4+CD8- and CD8+CD4- thymocytes. Also double 
staining for CD4 and a f-T C R  showed a gradual increase in expression of TCR as 
thymocytes matured (determined by an increase in the intensity of TCR staining). This 
showed the development of double-positive immature thymocytes (CD4-i-CDS+TCR'°'^) 
into (CD4-I-CD8-TCR*’*®'’) or (CD8-I-CD4-TCR'”®*’) mature single-positive thymocytes, 
which then become circulating T lymphocytes (Anderson et a i ,  1996). Staining of 
thymocytes with antibodies to the cell surface antigens CD4, CDS and ap-T C R  showed 
that there were no abnormalities in thymocyte development in the CD40 deficient mice 
compared to the wild-type mice.
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Figure 16. Flow cytometric analysis of lymphocytes from wild-type and CD40-/- mice, 
A.) peripheral blood, B.) Thymus, C.) Lymph nodes. Peripheral blood, thymus and 
lymph nodes were isolated from 8-week old mice and stained with following antibodies:
A.) PB-anti-B220, FITC-antiCD40, PE-anti-CD4, FITC-anti-CDS; B.) PE-anti-CD4, 
FITC-anti-CDS, FITC-anti-TCR; C.) PE-anti-CD4, FITC-anti-CDS, PE-anti-B220, 
FITC-anti-IgM. Cells were analyzed by FACS (Becton Dickinson, CellQuest). Results 
are presented as two-dimensional dot-plots in which each dot represents an individual 
cell. Similar results were obtained in three experiments.
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4.2 In vitro B cell response to CD40 engagement
Antigens which stimulate proliferation and antibody production by B cells can be divided 
into two categories. Thymus-dependent or thymus-independent antigens. Thymus- 
dependent antigens are protein derived peptides, which can only induce the production of 
antigen specific antibody, if the peptide is recognized in association with MHC class II 
by antigen specific T cells, this leads to mutual activation of both B and T cells, and the 
production of antigen specific antibody. Therefore, antibody production in response to 
protein antigens requires T cell help. The activation and proliferation of B cells in 
response to protein antigens require that B cells recognize the antigen via the B cell 
receptor and also require a second signal through CD40 (Rathmell et al., 1996). Antigens 
that stimulate proliferation and antibody production by B cells in the absence of MHC 
class II restricted T cell help are classified as thymus-independent antigens (Mond et a i ,  
1995). Included within the category of thymus-independent antigens are 
lipopolysaccharide (LPS) derived from gram-negative bacterial cell walls, dextran, 
pneumococcal capsular polysaccharide, and Ficoll. In vitro studies have shown that B 
cells proliferate in response to CD40 engagement by anti-CD40 monoclonal antibody 
(Ledbetter et al., 1987) and that B cells proliferate and undergo cytokine-dependent 
immunoglobulin isotype switching in response to ligation by a soluble CD40 ligand 
(Armitage et al., 1992a). To confirm the absence of CD40 in the mutant mice, I 
examined the capacity of B cells from these mice to proliferate in response to various 
stimuli.
B lymphocytes were purified from the spleens of wild-type and CD40 mutant mice using 
MACS (Magnetic Cell Sorting of Mouse Leukocytes) B220 (CD45R) microbeads and 
positive selection (RS-k) columns as described in section 2.4.3. The resulting cell 
preparations were found to consist of greater than 95% pure B cells as determined by 
flow cytometric analysis (Becton Dickinson, CellQuest) of cell surface expression of 
B220, CD40, CD4 and CD8. Purified B lymphocytes from both wild-type and mutant
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mice (3.5 x 10  ^ B cells/well; 200 |il RPMI 1640) were then cultured for 72 hours with 
different stimuli (Figure 17.). Medium alone was used as a negative control (1.), LPS 
alone (2.), IL-4 alone (3.), LPS and IL-4 together (4.), CD40 monoclonal antibody 
alone (5.) and lastly CD40 monoclonal antibody with IL-4 (6.). Proliferation was 
measured by thymidine incorporation over a fixed time period (18-24 hours). 1 pCi 
(^H)thymidine was added to each culture well for the last 18-24 hours of a 72 hour 
culture period and at the end of the 72 hour culture period the cells were harvested and 
counted on a Betaplate counter as described in section 2.4.3. B cells were purified from 
three wild-type and three mutant mice and stimulated as described above (Figure 17). 
The results shown are from three different mice in each group with each mouse tested in 
triplicate wells. The results represent the mean proliferation of the three mice and the 
error bars represent the standard error of this mean. The Student t-test was used to 
calculate whether the results for B cell proliferation were significantly different in the two 
groups of mice. A P value of 0.05 or below was taken to be significant. The results of 
this assay show that B lymphocytes from both sets of mice proliferated strongly when 
stimulated with LPS. A slight increase in B cell proliferation was observed, if LPS and 
IL-4 were added together, however no synergistic effect on B cell proliferation seemed to 
occur. The B cell proliferation induced by LPS is thought to occur via cross-linking of 
surface IgM, leading to activation. This is a T-independent antigen requiring no T cell 
help for activation of the B cell and as a result of this the proliferation is independent of a 
functional CD40 protein. B cells from both mutant and wild type mice were able to 
proliferate in response to LPS and LPS together with IL-4. Although LPS is a T 
independent antigen, there does seem to be a slight impairment of the ability of mutant B 
cells to proliferate in response to LPS (2. P=0.025, 4. P=0.036, 5 % significance level). 
This reduced in vitro proliferative response of mutant B cells to LPS as compared to 
wild-type B cells, was not observed by Kawabe et at. (1994). However, in support of 
the data shown here, Castigli et al. (1994) showed that in 2 out of 4 of their experiments, 
spleen cells from CD40 deficient mice exhibited a small reduction in proliferation when 
stimulated with LPS or LPS and IL-4 as compared with wild type mice. In addition,
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Hasbold et al. (1994) demonstrated that stimulation of wild type mouse B cells with LPS 
led to substantial increases in the levels of surface expression of CD40, however it is still 
not known if CD40 is involved in B cell activation in response to LPS.
The CD40 monoclonal antibody used in this proliferation assay has been shown 
previously to induce proliferation in B lymphocytes (Klaus et a l ,  1994) even when used 
as a soluble molecule. Other experiments with different antibodies found that optimal 
activation of B cells via CD40 required antibody cross-linking, or presentation of the 
antibodies on a matrix (Banchereau et a i ,  1991). In the proliferation assays performed 
here, the CD40 monoclonal antibody was added directly to the cultures. Wild-type B 
cells were able to proliferate in response to addition of CD40 monoclonal antibody, 
however B cells from mutant mice showed very low levels of proliferation that were not 
much above background (5. P<0.001, 6. P<0.01). This confirmed that B lymphocytes 
from mutant mice were unable to proliferate in response to CD40 cross-linking as the 
CD40 molecule was absent.
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Figure \1. In vitro proliferative responses of B cells from wild-type mice and CD40 
deficient mice measured by incorporation of (^H)thymidine over a 18-24 hour period. 
LPS: Lipopolysaccharide, IL-4: Interleukin-4, CD40 mAB: CD40 monoclonal antibody, 
c.p.m.: counts per minute. B cells (3.5 x 10  ^ cells/well; 200 pi) were cultured for 72 
hours in 96 well round-bottom tissue culture plates in the presence of 2 pg/ml LPS, 50 
U/ml IL-4, 25 pg/ml CD40 mAB. Cultures were pulsed with I pCi/well of 
(^H)thymidine (Amersham) for the last 18-24 hours of a 72 hour culture period and then 
harvested onto glass fiber filters. (^H)thymidine uptake was measured by a liquid 
scintillation counter (1205 Betaplate, Wallac). The values shown are means ± s.e.m. of 3 
mice in each group.The P values for each comparison were detennined using the 
Student’s t-test. 1. P=0.96; 2. P=0.025; 3. P<0.01; 4. P=0.036; 5. P<0.001; 6. 
P<0.01. Results are representative of three experiments.
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4.3 Germinal Centre formation in CD40 deficient mice
As described in more detail in the introduction, germinal centres are the anatomical sites 
in secondary lymphoid tissues where B cells undergo somatic hypermutation and 
immunoglobulin isotype switching and differentiate into plasma cells or memory cells 
(Kelsoe, 1996). The formation of germinal centres is initiated by interaction between 
interdigitating dendritic cells (IDC) presenting antigen to antigen specific C D T  T cells 
(Figure 2. A.). These activated C D T  T cells then associate with naive antigen specific B 
cells (MacLennan et al., 1997). After this interaction between T and B cells, the activated 
T cells migrate into the light zone of the germinal centre or become recirculating effector- 
or memory-cells. Activated B cells differentiate into centroblasts forming the dark zone 
of the germinal centre. Centroblasts mature into centrocytes which are selected in the 
light zone of the germinal centre on the basis of their ability to bind and process antigen 
held on follicular dendritic cells (FDC) and also interact with activated germinal centre T 
cells. These T cells deliver a rescue signal via CD40L that allows centrocyte 
differentiation into plasma cells or memory B cells (MacLennan, 1994).
Patients suffering from hyper-IgM syndrome exhibit low levels of isotype switched 
immunoglobulins, IgG, IgA, and IgE, indicating a failure in the ability to switch from 
IgM to other immunoglobulins (Geha et al., 1979; Levitt et al., 1983). Affected males 
experience recurrent infections, usually within the 1st year of life, when levels of 
maternally-derived antibodies decline. More importantly it was found that these patients 
failed to form germinal centres. This was discovered to be caused by a defect in 
expression of CD40L or point mutations in CD40L (Korthauer et al., 1993). Further 
evidence that blocking the CD40-CD40L interaction in vivo with soluble anti-CD40L 
antibody was able to abrogate germinal centre formation was described more recently in 
mice (Foy et al., 1994). There is some controversy over the role of CD40-CD40L 
interaction in the formation of geiTnnal centres as other experiments show that mice 
treated with a soluble CD40-Ig fusion protein, which should block the CD40-CD40L
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interaction, developed germinal centres after immunization with a thymus-dependent 
antigen (Gray et al., 1994). CD40 deficient mice will provide definitive evidence to 
support hypotheses showing that the CD40-CD40L interaction is important for the 
formation of germinal centres.
In the spleen, the splenic white pulp surrounds the arteries, forming a peri arteriolar 
lymphoid sheath (PALS) consisting mainly of T lymphocytes. Closely associated with 
the PALS is a B cell rich area, called the marginal zone, containing primary lymphoid 
follicles. During antigenic stimulation, these primary follicles develop into secondary 
follices containing germinal centres (GC). Cellular interactions occuring in the germinal 
centre induce the B cell antigen receptor to mutate and switch isotype. Positive selection 
of B cells expressing high affinity receptors occurs, producing memory B cells and 
plasma B cells.
Currently the only way of determining if germinal centres are forming in primary follicles 
of secondary lymphoid tissues is by staining with peanut agglutinin (PNA). PNA is a 
plant lectin with specificity for terminal galactosyl residues which has been shown to 
bind germinal centre B cells (Kraal et al., 1982; Rose et al., 1980). In the experiments 
shown here, the formation of germinal centres was tested by immunizing wild-type and 
mutant mice with KLH in complete Freund’s adjuvant, a T-dependent antigen. Ten days 
after immunization, spleens were removed and placed in embedding compound and 
snap-frozen in liquid nitrogen (section 2.4.4). Tissue sections were cut using a cryostat 
and then fixed in acetone, stained with primary antibodies or biotinylated PNA. The 
sections were then washed in TBS and enzyme-conjugated secondary antibodies added. 
Sections were washed once more and substrate added (Diaminobenzidine or Fast red) 
and incubated until the desired colour intensity had developed. Counterstaining was 
carried out using hematoxylin, which stains nuclei blue. The staining procedure is 
described in detail in section 2.4.4.
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PNA staining of splenic tissue from wild-type and mutant mice is shown in Figure 18.A. 
top: wild-type; bottom: CD40-/-). In the wild-type mice primary follicles developed 
extensive germinal centres becoming secondary follicles. These germinal centres are 
composed of large clusters of actively proliferating B cells expressing high levels of 
PNA binding sites. Figure 18.A. (top: wild-type) shows a secondary follicle containing 
germinal centre B cells which stained brown, confirming that germinal centres (GC) do 
develop after antigenic challenge (KLH). Germinal centre B cells (GC), stained with 
PNA appear brown and lie in the middle of the lymphoid follicle. Biotinylated PNA 
binds germinal centre B cells, Avidin horseradish peroxidase conjugate then binds the 
biotin molecule and catalyses the oxidation of diaminobenzidene (substrate), resulting in 
a brown colour (Figure 18.A.). At the follicle periphery is a narrow zone of small 
lymphocytes called the mantle zone (Wheater’s Functional Histology, A text and Colour 
Atlas) which also showed PNA staining. Staining of the mantle zone with PNA occured 
in both wild-type and mutant mice (Figure 18.A. top: wild-type; bottom: CD40-/-). 
Experiments performed by Foy on wild-type mice treated with blocking anti-CD40L 
antibody (Foy et a l ,  1994) also exhibited PNA staining of the mantle zone. 
Furthermore, in CD40 deficient mice generated by Castigli, mantle zone staining was 
also seen (Castigli a/. 1994).
Staining of germinal centres in wild-type and CD40 deficient mice clearly showed 
(Figure 18.A. top: wild-type; bottom: CD40-/-) the absence of germinal centres in the 
CD40 deficient mice compared to wild-type mice. This was confirmed by double staining 
of splenic tissue with both PNA and with a monoclonal antibody specific for CD40 
(Figure 18.B. top: wild-type; bottom: CD40-/-). Biotinylated PNA binds germinal centre 
B cells, Avidin alkaline phoshatase conjugate then binds the biotin molecule and 
catalyses the conversion of fast red, resulting in a red colour. The FITC-conjugated anti- 
CD40 mAb stains CD40 positive cells, anti-FITC horseradish peroxidase conjugate then 
binds the FITC molecule and catalyses the oxidation of diaminobenzidene (substrate), 
resulting in a black staining (the diaminobenzidene substrate can be enhanced from
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brown to black by nickel chloride as shown in Figure 18. B. top: wild-type). Figure 18
B. (top: wild-type) shows a secondary follicle with germinal centre B cells, although less 
obvious than in Figure 18.A. (top: wild-type) The germinal centre B cells stained red 
with PNA (GC) and black (CD40 positive). In CD40 deficient mice, no clusters of 
germinal centre B cells were detected (Figure 18.B. bottom: CD40-/-). As shown in 
Figure 18.A. mantle zone lymphoid cells binds PNA in both wild-type and CD40 
deficient mice (Figure 18. B. top: wild-type; bottom: CD40-/-).
The splenic architecture, as assessed by the distribution of T and B cells (apart from 
germinal centre B cells) were similar in both wild-type and CD40 deficient mice (Figure 
18.C and D. top: wild-type; bottom: CD40-/-). In these experiments spleen sections were 
stained with a monoclonal antibody specific for CD79a to detect B cells and a CD3 mAb 
to detect T cells. The CD79a mAb binds the a -ch a in  of the co-receptor of surface IgM. 
Rabbit anti-CD3 and rabbit anti-CD79a binds T and B cells respectively (Jones et at.,
1993). Goat anti rabbit horseradish peroxidase conjugate then binds the rabbit antibodies 
and catalyses the oxidation of diaminobenzidene (substrate) resulting in a brown colour 
(Figure 18. C. and D.). In these experiments I did not distinguish between resting and 
actively proliferating follicular B cells using anti-IgM, anti-IgD antibodies (as the B cells 
proliferate they lose surface expression of IgD).
In summary, wild-type mice, immunized with KLH displayed lymphoid follicles with 
germinal centres (secondary follicles). This was shown by intense staining of germinal 
centre B cells with PNA. In CD40 deficient mice, immunized with KLH, the lymphoid 
follicles resembled primary follicles with no recognizable germinal centres (Figure 18.B. 
bottom: CD40-/-). In occasional follicles, I observed faint staining of some cells with 
PNA (Figure 18.A. bottom: CD40-/-). This faint staining of cells with PNA in follicles 
was also observed by Castigli et al. (1994) in CD40 deficient mice.
If it is the case that the faint staining with PNA in CD40 deficient mice resembles 
germinal centre B cells, then one would have to assume that germinal centre B cells
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become activated independently of the CD40-CD40L interaction with alternative 
costimulatory molecules signalling during B-T or B-B cell interactions, leading to 
proliferation and differentiation of germinal centre B cells. Such a candidate molecule 
could be the signaling lymphocytic activation molecule (SLAM), a 70 kD glycoprotein 
constitutively expressed on CD45RO+ memory T cells, immature thymocytes, and a 
proportion of B cells. SLAM is a member of the immunoglobulin gene superfamily and 
belongs to the CD2 family of cell surface molecules. Activated CD4+T cells express both 
a membrane-form of SLAM (mSLAM) and a soluble secreted form of SLAM (sSLAM). 
Engagement of SLAM by specific mAB or soluble SLAM (SLAM is a high-affinity self­
ligand) induced proliferation of human activated CD4-I- T cells in a CD28-independent 
fashion (Cocks et a i ,  1995). In addition, the expression and function of SLAM on B 
cells was also investigated. The expression of mSLAM was significantly upregulated on 
both peripheral blood and splenic B lymphocytes when stimulated with anti-IgM mAb or 
anti-CD40 mAb. The most rapid effect was observed in response to anti-IgM mAb, 
which induced high levels of mSLAM expression on B cells after a 6 hour culture 
period. These data indicate that mSLAM is strongly upregulated on B cells after 
activation, and suggests that mSLAM is rapidly induced after recognition of antigen by 
surface Ig (Punnonen et al., 1997). Like T cells, B cells are capable of producing a 
soluble form of SLAM (sSLAM). The addition of recombinant sSLAM to cultures of B 
cells resulted in B cell proliferation in a dose-dependent manner. sSLAM also strongly 
enhanced proliferation of B cells cultured in the presence of anti-IgM mAb or anti-CD40 
mAb plus IL-4. Furthermore, sSLAM significantly enhanced IgM, IgG and IgA 
produced by B cells, but the effects of sSLAM were generally more potent when anti- 
CD40 mAb were added. These results indicate that SLAM-SLAM interactions enhance 
not only B cell proliferation, but also Ig synthesis by B cells (Punnonen et a l,  1997). I 
must point out that these experiments were performed on human T and B cells and that a 
murine form of SLAM has not yet been published. Nevertheless, one can speculate that, 
in CD40 deficient mice, T cells and B cells may become activated in a CD40-CD40L 
independent way in the T zone (PALS) (Figure 2. A.), via homophilic interaction
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between SLAM-SLAM during B-T cell interactions. The fact that SLAM is rapidly 
induced after activation (anti-IgM mAb) and that high expression levels are sustained for 
several days suggest that SLAM-SLAM interactions may play a role in mediating 
homophilic B cell contacts in germinal centres resulting in expansion of antigen specific 
B cells. B cells activated through SLAM-SLAM interactions could then start to express 
PNA binding sites, explaining the faint staining in occasional follicles in the absence of 
CD40.
The observation that B cell activation after SLAM-SLAM interaction was enhanced by 
anti-CD40 mAb supports the view that fully developed germinal centres would only 
appear if a functional CD40-CD40L interaction was present. The results described in 
Figure 18. confirm the pivotal role of the CD40-CD40L interaction in the formation of 
germinal centres and also showed that no other splenic architecture was affected.
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Figure 18. N o developm ent o f  germinal centres in C D 40 deficient m ice. Im m unohistochem ical staining  
o f spleen tissue sections. Cryostat sections o f  spleens from KLH im munized wild-type and C D 40  
deficient m ice. Sections were fixed in acetone, stained with primary antibodies or biotinylated PNA . The 
sections were then washed in TBS and enzyme-conjugated secondary antibodies added. Sections were 
washed once more and substrate added (Diam inobenzidine or Fast red) and incubated until desired colour 
intensity had developed. Counterstaining was carried out using hem atoxylin, w hich stains nuclei blue. 
A .) Top; wild-type; bottom: C D 40-/-. Staining o f germinal centre (GC) with biotinylated PNA  and 
A vidin horseradish peroxidase conjugate, germinal centres stain brown. M agnification 25x. B.) Top: 
wild-type; bottom: C D 40-/-. Staining o f germinal centres with biotinylated PN A  and C D 40m A B . 
Germinal centre B cells stain red and black. B cells positive for C D 40 stain black. M agnification 25x. C . 
and D .) Top: w ild-type; bottom: C D 40-/-. Staining o f  T and B cell areas with a m onoclonal antibody to 
C D 3 and to C D 79a, respectively. T and B cell areas are shown by the brown colour staining.
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M agnification lOx. E .)T o p : w ild-type; bottom: C D 40-/-. Cryostat sections o f  thym us tissue. Staining  
o f C D 40-positive ce lls  in the thymus with anti-C D 40 m A B . M agnification lOx.
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4.4 Serum immunoglobulin levels in CD40 deficient mice
Class, or isotype, switching is the process whereby a B cell changes the heavy chain 
class of the antibody it synthesizes by changing the heavy chain constant (C^ )^ region 
expressed, but not the light chain or heavy chain variable region (V^) regions. The 
change in antibody class, except to IgD, is effected by a DNA recombination event called 
switch recombination, which occurs between tandemly repeated sequences called switch 
regions. Switch recombination causes the recombined V(D)J gene segment, which is 
initially expressed with the gene, to be subsequently expressed with one of six 
(mouse) or seven (human) downstream genes (Stavnezer, 1996a). Because antibody 
specificity is determined by the variable regions of antibodies, class switching does not 
change the antigen binding specificity. However, class switching does change the 
effector function of the antibody because these are determined by the regions. Soon 
after emerging from the bone marrow, immature B cells which express IgM on their 
surface also start to express surface IgD, with the same region as the IgM. This event 
occurs in immature B cells in the absence of antigen stimulation (Stavnezer, 1996a). T- 
dependent antigens induce class switching during cognate interactions between T and B 
cells in the T cell zone of the spleen (Toellner et a i ,  1996) and class switching can also 
be triggered in centrocytes when they interact with T cells in the light zone of germinal 
centres (Liu et at., 1996). T-independent antigens induce class switching, probably by 
signals from surface Ig cross-linked by multivalent antigens. T-independent antigens do 
not stimulate germinal centre formation within follicles of lymphoid tissue. Thus B cells 
in which class switching is induced by T-independent antigens may be located in the 
splenic marginal zone (Mond et al., 1995). In addition to the absence of germinal centres 
in individuals with hyper-IgM syndrome it was also found that the patients had elevated 
or normal levels of IgM and low levels of isotype switched immunoglobulins, IgG, IgA, 
and IgE. This indicated a failure in the ability to switch from IgM to other 
immunoglobulins (Geha et al., 1979; Levitt et al., 1983).
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To determine the influence of a non-functional CD40-CD40L interaction on the 
production of isotype switched immunoglobulins in CD40 deficient mice, serum was 
taken from 12 week old wild-type and also from CD40 deficient mice and the levels of 
the different immunoglobulin isotypes in the two groups were compared. 
Immunoglobulin levels were determined by isotype-specific ELISA as described in 
section 2.4.6. These results are shown in Figure 19 and represent the mean 
immunoglobulin levels found in five wild-type and five CD40 deficient mice. The error 
bars represent the standard error of this mean. The Student’s t-test was used to calculate 
whether the results for each immunoglobulin isotype were significantly different in the 
two groups of mice. A P value below 0.05 was taken to be significant.
Elevated levels of IgM and IgG3 were found to occur in the mutant mice compared to the 
wild-type mice (1. P<0.02; 5. P=0.037). In contrast to this, levels of IgG l and IgG2b 
were significantly reduced in CD40 deficient mice compared with wild-type mice (2. 
P<0.001, 4. P<0.001). The levels of IgE expression in wild-type mice were extremely 
low and were only just detectable by ELISA. In the mutant mice, IgE levels were 
undetectable. Unexpectedly, the levels of IgG2a were not significantly different in the 
two groups of mice (3. P=0.36), and this expression was very low in both wild-type and 
mutant mice.
CD40 deficient mice exhibited elevated levels of IgM, confirming the findings in patients 
suffering from hyper-IgM syndrome who may also have elevated levels of IgM 
(Notarangelo et al., 1992). The presence of elevated levels of IgM and IgG3 in CD40 
deficient mice could be due to stimulation with T cell independent antigens, as it was 
found that IgM and IgG3 were the major isotypes of antibodies in T cell independent 
responses (Mongini et a i, 1981). Serum IgE was absent and significantly reduced levels 
of IgG l and IgG2b were found in CD40 deficient mice. The presence of elevated levels 
of IgG3 and normal levels of IgG2a indicates that isotype switching may also occur 
independently of the CD40-CD40L interaction. See “Discussion” for immune responses 
to T cell independent antigens in CD40 deficient mice.
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The results presented here (Figure 19.), investigating the serum immunoglobulin levels 
in unimmunized CD40 deficient mice, were compared to the results obtained in similar 
studies of CD40 deficient mice by Kawabe et a l, 1994 and also by Castigli et a l,  1994. 
Kawabe et a l  observed normal IgM levels and higher IgG3 levels in CD40 deficient 
mice compared to control mice. Serum levels of IgG l, IgG2a, IgG2b and IgA were 
significantly reduced (Kawabe et a l, 1994). Castigli et a l  also found that the IgM levels 
in CD40 deficient mice were similar to wild-type mice. Serum levels of IgG l and IgG2a 
were significantly reduced and IgE was absent. Normal levels of IgG3 and slightly 
reduced levels of IgG2b and IgA were observed (Castigli et a l, 1994). There were slight 
differences in the levels of the immunoglobulins measured in these studies however, the 
general trends in immunoglobulin production in CD40 deficient mice (reduced isotype 
switched immunoglobulins) were the same. The slight differences in the levels of serum 
immunoglobulins seen in these studies compared with the results presented in this thesis 
could be due to the different conditions in which these CD40 deficient mice were kept 
and the different pathogens that they may be exposed to.
The normal or elevated levels of serum IgM that were seen in patients with hyper IgM 
syndrome and also in CD40 deficient mice indicates that IgM antibody responses in both 
systems were independent of the CD40-CD40L interaction. The reduced levels of isotype 
switched immunoglobulins in the serum of CD40 deficient mice suggests that the CD40- 
CD40L interaction is important for the isotype switching from IgM to other 
immunoglobulins.
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Chapter 5: Cell-mediated immunity in CD40 deficient 
mice infected with bacillus Calmette-Guerin
5.1 Introduction
5.1.2 CD40-CD40L interaction in Thi development
Patients having hyper IgM syndrome experience recurrent infections, usually within the 
1st year of life, after levels of maternally-derived antibodies have declined. Most 
infections are of bacterial origin, but HIGM l Patients are unusually susceptible to 
infections with opportunistic pathogens and often suffer from Pneumocystis carinii 
pneumonia and Cryptosporidium  intestinal infection. These diseases are often observed 
with T-cell immunodeficiencies but not with forms of hypogammaglobulinemia other 
than hyper IgM syndrome (Notarangelo et a l ,  1992). This observation led researchers to 
ask whether the interaction between CD40-CD40L was involved in T cell-mediated 
immunity? It has been established that IL-12 is a key cytokine for the development of a 
Thl response as it induces the production of IFN-y in NK cells and T cells (Trinchieri,
1995). Results suggest that the CD40-CD40L interaction is important for the priming of 
Thl T cells via the stimulation of IL-12 secretion by antigen presenting cells. CD40 
cross-linking on human dendritic cells by CD40L upregulated the expression of CD80, 
CD86 and CD54, leading to an increased capacity of DCs to stimulate proliferation of 
autologous or allogeneic T cells and also of IFN-y production by these T cells. In 
addition, secretion of high levels of IL-12 by human DCs was induced upon CD40 
cross-linking (Celia et at., 1996; Peguet et al., 1995). A similar study, this time with 
murine dendritic cells showed, that CD40 cross-linking induced IL-12 production by the 
dendritic cells, and that IL-12 production could be downregulated by IL-4 and IL-10 
(Koch et al., 1996). IL-12 production by human monocytes could be triggered by 
activated T cells and this could be inhibited by a soluble CD40 (CD40-Ig) antibody 
blocking the CD40-CD40L interaction (Shu et al., 1995). An in vivo model of colitis 
(induced by the hapten reagent (2,4,6-trinitrobenzene sulfonic acid (TNBS)) is a Thl
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mediated disease. This was shown by the fact that the majority of infiltrating CD4^ T 
cells in this condition secreted IFN-y. Treatment with anti-CD40L antibody during the 
induction of the disease was able to prevent colitis occurring and a reduction in the levels 
of IL-12 was also observed (Stuber et al., 1996). In addition, CD40 cross-linking on 
dendritic cells induced the production of T N F -a , IL-8 and macrophage inflammatory 
protein (M IP -la ). The production of cytokines such as IL-8 and M IP -la  by dendritic 
cells may be important for the recruitment of cells to a site of inflammation (Stout & 
Suttles, 1996). A direct role for CD40-CD40L interactions in the induction of nitric oxide 
(NO) production by macrophages is indicated by the ability of anti-CD40L antibody to 
inhibit the induction of nitric oxide by fixed activated lymphocytes (Tian et al., 1995). 
This was supported by the observation that T cells from CD40L deficient mice were 
impaired in their ability to induce macrophages to produce T N F-a and nitric oxide (Stout 
et al., 1996).
5.1.3 Impaired T cell priming in CD40 and CD40L deficient mice
Two reports have described the impairment of antigen-specific T cell priming in CD40 
and CD40L deficient mice. To determine whether CD40L influences T cell 
responsiveness, CD40L deficient mice and wild-type mice were immunized with KLH 
and T cell in vitro recall proliferative responses were tested. The in vitro proliferative 
responses of T cells from CD40L deficient mice were considerably reduced compared to 
wild-type mice. Furthermore, a dramatic reduction in IL-4 and IFN-y production was 
seen in proliferative responses with T cells from CD40L deficient mice. The reduced 
response in CD40L deficient mice could either be caused by insufficient activation of the 
antigen presenting cells (APCs), no expression of costimulatory molecules (CD80, 
CD86), or a defect in the T cells. To test whether the APCs were causing the defect in T 
cell activation, APCs from wild-type mice were used to activate T cells in vitro from 
CD40L deficient mice immunized with KLH. Neither wild-type APCs nor 
lipopolysaccharide (LPS) activated B cells, which express costimulatory activity and thus 
might bypass a CD40L requirement, were able to restore the defect in proliferation.
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Whether APCs are intrinsically defective in CD40L deficient mice, was tested by 
adoptive transfer of wild-type T cells (CD4^) to CD40L deficient mice. Following 
immunization of the CD40L deficient mice with KLH, these transferred wild-type T cells 
responded vigorously to KLH. Furthermore, the proliferative response of CD40L 
deficient T cells and wild-type T cells is similar when stimulated with anti-CD3 or 
concanavalin A, confirming that CD40L deficient T cells do not have an intrinsic defect. 
These observations suggest that a signal through CD40L to the T cell is necessary for in 
vivo priming of T cells and that the reduced proliferation in CD40L deficient mice is not 
due to a defect APC activation or intrinsic T cell defect in CD40L deficient mice (Grewal 
et al., 1995). Another study showed that simultaneous cross-linking of CD3 and CD40L 
on human CD4^ T cells upregulated IL-4 synthesis. This indicated that CD40L might 
serve as a receptor which transduces a costimulatory signal to the T cell (Blotta et al.,
1996).
To test the ability of T cells primed in the absence of CD40 to provide T cell help for B 
cells, CD40 deficient mice and wild-type mice were immunized with KLH. Purified T 
cells from these mice were then injected into lightly irradiated CD40 deficient mice 
(hosts) with B cells expressing CD40 (wild-type B cells) from non-immune IgH"* 
congenic donors. These allotype-distinct “indicator” B cells enable the donor/recipient 
source of semm antibodies to be determined. Adoptive hosts were immunized with 
dinitrophenylated KLH (DNP-KLH). Ten days after cell transfer, the mice that had 
received T cells primed in a wild-type (CD40+/+) mouse produced anti-DNP IgM, IgG l, 
IgG2a and IgG2b antibodies and formed germinal centres in their spleens. Mice that 
received T cells primed in CD40 deficient mice produced only IgM antibodies and 
exhibited no splenic germinal centres. This indicates that T cells primed in the absence of 
CD40 are unable to provide the help required for normal B cells to class switch or to 
form germinal centres (van et a i ,  1995).
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5.1.4 Leishmaniasis in CD40 and CD40L deficient mice
Mice deficient for CD40 and CD40L have been used to establish that the CD40-CD40L 
interaction is required for protective immunity to the intracellular protozoan, Leishmania 
Major. This parasite infects macrophages and the severity of disease in different mouse 
strains infected with L. major is genetically determined. In the resistant strains such as 
C57BL/6 and CBA, T hl effector T cells are generated upon infection, whereas Th2 
responses are generated in the susceptible strain BALB/c (Heinzel et at., 1993). It has 
been shown that Thl-derived IFN-y and Th2-derived IL-4 play a role in protection from 
and exacerbation of experimental leishmaniasis, respectively (Sadick et al., 1990). These 
results were confirmed by the fact that experimental leishmaniasis could not be controlled 
in IFN-y deficient mice, which succumbed upon infection with L. major (Wang et al.,
1994). Another important cytokine in the control of L.major infection is IL-12. In vivo 
IL-12 treatment can cure BALB/c mice of L.major infection by changing a Th2 response 
to a Thl response (Heinzel et al., 1993). The infection of CD40 deficient and CD40L 
deficient mice with Leishmania major provided a means of determining the mechanisms 
involved in the production of IL-12 and generation of Thl responses to the parasite and 
also which molecules other than IFN-y were required for activation of macrophages. 
CD40L deficient mice bred onto a resistant background (C57BL/6), control C57BL/6 
(resistant) and BALB/c (susceptible) mice were infected with Leishmania major. CD40L 
deficient mice were susceptible to infection with L. major, and like the susceptible strain 
BALB/c, developed ulcerating lesions within 7 weeks of parasite challenge. The levels of 
IFN-y, IL-4 and IL-12 were measured. Lymph nodes cells taken from CD40L deficient 
mice secreted low levels of IFN-y when stimulated with a soluble leishmanial antigen in 
vitro, compared to control mice. The levels of IL-4 in CD40L deficient mice were 
comparable to susceptible BALB/c mice. Furthermore, T cells from CD40L deficient 
mice failed to induce IL-12 production by macrophages when stimulated with soluble 
leishmanial antigen in vitro. Complete protection from Leishmania major in CD40L 
deficient mice could be obtained by intraperitoneal injection of recombinant IL-12
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(Campbell et al., 1996). A similar study, where CD40 deficient mice were infected with 
Leishmania major showed that CD40 deficient mice developed systemic leishmaniasis. 
Lymph node cells from infected CD40 deficient and BALB/c mice produced significantly 
higher levels of IL-4 in response to L. major antigens than C57BL/6 (controls) mice. 
Cells from resistant C57BL/6 mice produced high levels of IFN-y and in contrast, only 
low levels of IFN-y were produced by CD40 deficient mice in response to L. major 
antigens. As shown for CD40L deficient mice infected with L. major, lymph node cells 
from CD40 deficient mice infected with L. major showed levels of IL-12 production that 
were reduced considerably compared to C57BL/6 mice and the IL-12 secretion was even 
lower than in BALB/c mice.
Nitric oxide produced by activated macrophages has been implicated as one of the 
effector molecules involved in killing Leishmania parasites (Liew et al., 1990; Wei et al.,
1995). The activation of macrophages to exert antiparasitic responses such as nitric oxide 
production was investigated in CD40L deficient mice infected with Leishmania 
amazonensis. Unlike L. major, where selected strains of mice are resistant to infection, 
most inbred strains of mice are susceptible to L. amazonensis. Infection of CD40L 
deficient mice with L. amazonensis resulted in a tissue parasite burden 50-fold higher 
than in the wild-type (C57BL/6) mice, and CD40L deficient mice failed to generate 
parasite specific immune responses. Lymph node cells from CD40L deficient mice, 
stimulated with parasite lysates for 72 h in vitro, failed to produce IFN-y, T N F -a and 
lymphotoxin in response to parasite antigen. Moreover, macrophages isolated from 
CD40L deficient mice did not produce any significant levels of nitric oxide after 
stimulation with parasite antigen, whereas macrophages from the control mice produced 
high levels of nitric oxide. Unlike the studies cited above, infection with L. amazonensis 
showed that the production of IL-12 in CD40L deficient mice was comparable to wild- 
type mice. One of the major contributing factors to the diminished resistance to L. 
amazonensis in CD40L deficient mice is probably the reduced capacity of macrophages 
to exert antiparasitic responses such as nitric oxide production (Soong et a l ,  1996).
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The CD40-CD40L interaction appears to be important for the induction of IL-12 and the 
production of nitric oxide (NO) by activated macrophages in response to infection with 
Leishmania species. A possible sequence of events could be that during infection of 
resistant strains of mice, APCs present leishmanial antigens to T cells, resulting in 
activation-induced expression of CD40L. CD40L positive T cells, possibly in 
combination with IFN-y, interact with CD40 on APCs and induce EL-12 production 
(Koch et a l ,  1996; Shu et at., 1995). IL-12 then stimulates NK cells and CD4^ T cells to 
secrete IFN-y, which drives CD4^ T cells towards a Thl phenotype (Trinchieri, 1995). 
Simultaneously, CD40L positive T cells would interact with macrophages via CD40 and 
induce the expression of nitric oxide, thereby increasing the microbicidal capacity of the 
macrophages (Stout et a l ,  1996; Tian et at., 1995).
5.1.5 Immune response to Mycobacterial infection
Mycobacterium tuberculosis and M. bovis are intracellular bacteria capable of persisting 
and replicating within resting macrophages. The precise mechanisms by which the cell- 
mediated immune response operates to effectively contain the bacillus are not fully 
understood. The requirement of both CD4^ and CD8^ T cells in the protective immune 
response to M. tuberculosis has been established. The in vivo depletion of either CD4^ or 
CD8^ T cells in mice (C57BL/6) reduced resistance to M. tuberculosis infection, whereas 
intact control mice were able to clear the infection (Muller et al., 1987; Orme et al., 
1992). However, the contributions of the different components of the T cell response are 
unclear. Patients with human immunodeficiency virus (HIV) have reduced CD4^ T cell 
counts and CD4^ T cells are thought to play a major role in controlling infections with 
M.tuberculosis, as HIV patients are more susceptible to M. tuberculosis infections than 
the non-HIV infected population (Hopewell, 1992). p2-microglobulin deficient mice 
which lack an efficient CD8^ T cell response, also show increased susceptibility to M. 
tuberculosis infection (Flynn et al., 1992). Several groups have shown, using gene- 
deleted mice, that nitric oxide, IFN-y, T N F-a and IL-12 are all essential for development 
of resistance to M. tuberculosis. Mice deficient for nitric oxide synthase (N 0S2), the
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gene producing nitric oxide, succumbed to M. tuberculosis infection within 50 days, 
whereas control (C57BL/6) mice survived the infection. The lack of NOS2 did not have 
any effect on granuloma formation and levels of IFN-y and T N F -a , as they appeared 
similar in control and N 0S 2  deficient mice (MacMicking et al., 1997). IFN-y deficient 
mice succumbed to infection with M. bovis (BCG) and the defect in IFN-y production 
led to an impaired production of nitric oxide by macrophages in response to M. bovis 
(Dalton et al., 1993). Upon infection with M. tuberculosis, IFN-y deficient mice 
developed granulomas but they failed to produce nitric oxide and eventually succumbed, 
due to the unrestricted growth of bacilli. Recombinant IFN-y was injected 
intramuscularly in an attempt to rescue IFN-y deficient mice from unrestricted growth of 
bacilli, but the treatment only delayed and did not prevent the fatal outcome of M. 
tuberculosis infection (Cooper et al., 1993; Flynn et al., 1993). The role of T N F -a was 
investigated by infecting BALB/c mice with BCG {bacillus Calmette-Guerin). Upon 
infection with BCG the mice developed granulomas and the production of T N F -a was 
shown to coincide with these granulomas. In vivo treatment with anti-TN F-a antibody 
prevented the development of granulomas and led to accumulation of TNF mRNA in 
BCG infected mice, leading to massive replication of BCG. This study indicates that 
T N F -a is essential for granuloma formation, which is thought to be required for 
localization and control of mycobacterial replication in tuberculosis (Kindler et al., 
1989). In addition to the role of T N F -a in granuloma formation, T N F -a  with IFN-y, 
induces the production of microbicidal reactive nitrogen intermediates (RNI) by 
macrophages, one of which is nitric oxide (Flesch & Kaufmann, 1990). The only 
demonstrated mechanism in vitro by which macrophages kill M. tuberculosis bacilli is 
activation by IFN-y and LPS or T N F -a to produce RNI (Flesch & Kaufmann, 1991). 
The use of mice lacking the TNF receptor confirms the role of T N F -a  in protection 
against M. tuberculosis. TNF receptor deficient mice succumb to M. tuberculosis 
infection within 30 days, whereas the control mice survive the duration of the 
experiment. After 2 weeks of infection the TNF receptor deficient mice contained 10- to 
50-fold more bacilli in the organs, compared with the control mice. Granuloma formation
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did occur in the TNF receptor deficient mice and equivalent numbers of granulomas were 
found in TNF receptor deficient mice and control mice, 12 days postinfection. However, 
the onset of granuloma formation in TNF receptor deficient mice was slightly delayed. 
Likewise, the production of RNI was delayed in TNF receptor deficient mice until 14 
days postinfection although once again levels of RNI production were similar to those 
observed in wild-type mice. The same results were obtained in mice, where T N F -a was 
neutralized in vivo by an anti-TN F-a antibody (Flynn et a i ,  1995a). This conflicts with 
the previous report (Kindler et al., 1989) where neutralization of TNF in vivo  by 
antibody to T N F -a abolished granuloma formation following infection with BCG. The 
reason for the discrepancy is unknown. Clearly, T N F -a is required early in infection to 
limit replication of bacilli within the organs and the way that this replication is limited is 
through the production of RNI. Complete absence of T N F -a or TNF signalling (TNF 
receptor) within the two first weeks of a mycobacterial infection was found to be fatal 
(Flynn et al., 1995a).
Finally, the role of IL-12 in resistance to M. tuberculosis infection was investigated. 
C57BL/6 mice normally survive more than 140 days when infected with M. 
tuberculosis, where as BALB/c mice are susceptible to the infection and only survive 
around 58 days (Flynn et al., 1995b). When BALB/c mice were given recombinant IL- 
12 at the initiation of infection with M. tuberculosis, their mean survival time doubled 
from 58 to 112 days. IL-12 treated mice had diminished bacterial burdens, whereas 
treatment with recombinant IFN-y had no effect on survival or bacterial burden. 
Treatment of IFN-y deficient mice with recombinant IL-12, did not increase survival, 
indicating that IL-12 does not induce protection against tuberculosis in mice in the 
absence of IFN-y. This supports the hypothesis that IL-12 increases resistance to 
tuberculosis by inducing IFN-y production from NK and/or T cells (Cooper et al., 1995; 
Flynn et al., 1995b).
Tuberculosis is the world’s leading cause of death in humans from a single infectious 
agent. Mycobacterium tuberculosis currently infects 2 billion people worldwide and
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causes 8 million new cases of tuberculosis and 2.9 million deaths annually (Kochi, 
1991). The disease is a major health problem in developing countries and has reemerged 
in recent years in many industrialized countries. This has been linked to the spread of the 
human immunodeficiency virus (HIV) and to a combination of social and economic 
factors (Fenton & Vermeulen, 1996). The only currently available vaccine, bacillus 
Calmette-Guerin (BCG) does not provide protection against M. tuberculosis infection in 
all individuals (Fine, 1989) and the lack of an effective vaccine is at least in part 
responsible for the reemergence of tuberculosis in industrialized countries. However, the 
development of an effective vaccine against Mycobacterium tuberculosis has been 
hampered by a poor understanding of the immunlogical mechanisms of protection and 
the pathogenesis of this disease. It is therefore important to investigate the precise 
mechanisms by which the cell-mediated immune response operates to contain and 
eliminate a mycobacterial infection. As resistance to both tuberculosis and leishmaniasis 
was associated with production of similar CD40-CD40L-associated mediators of 
immunity, including IFN-y, IL-12, T N F-a and nitric oxide (NO), this study was carried 
out to assess the role of the CD40-CD40L interaction in the induction of cell-mediated 
immunity and control of Mycobacterium tuberculosis.
Performing experimental work with Mycobacterium tuberculosis requires category 3 
facilities which were not available in our department, therefore I chose to use 
Mycobacterium bovis (BCG) as a model system for Mycobacterium tuberculosis.
5.2 Results
5.2.1 Survival of CD40 deficient mice infected with BCG
To investigate the role of CD40 in resistance to BCG {bacillus Calmette-Guerin) I 
compared the course of BCG infection in CD40 deficient mice (CD40-/-) and in sex- and 
age-matched heterozygous (CD40-I-/-) littermates. Heterozygous littermates (CD40-I-/-) 
were used as controls because the CD40 deficient mice were backcrossed onto the 
C57BL/6 background for 2 generations (129/Sv x C57BL/6)F2. This only gave
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homozygosity on 75% of all alleles, therefore the degree of homozygosity had to be the 
same in the control mice (CD40+/-) as in the CD40 deficient mice. Five 10 week old 
male mice were used in the CD40-/- group and in the CD40+/- control group. Mice were 
infected intravenously (tail vein) with 1 x 1 0 ^  colony-forming units (CFU) of bacillus 
Calmette-Guerin and three parameters of resistance were analyzed, survival, weight gain 
or loss and bacterial load in the spleen, liver and lungs. The health of the mice in each 
group was assessed by monitoring the weight loss or gain regularly throughout the 
infection, shown in Figure 20. The weight of the mice on each day of measurement is 
presented as the percentage weight gain as compared with the day zero levels (day zero is 
the first day of infection). There was no net weight loss during the course of infection in 
either group of mice, with both groups putting on weight during the 256 day observation 
period and surviving for the entire observation period.
An initial period of 11 days with equal percentage increase, followed by a decrease in 
percentage weight gain for the CD40 deficient mice compared to the control mice (day 
11-20). This is followed by a period of equal increase in percentage weight gain. 
Unfortunately, the mice were not weighed individually and therefore the values for the 
standard error of the mean cannot be given for each percentage increase.
There is a difference in weight, with the CD40 deficient mice being slightly heavier. This 
weight difference may be due to differences in the genetic backgrounds of individual 
mice. The CD40-/- mutation was generated in ES cells derived from a 129 genetic 
background and injected into a blastocyst with a C57BL/6 genetic backround. This 
results in mutant mice with a mixture of 129 and C57BL/6 genetic backgrounds. These 
mutant mice (129/C57BL/6) will be backcrossed onto a C57BL/6 genetic background, 
but backcrossing has to (selecting for the mutation) have taken place for 10 generations 
in order to achieve 99.91 % homozygosity of alleles. Therefore, the lower the number of 
backcrosses the more genes are expected to segregate and any variations seen in the 
weight may be due to differences in the genetic backgrounds of individual mice.
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The bacterial load in the spleen, liver and lungs was determined in both groups of mice, 
4 weeks after infection. Spleen, liver and lungs were removed into sterile PBS and 
homogenized as described in section 2.4.8, followed by plating out onto Middlebrook 
agar plates. These plates were incubated for 2-3 weeks at 37 °C. Middlebrook agar 
selects for growth of mycobacteria. The number of mycobacteria are presented as colony 
forming units (CFU, defined as bacterial colonies) and these were counted after 2-3 
weeks of culture. The results represent the mean of CFU from six mice in each group 
and the error bars represent the standard error of this mean. The Student t-test was used 
to calculate whether the results for CFU counts were significantly different in the two 
groups of mice. A P value of 0.05 or below was taken to be significant. The results of 
the CFU counts are shown in Figure 21.
The number of BCG CFU recovered from 1. spleens, 2. lungs and 3. livers of 
heterozygous control mice (CD40-I-/-) were compared with those recovered from CD40 
deficient mice (CD40-/-). The results are presented in Figure 21. CD40 deficient mice 
had a significantly higher parasite burden in the spleens (6.78x10^ ± 0.90x10^) 
compared to control mice (2.96x10^ ± 1.09x10'*) (P<0.001). The CFU counts in the 
lungs of CD40 deficient mice (6.60x10^ ± 2.08x10^) compared to the control mice 
(2.80x10^ ± 0.96x10^) were also significantly different (P<0.001). The CFU counts in 
the livers of CD40 deficient mice (10.77x10^ ± 6.15x10^) compared to control mice 
(7.23x10^ ± 3.16x10^) appear different in Figure 21., but a Student’s t-test revealed that 
this difference was not significant (P=0.27). These results show that CD40 deficient 
mice have raised parasite burdens in the spleen and lungs, suggesting that CD40 deficient 
mice, despite long-term survival (256 days), are more susceptible to infection with BCG 
than control mice.
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Figure 20. Percentage weight gain of heterozygote littermate controls (CD40-H/-) and 
CD40 deficient mice infected with bacillus Calmette-Guerin (BCG). The weight gain is 
calculated as a percentage of the weight at the start of the experiment. CD40-/- (deficient) 
and CD40-I-/- (control) mice were infected i.v. with 1 x 10^ CFU of bacillus Calmette- 
Guerin and the course o f infection, survival and weight, were monitored for 256 days. 
There were five mice in each group and the weight is the cumulative weight of 5 mice.
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Figure 21. Bacterial burdens in bacillus Calmette-Guerin infected CD40+/- conti'ol mice 
and CD40-/- mice. CFU (colony-forming units) in 1. Spleen, 2. Lung and 3. Liver were 
determined 4 weeks after infection. The values shown are means of CFU counts ± 
s.e.m. of 6 mice in each group.The P values for each comparison were determined using 
the Student’s t-test. 1. Spleen: P<0.001; 2. Lung: P<0.001; 3. Liver: P-0.27.
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5.2.2 IFN-y production in CD40 deficient mice infected with BCG
The CD40-CD40L interaction has been directly implicated in pathways for the production 
of IL-12, nitric oxide and macrophage activation (Shu et al., 1995; Stout et al., 1996; 
Tian et a i ,  1995). In addition, the enhanced susceptibility of CD40L and CD40 deficient 
mice to Leishmaniasis was associated with an impaired generation of a Thl response, 
reflected by the production of low levels of IFN-y, TNF, IL-12, and nitric oxide 
(Campbell et al., 1996; Kamanaka a/., 1996; Soong et al., 1996). In view of these 
observations I infected CD40 deficient mice and control mice with BCG and then 
measured the induction of IFN-y production in response to PPD (Tuberculin Purified 
Protein Derivative) in vitro. IFN-y was detected using an ELIspot assay. The ELIspot 
assay relies on an anti-IFN-y antibody which is bound to the bottom of a 96-well tissue 
culture plate. Cells and antigen (PPD) are then added and incubated overnight. Cells 
recognizing the antigen will secrete IFN-y, which will be bound by the anti-IFN-y 
antibody. The cells are then removed and bound IFN-y can now be recognized with a 
secondary antibody coupled to alkaline phosphatase. A substrate is added and the 
alkaline phosphatase then converts this substrate to produce a coloured compound. A 
series of dilution’s of cell numbers allows very sensitive detection such that each spot 
represents a single cell secreting IFN-y. 1 x 1 0 ^  splenocytes were isolated from mice 4 
weeks post-infection and cultured overnight with PPD (described in section 2.4.7). 
Triplicate wells per mouse were counted and the values shown are means ± s.e.m. of 5 
mice in each group. The P values for each comparison were determined using the 
Student’s t-test. A P value of 0.05 or below was taken to be significant. The results 
shown in Figure 22. represent the mean number of IFN-y producing cells in response to 
PPD in control mice (CD40+/-) and CD40 deficient mice (CD40-/-). The control mice 
exhibit approximately 225 IFN-y producing cells per 1.0 x 10  ^ splenocytes, whereas 
CD40 deficient mice exhibit less IFN-y producing cells, only 100 per 1.0 x 10  ^
splenocytes. These results show a significant reduction in the IFN-y response to PPD 
(BCG infection) in CD40 deficient mice (P<0.001). The reduced levels of IFN-y in the
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CD40 deficient mice in response to a mycobacterial infection may explain the raised 
parasite burdens found in this study (Figure 21.). The results are discussed further in 
relation to other studies (see Discussion).
Histology was performed on control and CD40 deficient mice four weeks after infection 
with BCG. Spleen, lungs and liver were taken out and fixed in formalin, embedded in 
paraffin and tissue sections stained with hematoxylin and eosin (H&E). In addition, 
tissue sections were stained for the presence of acid-fast bacilli (mycobacteria) as 
described in section 2.4.9. Figure 23. (A .I.: CD40-I-/- and B .I.: CD40-/-) shows the 
presence of localized mycobacteria in macrophages of liver-sections from control (A .I.) 
and CD40 deficient mice (B .l). The bacilli appear as bright pink dots which is due to the 
high concentration of lipids in the mycobacterial walls which are responsible for the acid 
resistant staining with fuchsin red (hence acid-fast bacilli) and can easily be localized. A 
comparative quantitative analysis of the number of bacilli (BCG) can be performed by 
choosing at random ten optical fields per histological slide and counting the number of 
bacilli. Such an analysis should have 5 mice in each group and the result should be 
expressed as a mean value ± s.e.m (Kindler et a i,  1989). In this instance, the slides 
should be coded so that they can be read blind. The code should only be broken once all 
the slides have been analyzed. If the number of bacilli present in the tissue is so high that 
a quantitative histological determination is impossible, then a colony forming unit (CFU) 
assay should be used (Figure 21.).
A BCG infection results in formation of granulomas consisting of large numbers of 
activated macrophages, surrounded by lymphocytes in the organs of infected mice. The 
formation of granulomas contains the mycobacterial infection and prevents the continued 
growth and dissemination of bacilli (Nibbering et al., 1989; Pelletier et a i, 1982).
In order to asses the formation of granulomas in CD40 deficient and control mice H&E 
staining of liver-sections (Figure 23. A .2.: CD40-1-/- and B.2.: CD40-/-) was performed. 
Hematoxylin preferentially stains acidic structures blue/purple, therefore activated cells
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with high levels of DNA and RNA stain heavily and are blue. Eosin stains basic 
structures pink, so that proteins and the cytoplasm of cells appears pink. The 
accumulation of many activated macrophages and lymphocytes with high concentrations 
of RNA, DNA and ribosomes can be readily seen as heavily blue stained cells in tissue 
sections, denoting the presence of a granuloma.
The H&E staining revealed the formation of granulomas in both control mice and CD40 
deficient mice. There appeared to be fewer granulomas in control mice and these were 
smaller and less densely packed with activated macrophages and lymphocytes than the 
granulomas in CD40 deficient mice. A comparative quantitative analysis of the number of 
granulomas in control and mutant mice can be performed by counting at random ten 
optical fields per histological slide. In the same way as is described for determination of 
bacilli numbers, the slides should be blinded. Such an analysis should have 5 mice in 
each group and the result should be expressed as a mean value ± s.e.m (Kindler et a i,  
1989). In addition, the size of the granulomas can be estimated if the area of the optical 
field is known (Nibbering et a i,  1989).
Figure 23. (A.3.: CD40+/- and B.3.: CD40-/-) shows granulomas from control and 
mutant mice at a higher magnification (400x). This allows us to see that the individual 
granuloma in the mutant mouse (Figure 23. B.3.) is larger and more densely packed with 
blue-stained cells, indicating the presence of more activated macrophages and lymphoctes 
than the individual granuloma shown in the control (Figure 23. A .3.). Spleen- and lung- 
sections showed the same pattern with raised numbers of granulomas in the CD40 
deficient mice (data not shown).
Infection of control and CD40 deficient mice with BCG results in significantly increased 
numbers of bacilli (CFU) in the spleen and lungs of CD40 deficient mice (Figure 21.). 
The ability of the CD40 deficient mice and control mice to generate a Thl response 
towards mycobacterial antigens was assessed in vitro. This was carried out by looking at 
the ability of splenocytes from BCG infected mice from each group to make IFN-y in
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response to culture with PPD. This revealed that the splenocytes of CD40 deficient mice 
secreted significantly less IFN-y in response to PPD (Figure 22.). Granuloma formation 
occurred in response to BCG infection in both control and CD40 deficient mice, however 
the number and size of granulomas appeared increased in CD40 deficient mice (Figure 
23). CD40 deficient mice survived infection with BCG (Figure 20.), nevertheless the 
increased numbers of bacilli in spleen and lungs, and the reduced production of IFN-y in 
response to mycobacterial infection indicates that CD40 deficient mice are more 
susceptible to infection with BCG than control mice.
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Figure 22. IFN-y production by spleen cells o f BCG infected control (CD40-h/-) and 
CD40 deficient (CD40-/-) mice. Four weeks after infection with BCG, spleens were 
removed and I.O x 10  ^splenocytes were stimulated with PPD (1 pg/ml). The number of 
cells producing IFN-y in response to PPD was detected in an ELIspot assay. Results are 
given as the number of IFN-y producing cells per 1.0 x 10^ splenocytes (2. PPD). The 
control (I. Medium) is splenocytes cultured without PPD. Triplicate wells per mouse 
were counted and the values shown are means ± s.e.m. of 5 mice in each group. The P 
values for each comparison were determined using the Student’s t-test. I. Medium: 
P=0.36; 2. PPD: P<0.001.
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Figure. 23. Histology of liver-sections from bacillus Calmette-Guerin infected CD40-I-/- 
control mice and CD40-/- mice. Mice were infected i.v. with 1 x 1 0 ^  CFU of bacillus 
Calmette-Guerin and killed four weeks later. Liver-sections were stained by the Ziehl- 
Neelsen method for acid fast bacilli (mycobacteria), A .I.: CD40-I-/-; B .l.: CD40-/-. 
Arrows indicate bacilli localized in macrophages. Magnification lOOx. Liver-sections 
were also stained with hematoxylin and eosin (H&E), A .2: CD40-I-/-; B.2. CD40-/-. 
Arrows indicate granuloma. Magnification 40x. A .3.: CD40-I-/-; B.3.: CD40-/-. Arrows 
indicate disintegrated liver tissue. Magnification 400x.
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Chapter 6: Discussion
6.1 Generation of CD40 deficient mice
There are many factors that must be considered when making a gene-deleted mouse. 
Firstly, the time that is required for the process is lengthy. It is probably best therefore to 
plan to delete a gene that has been cloned in your own or a closely collaborating 
laboratory. This ensures extra time so that changes to the different steps involved in the 
long process can be made. Secondly, gene-deleted mice may well be more susceptible to 
infections than intact mice. This means that the conditions under which the animals are 
housed must be very well regulated. SPF (specific pathogen free) facilities must be used 
if the specific deletion affects immune functions. However even specific pathogen free 
facilities may have to be modulated as deficient mice may display a different panel of 
infections that are not normally tested for under normal SPF requirements. Lastly, clean, 
pathogen-free mice which are used to provide blastocysts for microinjection will give 
better yields of blastocysts than infected mice and this will aid in the process of making 
chimaeric animals.
The two most difficult processes involved in making a gene-deleted mouse are the 
generation of targeted ES cells and the subsequent germline transmission of this targeted 
mutation. Generation of targeted ES cells is dependent on the targeting frequency of the 
targeting vector which is directly correlated to the length of homologous sequences 
present in the targeting vector (Hasty et al., 1991a). The results of the homologous 
recombination events that I found with the two different constructs that I made would 
tend to support this view since the length of homology in construct 2 (Figure 8.) was 
greater than that in construct 1 and it was only with this constmct that I was able to 
generate any targeted ES cell clones. The length of the construct is governed by other 
considerations such as the need for unique restriction enzyme sites and sequences for an 
external probe that allows unambiguous Southern blot analysis. Another factor that can 
be considered when making a targeting vector is the use of a negative selection marker
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(TK) in the targeting vector outside the region of homology. This would reduce the 
number of G418 resistant clones considerably. The advantages of this negative selection 
would be the decreased the number of clones that needed to be screened to obtain 
targeted ES cell clones and this may shorten the process by several weeks.
The culture conditions that need to be used to keep ES cells growing in an 
undifferentiated state are crucial. Even with stringent culture conditions abnormal variant 
cell clones will appear in the ES cell population with increased time in culture. Some of 
these variants will have an obvious abnormal karyotype and are unlikely to be able to 
contribute to the germline. For this reason, karyotyping was performed on both ES cell 
lines and targeted ES cell clones (Figure 11-13.) to ensure a normal karyotype. As 
shown in Table 2. and Figure 12., a seemingly normal karyotype in the 34 R1 ES cell 
clone did not guarantee germline transmission. It should be noted that both the R1 and 
D3 ES cell line (unmanipulated) was tested for germline transmission prior to generation 
of targeted ES cell clones. In contrast to the D3 ES cell line, the R1 ES cell line seemed 
to grow slower, otherwise it displayed normal morphology.
The results shown in Table 2. indicates how rare it was to achieve germline transmission 
despite the fact that all targeted ES cell clones had been karyotyped. The best indicator of 
the chance of germline transmission is the male to female ratio of chimaeras. As 
mentioned earlier, the conversion of a female blastocyst to a male chimaera indicates that 
the male ES cells are capable of colonizing the germline cells and possibly passing on the 
mutated allele. Therefore in this case more than 50% of the chimaeras will be male which 
I found to be the case for chimaeras generated from the 55 D3 ES cell clone. Of a total of 
33 male chimaeras, derived from the 55 D3 ES cell clone, only one male chimaera 
managed to pass on the mutated allele.
The ratio of male to female chimaeras is a better indicator of the chance of germline 
transmission than coat colour. All 16 male chimaeras derived from the 34 R1 ES cell 
clone were 80-95% agouti (Figure 14.). This indicates that most of the tissues in these
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mice were ES cell derived, however when bred to check for germline transmission, some 
were sterile or only produced wild-type offspring. The ES cells were obviously capable 
of differentiating into somatic cells but could not differentiate into germline cells and the 
reason for this is unknown. Ideally the majority of targeted ES cell clones should 
contribute to the germline. The resulting homozygous mutant mice, derived from two 
independent ES cell clones, can then be analysed and found to have the same phenotype. 
This confirms that the phenotype of the homozygous mutant mice really is a result of the 
targeted mutation. One last important factor to consider is that all cells grown in culture 
can become infected with mycoplasma. Mycoplasma does not always have an obvious 
effect on cell growth or morphology but can cause chromosome damage and severely 
reduce the efficiency of obtaining ES cell chimaeras. All the ES cell lines and clones used 
in this study were rigorously screened for mycoplasma and the results were always 
found to be negative.
The production of chimaeras by blastocyst injection, as described in Chapter 3, is the 
prevalent method used by many laboratories. While this method is effective for the 
production of chimaeras, including germline chimaeras, it does have some practical 
limitations. The main limitations are the cost of the equipment used and the man-hours 
required to acquire the skills needed to make good holding and injection needles. This is 
time-consuming but critical to the success of the injection process. In addition, 
successful injection of 25-30 blastocysts per day requires several months of practise. 
This technique alone required 1-2 months practise before I became proficient.
These considerations have lead to the investigation of alternative methods of chimaera 
production. A simpler technique has been developed that requires no expensive 
equipment and much less practice (Wood et al., 1993). This method is based on the 
observation that ES cells aggregate with morulae (the zona pellucida has been removed) 
and therefore all that is required for chimaera production is to bring the two cell 
populations into contact. Although the ES cells initially attach to the outside of the 
morulae they are efficiently internalized and by the blastocyst stage chimaeric embryos
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contain ES cell-derived cells in the inner cell mass. The chimaeras (morulae and ES cells) 
are then cultured overnight to the blastocyst stage before transfer into a pseudopregnant 
foster mother. Comparison of germline chimaeras produced by blastocyst injection and 
morulae aggregation revealed that an equal number of germline transmitters occurred 
with both methods. R1 ES cells were used in these experiments. The production of 
chimaeras by the aggregation method is well worth considering if no one in the 
laboratory has experience in blastocyst injection.
6.2 Analysis of CD40 deficient mice
6.2.1 Lymphocyte development in CD40 deficient mice
When I was screening ES cells for homologous recombination events, two papers were 
published showing that CD40 deficient mice had impaired immunoglobulin class 
switching and germinal centre formation (Castigli et a i ,  1994; Kawabe et al., 1994). 
Another paper on CD40 ligand deficient mice (Xu et al., 1994) was also published with 
essentially the same findings. The rational behind continuing to make the gene-deleted 
mouse was that it was becoming clear that CD40 expression was much wider than first 
thought and that many different cell types within the immune system could potentially be 
regulated by the CD40-CD40L interaction, providing opportunities for the investigation 
of a complex issue. I will go on to discuss my results and compare them with those 
found in these other papers.
In this study, analysis of lymphocytes in the periphery (peripheral blood and lymph 
nodes) and thymus (Figure 16.) of CD40 deficient mice revealed no change in the 
proportions and phenotype of B and T lymphocytes. B cells made up similar proportions 
of the lymphocyte population of peripheral blood and lymph nodes in both wild-type and 
CD40 deficient mice. The B cells in the CD40 deficient mice expressed normal levels of 
B220^ and IgM indicating that B cells lacking CD40 were still able to undergo normal 
maturation. Likewise no abnormal development of T lymphocytes in the thymus was 
observed. This was confirmed by staining thymocytes with T cell surface markers (CD4,
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CDS and ap-T C R ). CD40 was also found to be expressed on thymic epithelial cells 
(Figure 18. E.) and dendritic cells (Galy & Spits, 1992), suggesting that the CD40- 
CD40L interaction might also play a role in thymic selection, the process by which self­
reactive T cells are deleted from the T cell repertoire. Thymic selection involves both 
positive selection and negative selection. Positive selection is the process in which 
thymocytes whose TCRs bind self MHC molecules associated with self or foreign 
peptides are permitted to survive and all those that have no affinity for self MHC 
molecules die. Negative selection involves the deletion of thymocytes whose TCRs bind 
with high affinity to self peptide antigens in association with self MHC molecules 
(Anderson et a i ,  1996). It is clear that both positive and negative selection in the thymus 
requires recognition of peptide associated with MHC complexes by the TCR, but the 
requirement for additional costimulatory molecules is unclear. This is in contrast to the 
activation of naive peripheral T cells, where it has been demonstrated that recognition of 
peptide associated with MHC by TCR is insufficient for optimal T cell activation and that 
costimulatory molecules provided by APCs are necessary for complete T cell activation 
(Durie et al., 1994). To determine if CD40-CD40L interactions influenced thymic 
selection, the deletion of T cells expressing TCRs reactive against endogenous retroviral 
Mis (minor lymphocyte stimulating) antigens was examined in mice treated with anti- 
CD40L antibody. Due to the expression of Mis antigens encoded by endogenous mouse 
mammary tumor viruses, young adult BALB/c mice normally delete TCR expressing 
Vp3, V p i l ,  and Vpi 2 ,  but not TCR using Vp8. Mice treated from birth with anti- 
CD40L antibody were analysed for T cells expressing VP3, v p i  1, Vp i 2 ,  and Vp8, by 
flow cytometric analysis. Thymocytes expressing Vp3, V pl 1, and Vp l 2  were absent in 
the CD4^CD8 or CD4 CD8^ single positive thymocyte populations obtained from normal 
untreated BALB/c mice. However, analysis of Vp3, V p l 1, and Vp i 2  expression on 
single positive thymocytes from BALB/c mice treated with anti-CD40L antibody showed 
the presence of single positive thymocytes expressing Vp3, v p i l ,  and Vpl 2 .  The 
expression of these TCRs was similar to that seen in a nondeleting strain, C57BL/6. 
These results demonstrated that Mls-mediated deletion of self-reactive T cells was
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prevented as a result of anti-CD40L treatment. To further confirm the role of CD40L in 
Mis mediated deletion of thymocytes, analysis of TCR Vp usage in CD40L deficient 
mice was performed. Normal CBA/J mice (Mls'*'"’^ ) and CD40L heterozygous CBA/J F, 
mice delete a range of Vp-expressing T cells, including Vp3, Vp5, VP6, Vp7, Vp9, 
v p i  1, and V p l 2. In contrast, there was an increase in CD4^ and/or CD8^ single positive 
thymocytes using Vp5, VP6, Vp7, V p l 1, and Vp i 2  in CBA/J F, mice deficient in 
CD40L (Foy et al., 1995). To investigate the role of the CD40-CD40L interaction in the 
selection of T cells to other self antigens, an in vivo  system of negative selection 
involving TCR transgenic mice (AND TCR Tg) expressing an a /p  TCR specific for 
pigeon cytochrome c (PCC) in association with H-2E*^ class II MHC molecules and 
transgenic mice endgenously expressing PCC in the thymus were used. This system 
allows examination of the selection of transgenic thymocytes to an endogenously 
encoded “self antigen”. Mating the AND TCR transgenic mice with transgenic mice 
expressing PCC results in the recognition of PCC self antigen by thymocytes bearing the 
TCR specific for PCC and results in their deletion. To determine whether the CD40- 
CD40L interaction was required for the deletion of mature transgenic thymocytes in this 
model of negative selection, (AND TCR Tg X PCC Tg)F, mice were treated from birth 
with anti-CD40L antibody, and the thymocyte populations were examined four weeks 
later. The results, demonstrated a dramatic decrease in the percentage of CD4^ 
thymocytes in (AND TCR Tg X PCC Tg)F, mice compared with AND TCR transgenic 
mice. The administration of anti-CD40L antibody completely restored the CD4^ 
thymocyte compartment in the (AND TCR Tg X PCC Tg)F, mice. These results 
demonstrate that blockade of the CD40-CD40L interaction interferes with antigen- 
mediated deletion of thymocytes in this transgenic model of negative selection. 
Exogenous administration of PCCF (PCC peptide fragment) to AND TCR transgenic 
mice results in the deletion of DP (double positive) thymocytes. To determine whether 
administration of anti-CD40L antibody interfered with high-dose PCCF-mediated 
deletion of thymocytes, AND TCR transgenic mice were injected with PCCF, with or 
without coadministration of anti-CD40L antibody. The results showed that although
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administration of PCCF resulted in loss of DP thymocytes, coadministration of anti- 
CD40L antibody did not prevent this deletion. The results demonstrate that deletion of 
DP TCR transgenic thymocytes by high concentrations of antigen does not appear to be 
dependent upon the CD40-CD40L interaction. The involvement of the CD40-CD40L 
interaction in negative selection mediated by exogenous superantigens was also 
investigated. Administration of SEB (Staphylococcus Enterotoxin B) to neonatal BALB/c 
mice causes the deletion of Vp8-bearing T cells. Neonatal BALB/c mice were 
administered SEB alone or in combination with anti-CD40L antibody. SEB caused a 
dramatic loss in the Vp8-bearing T thymocytes in the CD4 and CD8 single-positive 
compartment. Coadministration of SEB and anti-CD40L antibody did not alter selection 
of Vp8-bearing thymocytes, suggesting that SEB-mediated deletion occurs 
independently of the CD40-CD40L interaction. These results showed that negative 
selection mediated by exogenously administered antigen/superantigen appeared to be 
independent of CD40-CD40L interactions, whereas negative selection mediated by 
endogenously expressed antigens was dependent on the CD40-CD40L interaction. Foy 
et al. (Foy et al., 1996) hypothesized that the clonal deletion that occurs following 
administration of supraphysiological concentrations of antigens/superantigens overrides 
any requirement for CD40L-mediated signaling. Furthermore, CD40L-dependent 
selection may also be related to the affinity/avidity of the interactions between TCR and 
MHC/Ag. In the model of viral-superAg-mediated deletion, mature antigen-specific T 
cells proliferated poorly in response to Mis, suggesting that thymocytes bearing these 
TCRs also interacted with Ags/SAgs in a low affinity/avidity fashion. Therefore CD40- 
CD40L interactions might provide additional costimulatory signals necessary to facilitate 
the deletion of thymocytes bearing TCRs of low affinity/avidity. In contrast, CD40- 
CD40L interactions may not be required for deletion mediated by high-affinity TCR 
ligands such as high dose PCC peptide and SEB, which elicit strong proliferative 
responses from mature T cells.
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Expression of CD86 in the thymus of CD40L deficient mice and in mice treated with 
anti-CD40L was also investigated (Foy et a i ,  1995). The results of quantitative 
immunohistochemical analysis revealed that the expression of CD86 in the medulla 
region was substantially reduced. This suggested that CD40L expression was critical for 
CD86 expression and that the reduced expression may have contributed to the defects in 
negative selection observed in the absence of CD40-CD40L interactions. Two models 
have been proposed which would explain the involvement of the CD40-CD40L 
interaction in negative selection of thymocytes. A negative signal is delivered by APCs 
expressing CD40 to the T cell via CD40L, inducing apoptosis in the T cell. Negative 
selection will not take place if CD40L is missing. The second model predicts that TCR 
recognition induces CD40L expression, which in turn engages CD40 and induces the 
upregulation of costimulatory molecules (CD86), which then induces a signal causing 
thymocyte death (Foy et al., 1996).
The analysis of CD40 deficient mice in this thesis and by Kawabe et al. (1994) and of 
CD40L deficient mice (Xu et al., 1994) revealed that proportions and numbers of B and 
T lymphocytes in peripheral lymphoid organs was normal and the pattern of thymocytes 
was indistinguishable in these mice compared with wild-type mice. Further experiments 
are obviously needed to clarify the role of the CD40-CD40L interaction in thymic 
selection.
The results in this thesis and by Kawabe et al. (1994) also showed that B cells retained 
their capacity to proliferate in response to EPS and EPS together with IL-4 (Figure 17.), 
however there was a slight reduction in the ability of CD40 deficient B cells to respond to 
EPS and EPS plus IL-4 (see results for further details). Cross-linking of mutant B cells 
with anti-CD40 antibody, did not induce proliferation. T cells from CD40L deficient 
mice and control mice responded equally well to mitogenic stimulation with PMA and/or 
ionomycin, or anti-CD3 antibody, indicating that CD40L deficient T cells are not 
defective in their ability to respond to mitogens (Xu et a i ,  1994).
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6.2.2 Germinal centre formation in CD40 deficient mice
Patients suffering from hyper-IgM syndrome do not have germinal centres (Korthauer et 
a i ,  1993) and blocking the CD40-CD40L interaction in vivo  with soluble anti-CD40L 
antibody has been shown to abrogate germinal centre formation in mice (Foy et al., 
1994). In this study the formation of germinal centres was tested by immunizing wild- 
type and mutant mice with KLH (Figure 18. A and B.). The absence of peanut 
agglutinin-binding B cells in CD40 deficient mice revealed that no germinal centres 
developed in CD40 deficient mice. Histological analysis with specific staining for T and 
B cell areas of the spleens of CD40 deficient mice revealed normal splenic architecture, 
indicating that a general dismption of splenic architecture did not account for the inability 
of CD40 deficient mice to form germinal centres. The lack of peanut-agglutinin binding 
in CD40 deficient mice, after immunization with KLH, was also demonstrated by 
Kawabe et al. (1994). In addition, CD40L deficient mice, immunized with SRBC (Sheep 
Red Blood Cells), failed to develop germinal centres. An interesting finding concerning 
the role of the CD40-CD40L interaction in germinal centre maintenance is that the 
administration of anti-CD40L antibody in mice causes the disappearance of preexisting 
germinal centres (Han et al., 1995). It has been established that germinal centre B cells 
apoptose upon isolation and that CD40 cross-linking can “rescue” them from death (Liu 
et al., 1992). Therefore, the immediate assumption is that anti-CD40L antibody treatment 
causes the loss of germinal centres due to increased apoptosis or it is possible that loss of 
the CD40-CD40L interaction in germinal centres causes B cells to migrate to the bone 
marrow and terminally differentiate into plasma cells. This hypothesis would be 
consistent with a recent in vitro study showing that human germinal centre B cells, when 
cultured with CD40L expressing T cells, differentiate into memory cells but the removal 
of CD40L expressing T cells resulted in terminal differentiation of germinal centre B cells 
into plasma cells (Arpin eta l., 1995).
Since it is clear that CD40L plays an important role in germinal centre formation and 
maintenance, it is important to determine which cells within the germinal centres are
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capable of expressing CD40L. Early studies in mice immunised with KLH showed no 
expression of CD40L in the germinal centres and marginal zones of their spleens. 
Instead, the expression of CD40L was restricted to T cells in the outer peri arteriolar 
lymphocyte sheaths (outer-PALS), and around the terminal arterioles (TA). Antibody- 
producing B cells specific to KLH have been found in close proximity to CD40L 
expressing T cells (Van et al., 1993). Furthermore, studies in human tonsils have shown 
a subset of T cells which contain preformed CD40L that can be mobilized upon 
activation. The T cells containing preformed CD40L were found predominantly in the 
outer zone of the germinal centres and could be important for the maintenance of 
germinal centre integrity (Casamayor et al., 1995). The different results in murine and 
human systems may be due to species differences or lack of sensitivity of the murine 
anti-CD40L antibody. Activated T cells expressing a membrane-bound form of CD40L 
can also secrete a soluble form (Graf et al., 1995). The soluble form of CD40L may be 
the active factor in maintaining germinal centre B cell proliferation. In addition, human B 
cells can express CD40L (Grammer et al., 1995) and mouse B cells express CD40L in 
their cytoplasm which is released into the supernatant when B cells are activated with 
anti-Ig and anti-CD40 antibodies (Wykes et al., 1998). Whether soluble CD40L secreted 
by either T cells or B cells is important for germinal centre formation and maintenance is 
currently unknown.
The interpretation of these studies suggests that signals via CD40 are responsible for 
germinal centre formation and maintenance. Experiments with CD40 deficient mice have 
revealed new information about the CD40-CD40L interaction. To investigate CD40L- 
transduced signals (signals to the T cell via CD40L), CD40 deficient mice were 
immunized with DNP-KLH and injected with a soluble CD40-Ig fusion protein to cross­
link the CD40L. Ten days after immunization, mice treated with soluble CD40-Ig had 
formed germinal centres, whereas mice injected with human IgGl had not. Interestingly, 
CD40 deficient mice treated with CD40-Ig were still unable to make class switched 
antibodies (van et a l ,  1995). This indicated that CD40 signaling to B cells was required
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for isotype switching but was not necessary for the initiation of germinal centre 
formation. These data may explain the discrepancy between experiments in CD40 and 
CD40L deficient mice, which do not form germinal centres or memory B cells, and those 
in normal mice treated with soluble CD40-Ig (to block the CD40-CD40L interaction) 
which do form germinal centres but still have no memory B cells (Gray et al., 1994). 
The observation that CD40L can also be expressed on B cells (Grammer et al., 1995) 
means that one cannot distinguish whether the effect of the soluble CD40-Ig is due to 
CD40L transduced signals to T cells or B cells. However as a defect in T helper cell 
function was also seen in CD40 deficient mice (see Chapter 5), this signal is most likely 
to be directed to T cells. The germinal centres that formed after soluble CD40-Ig 
treatment of CD40 deficient mice were underdeveloped, there were fewer and smaller 
than in wild-type mice. It is possible that the CD40 signal to B cells is important for their 
progression within the germinal centres as indicated in the experiments described earlier 
(Arpin et al., 1995; Liu et al., 1992). These experiments suggest that transduction of 
signals by CD40L to T cells can initiate germinal centre formation but for full maturation 
of germinal centres and the production of class switched immunoglobulins, signals to B 
cells via CD40 are required.
6.2.3 Serum immunoglobulin levels in CD40 deficient mice
A  characteristic feature of hyper IgM syndrome in humans is the difference in serum 
immunoglobulins levels as compared with healthy individuals. Serum from hyper IgM 
syndrome patients contains normal or elevated levels of IgM, but low to undetectable 
levels of other immunoglobulin isotypes. To determine whether mice deficient in CD40 
exhibited similar alterations in serum immunoglobulin levels, wild-type and CD40 
deficient mice were bled and the levels of serum IgM, IgGl ,  IgG2a, IgG2b, IgG3, and 
IgE were determined (Figure 19). The results demonstrate that, like HIGM l patients, 
CD40 deficient mice express elevated levels of serum IgM. This was also shown to be 
the case in the CD40 deficient mice studied by Kawabe et al. (1994). In contrast, CD40L 
deficient mice displayed completely normal serum IgM levels (Xu et al., 1994).
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In this thesis, the serum immunoglobulin levels in unimmunized CD40 deficient mice, 
were compared to the results obtained in two other studies of CD40 deficient mice 
(Castigli et a i, 1994. Kawabe et al, 1994). Both studies showed normal levels of IgM in 
CD40 deficient mice compared to control mice. Serum levels of IgG 1, IgG2a, IgG2b 
and IgA were significantly reduced, however IgG3 was significantly higher (Kawabe et 
al., 1994). Castigli et al. (1994) also found that levels of IgG l and IgG2a were 
significantly reduced and they found that IgE was absent in the CD40 deficient mice . 
Normal levels of IgG3 and slightly reduced levels of IgG2b and IgA were observed 
(Castigli et a l, 1994). There were slight differences in the levels of the immunoglobulins 
measured in these two studies and also in the results presented in this thesis, which could 
be attributed to the different conditions that the mice for the different studies were kept 
in, however the general trends in immunoglobulin production in CD40 deficient mice 
(reduced isotype switched immunoglobulins) were the same.
The normal or elevated levels of serum IgM that were seen in patients with hyper IgM 
syndrome and also in CD40 deficient mice indicates that IgM antibody responses in both 
systems were independent of the CD40-CD40L interaction. The reduced levels of isotype 
switched immunoglobulins in the serum of CD40 deficient mice suggests that the CD40- 
CD40L interaction is important for the isotype switching from IgM to other 
immunoglobulins.
Antigens which stimulate antibody production by B cells can be divided into two 
categories, thymus-dependent or thymus-independent antigens. Thymus-dependent 
antigens are protein derived peptides, which can only induce the production of antigen 
specific antibody if the peptide is recognized in association with MHC class II by antigen 
specific T cells. This leads to mutual activation of both B and T cells and the subsequent 
production of antigen specific antibody. Therefore antibody production in response to 
protein antigens requires T cell help. Antigens that stimulate antibody production in the 
absence of MHC class II restricted T cell help are classified as thymus-independent 
antigens (Mond e ta l ,  1995). Included within this category are lipopolysaccharide (EPS)
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derived from gram-negative bacterial cell walls, dextran, pneumococcal capsular 
polysaccharide, and Ficoll.
To investigate the role of the CD40-CD40L interaction in humoral immune responses to 
both thymus-dependent and thymus-independent antigens. CD40 deficient mice were 
immunized with a thymus-dependent antigen, ovalbumin, on day zero and day 22 of the 
experiment. Antigen specific antibody responses were measured by isotype-specific 
ELISA on day 7, 14 and 28. CD40 deficient mice completely failed to mount primary 
(day 7) and secondary (day 28) anti-ovalbumin antibody responses of all 
immunoglobulin isotypes except for the IgM class. Anti-ovalbumin IgM responses were 
normal or slightly higher than IgM responses in wild-type mice. These results indicate 
that immunoglobulin class switching did not take place in response to thymus-dependent 
antigens in CD40 deficient mice. However, the ability to produce antibodies in response 
to thymus-independent antigens, such as LPS or Ficoll, did not appear to be affected in 
these mice. When immunized with LPS or Ficoll, CD40 deficient mice developed anti- 
LPS or anti-Ficoll antibody responses of IgM as well as IgG immunoglobulin isotypes 
(IgG l, IgG2a, IgG2b, IgG3) (Kawabe e ta l., 1994).
This suggests that the signal through CD40 is not required for in vivo  thymus-dependent 
IgM responses and thymus-independent responses but is required for immunoglobulin 
class switching in primary and secondary immune responses to thymus-dependent 
antigens.
Similar experiments were performed in CD40L deficient mice (Xu et al., 1994). CD40L 
deficient mice were immunized with a thymus-dependent antigen, sheep red blood cells 
(SRBC), and the primary anti-SRBC antibody response was analysed 5 days later. 
CD40L deficient mice failed to produce any anti-SRBC IgM antibody responses. This is 
consistent with earlier studies in which in vivo CD40-CD40L interactions were blocked 
by an anti-CD40L antibody (Foy et a i,  1993). To confirm the defect in primary humoral 
responses, CD40L deficient mice were immunized with the thymus-dependent antigen,
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KLH. On day 7 and 19 the antibody responses to KLH were analysed. The primary (day 
7) anti-KLH IgM response was reduced compared to the wild-type response. Analysis of 
the secondary (day 19) anti-KLH IgG l response demonstrated that CD40L deficient 
mice were incapable of mounting a secondary IgG l response to this antigen. There is 
obviously a difference in the way that CD40L deficient mice respond to different thymus- 
dependent antigens. KLH may have some mitogenic activity independent of the CD40- 
CD40L interaction. In addition, CD40L deficient mice were immunized with the thymus- 
independent antigen Ficoll, and anti-Ficoll IgM and IgG3 responses were determined on 
day 6 after immunization. CD40L deficient mice developed similar anti-Ficoll IgM and 
IgG3 responses as control animals, confirming that antibody responses to thymus- 
independent antigens are independent of the CD40-CD40L interaction.
There are significant similarities between the results observed with CD40 and CD40L 
deficient mice and patients suffering from hyper IgM syndrome. In all cases, low levels 
of IgG isotypes, IgA, and IgE have been observed. CD40 and CD40L deficient mice 
have normal or slightly elevated levels of IgM. In HIGM l patients the IgM levels are 
significantly elevated, and this may reflect the persistent response of these patients to 
pathogens such as bacteria. In mice, IgM and IgG3 are known to be the major antibody 
isotypes stimulated in thymus-independent responses (Mongini et al., 1981). The normal 
capability of B cells to produce IgM and IgG antibodies to thymus-independent antigens 
and IgM to thymus-dependent antigens may be the reason why normal or slightly 
elevated serum levels of IgM and IgG3 are observed in CD40 and CD40L deficient mice.
Patients with hyper IgM syndrome make a poor antibody response to thymus-dependent 
antigens but mount strong humoral response to thymus-independent antigens 
(Notarangelo et al., 1992). Both CD40 and CD40L deficient mice are capable of eliciting 
normal antibody response to thymus-independent antigens, and show normal switching 
of antibody responses from IgM to IgG isotypes, IgA, and IgE. In contrast, 
immunoglobulin class switching from IgM to IgG isotypes, IgA, and IgE in both 
primary and secondary immune responses to thymus dependent antigens is impaired in
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CD40 and CD40L deficient mice. The capability of CD40 and CD40L deficient mice to 
mount a normal IgM response to thymus-dependent antigens in both primary and 
secondary immune responses indicates that IgM secretion is independent of the CD40- 
CD40L interaction.
These results suggests that in order for immunoglobulin class switching to occur in 
response to thymus-dependent antigens germinal centres are required. Germinal centres 
are only formed in response to thymus-dependent antigens and constitutes the site in 
which antigen stimulated B cells undergo somatic mutation and immunoglobulin class 
switching (MacLennan et al., 1997). The germinal centre reaction generates two 
populations of B cells, plasma B cells which are short-lived and memory B cells which 
are long-lived. The plasma cells secrete high-affinity isotype switched antibodies. Upon 
a secondary antigenic stimulation, high-affinity memory B cells differentiate into plasma 
cells, resulting in clearance of the antigen. Thymus-independent antigens do not stimulate 
germinal centre formation, but immunoglobulin isotype switching does take place and the 
capacity to generate memory B cells to thymus-independent antigens is associated with 
the appearance of antigen specific B cells in the marginal zones of the spleen (Mond et 
a/., 1995).
It has been established that the generation of memory B cells is dependent on the 
formation of germinal centres and the current dogma is that memory B cells express 
isotype switched immunoglobulins (IgG isotypes, IgA and IgE) and that B cells 
expressing IgM or IgD contribute little to the memory pool of B cells (Gray, 1993; Gray 
eta l., 1996). Adoptive transfer experiments by Foy et al. (1994) and Gray et al. (1994) 
confirmed the role of the CD40-CD40L interaction in the generation of memory B cells. 
CB17 (Igh^) mice were immunized with TNP-BSA and treated with Hamster Ig or anti- 
CD40L antibody. After four weeks, splenic B cells from these mice were adoptively 
transferred into KLH-primed BALB/c (Igh^ *) recipients. The recipients were subsequently 
challenged with TNP-KLH and the level of donor-specific IgG U  anti-TNP antibodies 
determined. The results showed that B cells from untreated or Hamster Ig-treated mice
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immunized with TNP-BSA produced high levels of donor-specific IgG l^ antibody, 
whereas mice which received B cells from mice treated with anti-CD40L antibody 
displayed an 80% decrease in the level of donor-specific IgG U  antibody produced. 
These results demonstrated that blocking the CD40-CD40L interaction inhibited the 
generation of functional memory B cells. As described earlier both CD40 and CD40L 
deficient mice failed to mount a secondary antibody response to thymus-dependent 
antigens. This confirms that memory B cells do not develop if the CD40-CD40L 
interaction is non-functional.
The role of the CD40-CD40L interaction in the generation of immune responses to viral 
infection was investigated by infecting CD40L deficient mice with lymphocytic 
choriomeningitis virus (LCMV). The primary anti-LCMV specific antibody responses 
were severely impaired in CD40L deficient mice, with reduced levels of IgG 1, IgG2a, 
IgG2b and IgG3. Unlike wild-type mice infected with LCMV, CD40L deficient mice 
were unable to sustain virus-specific antibody responses and showed a gradual decline in 
semm antibody levels over time. The CD40L deficient mice were also deficient in the 
generation of memory B cells as measured by a limiting dilution assay 60 days 
postinfection. In contrast to the severely impaired humoral responses, CD40L deficient 
mice were still able to generate a virus-specific CD8^ cytotoxic T cell response after 
LCMV infection and were able to clear the infection (Whitmire et a i ,  1996). A similar 
study examined the immune responses to LCMV, Pichinde virus and vesicular stomatitis 
virus (VSV) in CD40L deficient mice. The antibody responses to these viruses were 
severely compromised in CD40L deficient mice, however CD40L deficient mice did 
produce some virus-specific IgM and IgG2a. The antiviral antibody production in virus 
infected CD40L deficient mice took place in the absence of germinal centres and titres of 
virus-specific antibody decreased over time. Whether CD40L deficient mice failed to 
develop memory B cells after virus infection was investigated in adoptive transfer 
experiments. The results demonstrated that no virus-specific memory B cells were 
present in CD40L deficient mice 4 months postinfection in contrast to wild-type control
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mice. CD40L deficient mice mounted strong primary cytotoxic T lymphocyte (CTL) 
responses after infection with all of these viruses and cleared the infection with similar 
kinetics to wild-type control animals. LCMV-specific memory CTL activity was assessed 
by restimulating splenocytes from CD40L deficient and wild-type mice infected 2 months 
previously with LCMV for 6 days in vitro and then testing their ability to mediate virus- 
specific MHC-restricted CTL lysis in a ^'Cr-release assay. Splenocytes from CD40L 
deficient mice did mediate MHC restricted CTL lysis of LCMV-infected target cells, but 
the level of CTL activity was reduced considerably compared to wild-type mice. These 
results indicate that the CD40-CD40L interaction plays a role in the establishment and/or 
maintenance of CD8^ cytotoxic T lymphocyte (CTL) memory (Borrow et al., 1996). 
Taken together, these results confirm the crucial role of the CD40-CD40L interaction in 
B cell activation, antibody response to thymus-dependent antigens, germinal centre 
formation, immunoglobulin isotype switching and generation of memory B cells. 
Furthermore, the CD40-CD40L interaction appears to be important in the establishment 
of memory CTL.
6.3 Cell-mediated immunity in CD40 deficient mice 
infected with bacillus Calmette-Guerin
6.3.1 Susceptibiity of CD40 deficient mice infected with BCG
The results presented in Chapter 5 indicate an increased susceptibility of mice with a non­
functional CD40-CD40L interaction. This statement is based on the following 
observations. Infection of control and CD40 deficient mice with BCG revealed that 
CD40 deficient mice have a significantly increased number of mycobacteria in the spleen 
and lungs compared to control mice (Figure 21.). The development of a Thl response 
towards mycobacterial antigens following infection with BCG was assessed by an in 
vitro assay system (Eli-spot assay). Splenocytes from CD40 deficient mice infected with 
BCG secrete significantly less IFN-y in response to PPD (Figure 22.). Lastly, 
histopathological staining of liver-sections revealed that CD40 deficient mice had more
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granulomas that were bigger and more densely packed with cells than those seen in 
control mice (Figure 23.).
The increased susceptibility of CD40 deficient mice to BCG is likely to be due to the 
reduced ability of these mice to secrete IFN-y in response to a mycobacterial infection. 
The importance of IFN-y in the control of mycobacterial infections has been shown 
clearly in IFN-y deficient mice who are unable to survive infections with BCG or 
M.tuberculosis (Cooper er <3/., 1993; Dalton et al., 1993). The death of IFN-y deficient 
mice was shown to be due to insufficient activation of macrophages resulting in a 
reduced production of nitric oxide. This resulted in these mice having a very high 
parasite burden. A plausible explanation for the reduced production of IFN-y in CD40 
deficient mice upon infection with BCG, is a reduced production of IL-12 by activated 
macrophages and dendritic cells. The CD40-CD40L interaction was shown to be 
important for IL-12 secretion following activation of dendritic cells and macrophages 
(Celia era /., 1996; Peguet et al., 1995; Shu e ta l., 1995). EL-12 would then induce the 
production of IFN-y in T cells and NK cells, resulting in the development of a Thl 
response towards a mycobacterial infection. IFN-y and T N F -a in conjunction with 
activated T cells would result in macrophage activation and clearence of the infection. 
The enhanced susceptibility of CD40L and CD40 deficient mice to Leishmaniasis was 
associated with an impaired generation of a Thl response, reflected by the production of 
low levels of IFN-y, TNF, IL-12, and nitric oxide. From these studies it was concluded 
that the major contributing factor to increased susceptibility to Leishmania sp. was a 
diminished macrophage activation and nitric oxide production (Campbell et al., 1996; 
Kamanaka et al., 1996; Soong et al., 1996). Thus, in order to assess the level of 
macrophage activation, levels of T N F -a, IL-12, and nitric oxide must be measured in 
CD40 deficient mice infected with BCG. Furthermore the cells involved in the IFN-y 
production must be identified and characterised. The involvement of CD4‘" or CD8^ T 
cells in IFN-y production can be examined by blocking each subset of T cells with anti- 
CD4 or anti-CD8 antibodies and determining their effect.
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As shown by the experiments described above the development of protective immunity 
against a leishmanial infection is dependent on the development of a Thl response, 
which would lead to macrophage activation and eradication of the intracellular parasite. 
This is also the case for mycobacterial infections where the development of a Thl 
response is crucial for protective immunity. One of the key cytokines for protective 
immunity against mycobacteria is IFN-y as discussed at the beginning of this section 
(Cooper et a i ,  1993; Dalton et a i ,  1993), and this is correlated with a decrease in 
macrophage reactive nitrogen intermediates (RNI) production in these mice (Flynn et a l ,  
1993). Another key cytokine in protective immunity aganist mycobacteria is IL-12. 
BALB/c mice, a strain highly susceptible to infection with M. tuberculosis, were given 
recombinant IL-12 at the initiation of infection with M. tuberculosis. This treatment 
increased the mean survival time from 58 days to 112 days, indicating a role for IL-12 in 
protection against a mycobacterial infection. In contrast to the findings in the BALB/c 
model, IL-12 treatment of IFN-y deficient mice infected with M. tuberculosis did not 
increase survival time. This indicates that IL-12 does not induce protection against M. 
tuberculosis in the absence of IFN-y (Bloom et a l, 1995).
These experiments confirm the importance of IFN-y in protective immunity aganist a 
mycobacterial infection. CD40 deficient mice infected with BCG (this Thesis) displayed 
a reduced production of IFN-y in response to mycobacterial antigens (PPD) indicating 
that CD40 deficient mice are impaired in their ability to generate a Thl response. 
Granulomas consisting of activated macrophages and lymphocytes serve as an effective 
means of containing the mycobacteria and preventing their continued growth and 
dissemination (Fenton & Vermeulen, 1996). In CD40 deficient mice following BCG 
infection, I found that the numbers of granulomas appeared increased compared to 
control mice (Figure 23.). As granulomas are produced to control the infection why was 
an increase in the number of CFU recovered from CD40 deficient mice compared with 
wild-type mice? (Figure 21.). A hypothesis that could explain this apparent inconsistency 
is that macrophage activation is a key component of the protective immune response to
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M. tuberculosis infection. The only demonstrated mechanism by which macrophages kill 
mycobacteria is through activation by IFN-y and LPS or T N F -a to produce reactive 
nitrogen intermediates (RNI) (Flesch & Kaufmann, 1991). It is possible that the reduced 
levels of IFN-y in CD40 deficient mice would lead to reduced activation of macrophages. 
Without optimal macrophage activation upon infection with mycobacteria, the bacilli 
would continue to multiply, leading to increased numbers of bacilli in the organs. In 
CD40 deficient mice, the sub-optimal levels of IFN-y although not clearing the 
parasitaemia, would still lead to granuloma formation.
A recent study was published while the BCG experiments described in this thesis were 
being carried out. This study investigated the immune response of CD40L deficient mice 
to Mycobacterium tuberculosis (Campos et al., 1998). CD40L deficient mice infected 
with M. tuberculosis showed 100% survival during a 30 week period and mycobacterial 
counts after 3 or 6 weeks of infection in spleen, lung, and liver were indistinguishable in 
control and CD40L deficient mice. However later in infection (week ten), the CD40L 
deficient mice presented slightly elevated CFU in all three organs. Histopathologic 
examination of tissue sections taken at 6 weeks of infection revealed differences between 
the granulomas developing in CD40L deficient mice compared with those in control 
mice. The number of granulomas forming in all three organs of CD40L deficient mice 
was the same. This was also the case for all three organs in normal mice. However, the 
number of granulomas observed in the liver of CD40L deficient mice was reduced 
compared to control mice and the granulomas appeared disintegrated, lacked epithelioid 
cells and were reduced in size. Since the survival and mycobacterial counts were similar 
in control and CD40L deficient mice, these results indicated that organized granulomas 
are not essential for protection against M. tuberculosis. In vitro T cell proliferation and 
IFN-y production by splenocytes in response to PPD was identical in control and CD40L 
deficient mice and the production of IFN-y was abrogated by anti-CD4 mAb, but not by 
anti-CD8 mAb. This indicates that CD4^ T cells proliferate and produce IFN-y in 
response to M. tuberculosis antigens, independently of the CD40-CD40L interaction.
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Campos et al. ( 1998) could not detect IL-4 in the supernatants of any of the splenocyte 
cultures stimulated with PPD. The production of IL-12 and T N F -a was measured in 
vitro after stimulation of splenocytes with M. tuberculosis antigens. Similar levels of IL- 
12 were present in the supernatants of cultures of both control and CD40L deficient 
mice, in contrast to which TNF levels were slightly elevated in CD40L deficient mice. 
Finally, CD40L deficient mice did produce nitric oxide, albeit to a slightly lesser extent 
than control mice in response to M. tuberculosis antigens. The title of the paper in which 
this data appears states that the CD40-CD40L interaction does not affect the development 
of protective immunity to M. tuberculosis and that CD40L deficient mice are resistant to 
infection with M. tuberculosis. Perhaps to confirm this, granuloma formation and 
cytokine production will have to be measured at week 10 when the authors showed that 
M. tuberculosis CFU counts were different in CD40L deficient and normal mice.
In CD40L deficient mice infected with M. tuberculosis, the reduced number of 
granulomas which appeared small, disintegrated and lacking in epithelioid cells, was not 
caused by a decrease in T N F-a levels as these mice displayed slightly elevated levels of 
T N F -a. This is surprising given that T N F -a was shown to be crucial for granuloma 
formation in a study where mice were infected with BCG and then treated with anti- 
T N F -a  antibody. A nti-TNF-a treatment of mice resulted in a 10-fold decrease in the 
number of granulomas and those that formed were small and lacked epithelioid cells, 
compared to untreated mice. It was proposed that T N F -a released from macrophages 
into the microenvironment of developing granulomas could be involved in a process of 
autoamplification. T N F -a enhances its own synthesis and release, thereby inducing 
further macrophage accumulation and activation. This would then lead to fully developed 
granulomas and mycobacterial elimination (Kindler et al., 1989). TNF-receptor deficient 
mice infected with M. tuberculosis also showed granulomas which lacked epithelioid 
cells and seemed more loosely organized (Flynn et a i ,  1995a). Since the levels of TNF- 
a  in CD40L deficient mice infected with M. tuberculosis were slightly higher compared 
to the control mice, T N F -a  does not appear to be the only effector needed for fully
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developed granulomas. Other cytokines such as GM-CSF (Granulocyte/Macrophage 
Colony Stimulating Factor), IL-1 and IL-8, have been found in granulomas (Bergeron et 
a l ,  1997) and are probably involved in their development. Whether the production of 
these cytokines are influenced by the CD40-CD40L interaction is currently unknown. It 
will be interesting to see if CD40 deficient mice infected with BCG show reduced levels 
of T N F -a . I would not expect to see this, if further experiments confirm that more 
granulomas develop in CD40 deficient mice compared to control mice. What also 
remains to be determined is whether the granulomas in the CD40 deficient mice infected 
with BCG contain epithelioid cells, determined by silver staining for reticulum fibres, 
indicating fully developed granulomas.
CD40L deficient mice are susceptible to infection with Leishmania but are able to control 
infection by M. tuberculosis. The difference between these two infections is that there is 
no apparent T cell response following infection of CD40L and CD40 deficient mice with 
Leishmania (Campbell eta l., 1996; Kamanaka a/., 1996; Soong et al., 1996), whereas 
there is priming for T cell proliferation and IFN-y production following M. tuberculosis 
infection in CD40L deficient mice (Campos et al., 1998). If the CD40-CD40L interaction 
is not cmcial for the induction of a Thl response to a mycobacterial infection, then there 
must be some compensatory mechanism, which would lead to a Thl response and 
macrophage activation.
The interaction of M. tuberculosis with human dendritic cells was studied in vitro 
(Henderson et al., 1997). Cultured human dendritic cells were capable of phagocytosing 
live M. tuberculosis and this resulted in increased surface expression of costimulatory 
molecules, including CD80, CD40, and CD54 as well as MHC class I molecules. In 
addition, infected dendritic cells secreted elevated levels of cytokines, including T N F -a, 
IL-1, and IL-12. These results suggest that in addition to activation of dendritic cells to 
become competent antigen presenting cells in response to M. tuberculosis, they also 
secrete cytokines which could potentially induce macrophage activation and Thl 
development. E L -12 would induce antigen specific T cells to secrete IFN-y, which
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together with T N F-a induces activation of macrophages. Another study has shown that 
IL-12 is not the first cytokine to be produced in a mycobacterial infection (Flesch et al., 
1995). Murine macrophages were infected with BCG in vitro to assess whether IL-12 
production depended on other cytokines. Murine macrophages infected with BCG in 
vitro were only capable of producing IL-12 if they had been primed with rIFN-y. 
Stimulation with rIFN-y alone or infection with BCG alone did not induce expression of 
IL-12. To investigate the role of endogenously produced T N F -a in the induction of IL- 
12, an anti-TN F-a antibody was used. Addition of anti-TN F-a to infected murine 
macrophages in the presence of rIFN-y significantly reduced IL-12 production, 
indicating that IL-12 production by macrophages is dependent on both IFN-y and TNF- 
a . To investigate the influence of IFN-y and T N F-a on IL-12 induction in vivo, IFN-y- 
Receptor deficient- and TNFRl deficient-mice were infected with BCG and spleen cells 
were analysed for IL-12 mRNA and IL-12 protein 3 h after infection. Splenocytes from 
both mutant strains failed to express IL-12 (determined by ELISA) after infection with 
BCG as analysed by RT-PCR. In vitro stimulation of spleen cells with rIFN-y or BCG 
did not induce IL-12 production, whereas splenocytes from control mice did produce IL- 
12. The authors argue that IL-12 production by macrophages in response to 
mycobacterial infection depends on IFN-y and TN F-a, therefore macrophage derived IL- 
12 is not the first cytokine to induce a protective antimycobacterial immunity mediated by 
Thl cells. In view of the two studies discussed above, one can speculate that dendritic 
cells which have phagocytosed Mycobacterium sp. would secrete sufficient levels of IL- 
12, which would activate antigen specific NK and T cells to secrete IFN-y. IFN-y and 
TN F-a would then activate EL-12 production in macrophages.
It has recently been reported that Toxoplasma gondii another intracellular pathogen, 
induces in vivo IL-12 production by dendritic cells independently of the CD40-CD40L 
interaction (Sousa et al., 1997). Macrophages infected in vitro with T. gondii did not 
produce any detectable levels of IL-12 unless primed with exogenous IFN-y, in contrast, 
whole splenocytes produced significant levels of IL-12 after infection with T. gondii.
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When spleen cells were separated into adherent and nonadherent cells, T. gondii induced 
IL-12 production was found in the adherent fraction composed mainly of macrophages 
and dendritic cells. To determine if IL-12 production by spleen cells in response to T. 
gondii also occurred in vivo, mice were infected with T. gondii and splenocytes were 
analysed for IL-12 production. Maximum IL-12 production could be detected as early as 
three hours after infection. The EL-12 produced in vivo  appeared to be active because 
spleen cells from T. gondii infected mice produced increased levels of IFN-y when 
restimulated in vitro with T. gondii. This enhancement of IFN-y production was 
specifically dependent on IL-12 induction in vivo as it was not seen in IL-12 deficient 
mice. These results demonstrate that spleen cells can produce IL-12 in response to T. 
gondii, and that IL-12 production in vivo can prime an IFN-y response. 
Immunohistochemical staining of spleen sections from T. gondii infected mice revealed 
that dendritic cells were responsible for the production of IL-12 but not by splenic 
macrophages since production of IL-12, by macrophages, could not be detected in vitro 
three hours after infection. The major mechanisms involved in EL-12 induction appear to 
be signaling through dendritic cell surface CD40, after cross-linking by T cell expressed 
CD40L. Spleen cells from CD40L deficient mice infected with T. gondii secreted 
substantial levels of IL-12, suggesting that T. gondii induced IL-12 production by 
dendritic cells did not require cross-linking of CD40 on dendritic cells by CD40L on T 
cells. To exclude the possibility that other cognate T cell-dendritic cell interactions may 
be responsible for IL-12 production, SCID mice were infected with T. gondii. SCID 
spleen sections showed IL-12 staining comparable to wild-type controls and spleen cells 
stimulated in vitro with T. gondii also produced high levels of IL-12. Based on these 
results, a model is proposed for the role of macrophage versus dendritic cell derived IL- 
12 in immunity to microbial infections. Dendritic cells produce EL-12 early in infection 
due to direct stimulation by microbial stimulation, and present antigen to antigen-specific 
T cells. During the DC-T cell interaction, engagement of CD40 on the DC by CD40L on 
the T cell induces the continued production of IL-12 by DC, further driving Thl 
development. DC derived IL-12 might also activate NK cells in lymphoid tissue, which
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then produce IFN-y, further stimulating T helper cells to differentiate towards Thl 
effectors. On the other hand, IL-12 produced by macrophages in response to microbial 
infection could be important at the site of infection. Macrophage derived IL-12 could then 
further stimulate NK and T cells to produce IFN-y, which would then increase the 
microbicidal activity of the macrophages.
The results presented in this thesis indicate that the CD40-CD40L interaction is important 
for the development of protective immunity against infection with Mycobacterium Bovis 
(BCG). This is in contradiction to experiments where CD40L deficient mice were 
infected with Mycobacterium tuberculosis. These experiments revealed that protective 
Th 1 immunity against M. tuberculosis developed in CD40L deficient mice (Campos et 
al., 1998). The discrepancy in these two studies could be due to the different genetic 
backgrounds of the two groups of mice. The CD40 deficient mice used for experiments 
in this thesis were on a (129SvxC57BL/6)F2 background, whereas the CD40L deficient 
mice were on a C57BL/6 background (backcrossed for seven generations). C57BL/6 and 
BALB/c mice both have the same allele of the beg gene. In a study by Pelletier and co­
workers, resistance or susceptiblity was determined by the number of CFU (BCG) 
recovered from the spleens of infected mice within the first 3-4 weeks after infection 
(Pelletier et al. 1982). However is only one of the many genes that may govern the 
susceptibility or resistance of a certain strain of mouse to an infectious disease. If these 
two strains of mice are infected with M. tuberculosis, C57BL/6 mice survive more than 
140 days, whereas BALB/c mice succumb after 42 days. Therefore, despite the same 
susceptibility gene at the beg locus , C57BL/6 mice are highly resistant to infection with 
M. tuberculosis. The increased susceptibility to infection with BCG in CD40 deficient 
mice could be attributed to a 129Sv susceptible genetic background. This explanation is 
called into question by some unpublished observations quoted by Flynn et al. (1996) 
who found that 129Sv and (129SvxC57BL/6)Fl mice have similar infection profiles as 
C57BL/6 mice, when infected with M. tuberculosis.
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Chapter 7: Conclusion
It is well established that cell-cell interactions play a pivotal role in the regulation of the 
immune response. Attempts to identify interacting molecules on B and T cells led to the 
discovery of the receptor-ligand pair CD40-CD40L, which in recent years has been 
shown to be important in both humoral and cell-mediated immunity. Antibodies cross- 
linking CD40 on B cells were found to induce proliferation and cross-linking CD40 in 
the presence of cytokines was shown to induce immunoglobulin class switching and 
secretion of immunoglobulins. The phenotype of hyper IgM syndrome, low or absent 
IgG, IgA and IgE, indicated a failure in the ability to switch from IgM to the other 
immunoglobulin isotypes. The development of a soluble CD40 (sCD40) molecule, by 
fusing the extracellular domain of human CD40 to the constant region of human IgG 1, 
was an important step in the identification of CD40L function. The use of this chimaeric 
protein in the analysis of T cells from patients suffering from hyper IgM syndrome, 
revealed that T cells from these patients were unable to bind sCD40. The lack of sCD40 
binding was due to mutations in the CD40L protein. In addition to low or absent isotype 
switched immunoglobulins, patients with hyper IgM syndrome displayed no germinal 
centres.
The discovery of homologous recombination in embryonic stem (ES) cells and the 
subsequent generation of “knock-out” mice made it possible for me to produce an in vivo 
model for hyper IgM syndrome by generating mice deficient for CD40 (Chapter 3). 
Analysis of CD40 deficient mice (Chapter 4) revealed an impaired ability to produce 
isotype switched immunoglobulins (IgG isotypes, IgA and IgE) and an absence of 
germinal centres. Immunoglobulin class switching in response to thymus-dependent 
antigens, in both a primary and secondary response, did not occur in CD40 deficient 
mice. IgM secretion to thymus-dependent antigens were seen in both primary and 
secondary immune responses. Immunoglobulin class switching in response to thymus- 
independent antigens was unaffected by a disrupted CD40-CD40L interaction. As a
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result of no germinal centre formation and impaired immunoglobulin class switching, 
memory B cells did not occur in CD40 deficient mice. Similar results were obtained with 
CD40L deficient mice. The results presented in this thesis confirm the crucial role of the 
CD40-CD40L interaction in the initiation of humoral immune responses to thymus- 
dependent antigens.
When the CD40-CD40L receptor-ligand was first discovered, it was thought that a 
receptor-ligand pair with a single function (the regulation of humoral immunity) and no 
redundancy had been found. Since then many studies with CD40L and CD40 deficient 
mice have revealed that the CD40-CD40L interaction is involved in cell-mediated 
immunity as well as humoral immunity. Disruption of the CD40-CD40L interaction 
resulted in impaired T cell activation, either by direct signaling via CD40L or by a 
reduced production of IL-12, which would impair the development of a Thl response. It 
was established that the CD40-CD40L interaction was required for protective immunity 
to Leishmania major and Leishmania amazonensis. The lack of protective immunity to 
Leishmania in CD40L and CD40 deficient mice was due to a reduced production of IL- 
12 and IFN-y, resulting in a reduced macrophage activation. The susceptibility to 
infections with Pneumocystis carinii and Cryptosporidium in patients suffering from 
hyper IgM syndrome and the results from the Leishmania studies mentioned above, 
prompted my investigation of whether CD40 deficient mice were capable of developing a 
protective Thl response to infection with mycobacteria (BCG). The studies presented in 
Chapter 5 indicate that although CD40 deficient mice do develop a Thl response to 
BCG, this response is less efficient and these mice produce lower levels of IFN-y when 
compared with normal control mice. The CD40 deficient mice are more susceptible to 
BCG infection and this is indicated by the increased numbers of bacilli found in the 
spleen and lungs, compared to control mice.
Ever since the discovery of the CD40-CD40L interaction, the different effector functions 
in which the CD40-CD40L interaction are involved, has increased dramatically. 
Although the initial studies on CD40 focused on its role in humoral immunity, several
168
7: Conclusion
observations suggested that CD40-CD40L interactions played a broader role in the 
immune system. Studies have shown that APCs are activated following CD40 cross- 
linking, leading to upregulated expression of costimulatory molecules and cytokines. 
Likewise, macrophage effector functions are induced following CD40 cross-linking. The 
CD40-CD40L interaction is also involved in cell-mediated inflammatory responses. 
Cross-linking CD40 on endothelial cells induces the expression of CD62E (E-selectin), 
CD 106 (vascular cell adhesion molecule; VCAM) and CD54 (intercellular adhesion 
molecule; ICAM). This demonstrates that endothelial cells respond to stimulation through 
CD40 by expressing selectins and adhesion molecules that promote homing and 
extravasation of peripheral blood leukocytes (Stout & Stuttles, 1996).
Three recent studies have shown that T cell help for cytotoxic T lymphocytes (CTL) is 
mediated by the CD40-CD40L interaction (Bennet et a l, 1998; Ridge et a l, 1998; 
Schoenberger et al, 1998). It was shown that mice lacking T helper cells (MHC class II 
deficient mice) could not mount a CTL response when injected with professional APCs 
that displayed an antigen recognized by antigen specific CTLs. However, a CTL 
response could be induced by injecting the mice with an antibody against CD40. Cross- 
linking CD40 leads to activation of the APCs, a function normally carried out by CD40L 
expressed on the surface of T helper cells. The anti-CD40 antibody in these experiments 
acted as a substitute for T helper cells. Mice lacking either CD40 or CD40L could not 
mount T helper-dependent CTL responses, confirming the findings described above. The 
traditional model of CTL activation requires that T helper cells and CTLs recognize 
antigen on the same APC. The T helper cell is activated and secretes IL-2 which 
contributes to activation of the CTL, a three cell interaction. A new model has been 
proposed, the sequential two-cell interaction where the APC becomes activated via CD40 
ligation by the T helper cell and is “conditioned” or activated in some way such that it is 
then able to activate CTL* s. There is therefore no need for both the T helper cell and the 
CTL to recognize antigen on the same APC. The ever widening effector functions of the
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CD40-CD40L interaction in the regulation of the immune system means that CD40 
deficient mice will prove a very valuable tool for future experiments.
One of the first things that I would like to do is to follow on from the studies described in 
this thesis on CD40 deficient mice infected with BCG. I would like to look at the 
immune response to Mycobacterium tuberculosis in my CD40 deficient mice and I would 
like to perform a thorough investigation of the levels of different cytokines produced by 
these mice in response to this infection.
Another interesting study would be the infection of my CD40 deficient mice with the 
malaria parasite Ptasrnodium chabaudi chnbaudi . The course of infection in C57BL/6 
mice is characterized by two phases of parasite control, the first is a rapid phase (7-14 
days) which decreases the parasitaemia from the peak of infected erythrocytes of 30% to 
1 -2 %, and the second is a long chronic phase (18-60 days) with a small recrudescence in 
which the parasites are maintained at very low levels before being eliminated. In the first 
phase, the predominant parasite-specific CD4^ T cell response is that of a Thl type, 
producing IFN-y and IL-2. As the infection progresses the frequency of Thl cells 
decreases and the frequency of Th2 cells increases and the second phase of the immune 
response is predominantly CD4^ T cells producing increased levels of IL-4 which 
increase production of specific anti-malaria antibodies (Langhome et a l, 1989). The 
infection of CD40 deficient mice would provide information about the importance of 
either a Thl or Th2 response in the development of protective immunity to the 
erythrocytic stages of a P. chabaudi chabaudi infection..
Gene targeting in ES cells is now commonly used to inactivate genes and the resulting 
“knock-out” mice have become standard tools to understand gene function. The field of 
gene targeting has advanced. enormously with the discovery of a site-specific 
recombinase (Cre-recombinase) for gene modification in ES cells and mice (Kuhn & 
Schwenk, 1997). This recombinase allows a much greater flexibility in gene 
modification. Cre-mediated recombination excises a DNA segment flanked by
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recognition sites (loxP sites, 34 bp each) as a circular molecule, leaving a single 34 bp 
loxP site in the genome. The modification of the ES cell genome using the CRE/loxP 
recombination system involves two steps: a genetic modification with loxP sites 
(targeting construct with loxP sites) is first introduced into the ES cell genome by 
homologous recombination, subsequently the desired, final structure of the targeted 
locus is generated by site-specific recombination between two loxP sites by transient 
expression of Cre recombinase. An important application of Cre-mediated recombination 
is the removal of the selection marker gene to avoid its possible interference with the 
expression of the t^geted gene. Cre-mediated recombination provides the opportunity to 
study the effects of targeted point-mutations, deletions or insertions on gene function. 
The ES cells resulting from Cre-mediated recombination would then be injected into 
blastocysts giving rise to chimaeras, which would be bred for germline transmission. 
The CrdloxP recombination system can also be used for conditional gene targeting. 
Conditional gene targeting can be defined as a gene modification which is restricted to 
certain cell types or developmental stages of the mouse. Conditional gene targeting 
requires the generation of a mouse strain containing a /oxP-flanked segment of a target 
gene (both alleles must be Zoxf-flanked) and a second strain (transgenic) expressing Cre 
recombinase. The recombinase activity can be expressed constitutively or upon induction 
in specific cell types or tissues or at different developmental stages by using a cell, tissue 
or stage specific promoter controlling Cre. A conditional mutant is then generated by 
crossing these two strains so that the modification occurs in those tissues in a controlled 
fashion through the activity of the Cre recombinase. The specificity of conditional gene 
targeting makes this an extremely powerful technology that is now replacing 
conventional gene targeting methods.
methods.
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Appendix A
Primer sequences
(Genosys Biotechnologies Ltd.)
Primer 1.
CD40 sense, exon 1 :
5 ’ -cagtcaagcttcccgaagaccccgccctcttcc-3 ’
Primer 2
CD40 sense, exon 2:
5’-agggcagtgtgttacgtgcagtga-3'
Primer 3
CD40 antisense, exon 3:
5’-gggttcacagtgtctgtgctg-3'
Primer 4
CD40 antisense, downstream of exon 4:
5 ’ -cagtctgagctgactcccaagggagcc-3 ’
Primer 5
CD40 antisense, exon 5:
5'-gatgactgattggagaagaagccg-3'
Primer 6
CD40 sense, exon 6:
5 ’ -cagtggatccggggaagtcttcccagaagac-3 '
Primer 7
CD40 sense, exon 7:
5'-gcgtttaaagttcccctagtgacc-3'
Primer 8
CD40 antisense, exon 8:
5-ggcgggatccaatacaagctctct-3'
Primer 9
CD40 antisense, exon 9:
5 ’ -tgcagtgtctcctgcactggagca-3 ’
Primer 10
CD40 antisense, downstream of exon 9;
5 ’ -aagcagttccagggttcagaccag-3 ’
Primer 11 
Neo F3 sense:
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5’-cccgattcgcagcgcatcgccttc-3'
Primer 12
T7 primer sense (Promega):
5 ’-gggcgaattcgagctcggtacccg-3 ’
Primer 13
Linker oligo {SaB restriction site):
5 ’-aattttagctagcgtcgactaga-3 ’
Primer 14
Linker oligo {SaB restriction site):
5’-aatttcagtcgacgctagctaa-3’
Appendix B
Antibodies
FTTC-conjugated Rat anti-mpuse CD40 monoclona] antibody 
Isotype; Rat IgGj,, k . Clone: 3/23. (Phamüngen). 
PE-conjugated Rat anti-mouse CD45R/B220 monoclonal 
antibody. Isotype: Rat IgGj., k . Clone: RA3-6B2. 
(Pharmingen).
PE-oonjugated Rat anti-mouse CD4 (L3T4) mnnnrinnal 
anübody. Isotype: Rat (Lou/WSl) IgGj., k . Clone: H129.19. 
(Pharmingen).
Eire-conjugated Rat anti-mouse Ly-2 (CD8a) monoclonal 
antibody. Isotype: Rat IgGj,. Clone: 53-6.7. (Boehringer 
Mannheim).
FTTC-conjugated Rat anti-mouse IgM monoclonal antibody. 
Isotype: Rat IgGj^. Clone: n/41. (Pharmingen). 
FTTC-conjugated Hamster anti-mouse ap  TCR monoclonal 
antibody. Isotype: Armenian hamster IgG. Clone: H57-597. 
(Pharmingen).
R4 hybridoma: secreting anti-mouse IFN-y antibody. 
Biotin-conjugated Rat anti-mouse IFN-y antibody. Cat. no.
18112 D. (Pharmingen).
Streptavidin poly alkaline phosphatase. Cat. no. S-5795. 
(Sigma).
Biorad: AP-conjugate substrate kit. Cat.no. 170-6432.
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Antibodies used in Immunohistochemistry 
Primary antibodies:
1.) Biotinylated Peanut agglutinin (Vector laboratories).
2.) FTTC conjugated rat anti-mouse CD40, Clone: 3/23. 
(Pharmingen).
3.) Rabbit anti-CD3 (Jones et al, 1993).
4.) Rabbit anti-CD79a (Jones et al., 1993).
Secondary antibodies:
1.) Avidin horseradish peroxidase conjugate (DAKOPATTS P 
364).
2.) Rabbit anti-FTTC horseradish peroxidase conjugate 
(DAKOPATTS P 404).
3.) Goat anti rabbit horseradish peroxidase conjugate 
(DAKOPATTS P 162).
4.) Avidin alkaline phoshatase conjugate (DAKOPATTS P 365).
Substrate:
DAB (Diaminobenzidene) (Sigma D 5637)
Fast red. (Sigma F 1500).
Antibodies used for ELISA
Coating antibodies: Goat anti-mouse IgM (Fc)/7s, goat anti-mouse IgGl (Fc)/7s,
goat anti-mouse IgG2a (Fc)/7s, goat anti-mouse IgG2b (Fc)/7s, 
goat anti-mouse IgG3 (Fc)/7s, goat anti-mouse IgE (Fc)/7s, 
(Nordic Immunology).
Standards: Mouse IgM (Sigma, cat. no. M-7394), mouse IgGl (Sigma, cat.
no. M-1398), mouse IgG2a (Sigma, cat.no. M-9144), mouse 
IgG2b (Sigma cat.no. M-7644), mouse IgG3 (Sigma, cat no. M- 
1645), mouse IgE (Pharmingen cat.no. 0512ID).
Anti mouse-Ig conjugates. (Alkaline phosphatase conjugated):
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Goat anti-mouse IgM-AP (cat. no. 1020-01), goat anti-mouse 
IgGl-AP (cat. no. 1070-04), goat anti-mouse IgG2a-AP (cat. no. 
1080-04), goat anti-mouse IgG2b-AP (cat. no. 1090-04), goat 
anti-mouse IgG3-AP (cat. no. 1100-04), rat anti-mouse IgE-AP 
(cat. no. 1130-04). Southern Biotechnology Associates.
Substrate: PNPP (p-Nitrophenyl Phosphate). Sigma cat. no. N-9389.
205
Appendices
Appendix C
Books
Essentials of Medical Statistics. Betty R. Kirkwood. Blackwell Science. 1988.
Flow Cytometry. A Practical Approach. M. G. Ormerod. Oxford University Press. 
1994.
Gene Targeting. A Practical Approach. A. L. Joyner. Oxford University Press. 1993.
Guide to Techniques in Mouse Development. Edited by Paul M. Wasserman, and Melvin 
L. DePamphilis. 1993. Academic Press.INC.
Laboratory Protocols for Conditional Gene Targeting. Raul M. Torres and Ralf Kuhn. 
Oxford University Press. 1997.
The Leucocyte Antigen Facts Book. A. Neil Barclay. Academic Press. Second Edition
1997.
Appendix D
Abbreviations
bp base pair
BGG Bovine Gamma Globulin
BSA Bovine Serum Albumin
ddHjO double distilled water
DMEM Dulbecco’s Modified Eagle’s Media
DMSO DiMethyl SulfOxide
DNP 2,4-DiNitrophenyl
cDNA complementary DNA
CD Cluster of Differentiation
206
Appendices
CGG
EDTA
ES cells
FACS
FCS
FITC
G418
lU
kb
KLH .
LIF
LMPl
mAb
MHC
NEO
NIP
OVA
PBS
PE
PCR
PNPP
RNase
RT
RT-PCR
s.e.m.
SDS
TBS
TK
TM
Chicken gamma globulin 
EthyleneDiamine Tetra-Acetic acid 
Embryonic Stem cells 
Fluorescence Activated Cell Sorting 
Fetal Calf Serum 
Fluorescein IsoThioCyanate 
geneticin“", Gibco 
International Units 
kilobase
Keyhole Limpet Hemocyanin 
Leukaemia Inhibitory Factor 
Latent infection Membrane Protein 1 
monoclonal Antibody 
Major Histocompatibility Complex 
Neomycin (G418 resistance gene) 
4-hydroxy-3-iodo-5-nitrophenyl 
Ovalbumin
Phosphate-Buffered Saline 
PhycoErythrin 
Polymerase Chain Reaction 
P-Nitrophenyl PhosPhate. 
Ribonuclease 
Room Temperature 
Reverse Transcriptase PCR 
standard error of the mean 
Sodium Dodecyl Sulphate 
Tris Buffered Saline 
Thymidine Kinase 
Melting Temperature
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TNF Tumor Necrosis Factor
TNFR Tumor Necrosis Factor Receptor
TRAF TNFR-Associated Factor
UV Ultraviolet
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